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Abstract/ Summary  
Ryanodine receptors (RyRs) are calcium channels located on the endo(sarco)plasmic 
reticulum of muscle cells and neurons.  They are the largest ion channels known 
made up of four monomers, each 565kDa in size. Mammals have 3 different RyR 
isoforms, encoded by different genes, while insects express only one isoform of the 
receptor, which is only 46% similar (at the amino acid level) to its mammalian 
counterpart(s). RyRs function to regulate the release of luminal Ca2+ stores into the 
cell cytoplasm and play a key role in muscle excitation-contraction coupling (ECC). 
The plant alkaloid ryanodine, from which the receptor derives its name, has been 
investigated extensively as a potential pest control agent, but to date no commercial 
products have been identified. Recently two synthetic insecticides selectively 
targeting pest RyRs were introduced to the market. These compounds belong to the 
novel group of insecticides called diamides.  
In this study two insect ryanodine receptors were isolated sequenced and cloned into 
suitable expression vectors from economically important pests M. persicae and P. 
xylostella to identify protein site of interaction for the novel compounds. Both 
proteins were expressed in HEK 293 cells and Sf9 cells and analysed for evidence of 
function using ryanodine binding assays and calcium release imaging. In the case of 
M. persicae RyR the expression level was not sufficient to obtain any functional 
data. However the expression of P. xylostella RyR showed evidence of function in 
both HEK and Sf9 cells.  
Functional studies showed that expressed P. xylostella RyR can bind [3H] ryanodine 
and respond to various caffeine concentrations; the protein was also sensitive to both 
diamide compounds.  DNA sequencing of RyR from field evolved diamide resistant 
strains of P. xylostella identified a mutation causing amino acid change G4946E. 
Functional analysis of modified RyR construct in Sf9 cells showed significantly 
reduced sensitivity to to both diamide compounds while retaining caffeine and 
ryanodine sensitivity comparable to the expressed WT form. 
.  
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Chapter I 
1.1 Global pest control and food security  
There are many challenges facing modern agriculture today, for example, an 
estimated increase in the global population to 9 billion by 2050, climate change and 
limited arable land and water supplies. Historically, the major problem for 
agriculture was insufficient yields leading to food shortages. However, a series of 
research initiatives and technology transfer programmes in the second half of 20th 
century, commonly referred to as the Green Revolution, not only introduced new 
practices in how food is produced but also shifted the perception of agriculture as a 
subsidiary sector to a highly commercial one. In developed countries this resulted in 
a steady surplus in food production and removed the threat of food shortages. It was 
also one of the contributing factors which led to the sustained increase of the human 
population since the 1960’s to over 7 billion today [1, 2]. However, according to the 
FAO (Food and Agriculture Organisation), the continued sharp increase in 
population growth and dietary changes in emerging economies (high meat and milk 
demand) will require a further 70% increase in overall food production by 2050. This 
means that we will need to  increase cereal production by one third from today’s 2.1 
billion tonnes to 3 billion tonnes worldwide [3]. Additionally, the expansion of 
biofuels as an alternative energy source and the decrease in quality of arable land due 
to climate change and pollution are problems which will need addressing [2]. It is 
believed that we are at the dawn of a second Green Revolution, which will increase 
the productivity and sustainability of agriculture not only by improving crop yield 
but also by decreasing losses and minimizing adverse environmental impacts, 
resolving the issue of world hunger and closing the income gap between urban and  
rural areas [4]. It is hoped that these ambitious goals are going to be achieved by 
optimising the management and use of current technologies, and by the introduction 
of new technologies through continuous research and development driven by private 
sector and government programmes [4].  
Effective pest control is one of the interventions currently employed to minimize 
crop losses and increase agricultural output.  Since the Green Revolution there has 
been a big increase in the use of synthetic pesticides to control insects, weeds and 
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fungi and this, together with improved agricultural practices and crop varieties,  has 
resulted in  more than a doubling in crop production in the last 50 years [4]. Despite 
the increased use of crop protection methods, yield losses to pests remains one of the 
main challenges for agriculture. The exact percentage of yield loss is dependent on 
the region and the type of crop planted, with the average potential loss being  35% 
[5]. It was estimated that in 2007 the global pesticide market was worth $29 billion 
US dollars with insecticides making up approximately 28% of this total. It was also 
noted that the demand for biologically active chemicals was likely to rise [6]. A 
recent market forecasting report by BCC research 
(http://www.bccresearch.com/report/download/report/chm029d) estimates that the 
global pesticide market was worth $37.5 billion in 2011 and $46.1 billion in 2012, 
with the total market value expected to reach $65.3 billion in 2017 [7]. One of the 
main drawbacks of increased chemical pesticide usage is the associated risks for 
adverse environmental impacts. Unintended environmental consequences can often 
not be predicted or foreseen, as in the case of early synthetic insecticides such as 
DDT [8]. The second problem for pesticide sustainability is the development of 
resistance in target pests due to a high selection pressure imposed by frequent (and in 
many cases misapplied) spraying. For insecticides, it is estimated that around 600 
insect and mite species are resistant to at least one class of currently used 
commercial compound [9]. Thus there is a need for the development of novel 
methods of pest control and for the discovery of new and safer insecticidal 
chemistries with improved efficacy and toxicological profiles. In the meantime, an 
understanding of insecticide resistance mechanisms and of the mode of action of 
approved pesticides can often lead into development of useful diagnostic tools for 
monitoring resistance in the field and thereby provide opportunities to enhance and 
sustain pest management strategies globally, by giving updated advice to farmers and 
growers on which chemicals they should deploy to best effect. 
 
1.2 Insect control and synthetic insecticides 
The two major strategies currently deployed to control insect pest populations are 
biological control agents and synthetic insecticides. Biological control includes the 
use of the insects own natural enemies to reduce population size and / or the 
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introduction of pathogens to kill the insect [10]. One of the most successful 
biological agents used to control some lepidopteran species is a gram positive 
bacteria, Bacillus thuringiensis. This  produces cry toxins which are the main source 
of its insecticidal activity and can be used as a supplement or alternative treatment to 
synthetic insecticides [11]. Over the past ten years, genes for the production of cry 
toxin have been successfully engineered into crops such as tobacco, cotton or maize 
for better protection against insect pests, reducing the need for insecticide treatment 
[12, 13]. Despite some notable successes achieved by utilizing biological agents, by 
far the most widely used control measures at present still involve deployment of 
synthetic compounds. The discovery of the insecticidal properties of DDT in the 
early 1940’s [14, 15] subsequently led to the large scale use of chemical insecticides 
to control pests in agriculture. Today, most commercially available insecticides on 
the market act on one of 5 main targets: chitin synthesis, mitochondrial respiration, 
the voltage-gated sodium channel, the nicotinic acetylcholine receptor and the γ 
aminobutyric acid (GABA) receptor. Of these, only 4 classes of insecticides 
targeting the latter 3 sites have managed to achieve major commercial success. The 
current bestselling insecticides belong to the neonicotinoid, pyrethroid and 
organophosphate classes of chemistry (Figure 1). All 3 groups exploit different 
targets on  the insect nervous system [16]. 
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Figure 1 Global sales of insecticides showing market share for different chemical classes 
[16] (Original Source: Agranova, Orpington, Kent, United Kingdom, 
http://www.agranova.co.uk/awa10.asp ). 
 
1.2.1 Diamide insecticides  
Diamides are a relatively new class of synthetic insecticides which cause an 
uncontrolled calcium release within insect muscle cells and disrupt the insect’s 
intracellular calcium homeostasis through selectively targeting and activating 
ryanodine receptors (RyRs), giving symptoms of poisoning including feeding 
cessation, muscle paralysis and death [17, 18]. The 3 main compounds belonging to 
this class are flubendiamide, chlorantraniliprole and cyantraniliprole (Figure 2).  
Since their recent introduction to the market in 2007, diamides have been a great 
commercial success (Figure 1), with sales of chlorantraniliprole alone reaching $500 
million US dollars in 2011 [19]. Up until the introduction of diamides, there has 
been no successful commercialisation of insecticides targeting the RyR or any other 
aspects of cell calcium signalling and homeostasis [17]. Ryanodine, a plant alkaloid 
extracted from the South American shrub Ryania speciosa, has been used as a 
botanical insecticide for almost 60 years. However, its high toxicity to mammals 
makes it unsuitable for wide-scale use [20] 
(http://www.epa.gov/oppsrrd1/REDs/factsheets/2595fact.pdf) (A more detailed 
description of  the mode of action of ryanodine on the RyR channel is described in 
section 1.7.2). Attempts to create commercial compounds based on ryanodine [21], 
with an improved toxicological profile towards vertebrates, have had only moderate 
success. Ryanodol and 9,21-didehydroryanodol have low vertebrate toxicity, but did 
not become economically important chemicals [22]. 9,21-didehydroryanodol, unlike 
ryanodine, does not cause muscle contraction but rather inhibits contraction through 
the modulation of potassium channels [21]. Another unrelated compound, Verticilide 
(isolated from Verticillium sp), has 10x higher affinity towards cockroach RyR over 
a mouse RyR1 isoform; however the nature of the interaction with RyR is unknown 
[23]. 
The successful commercialisation of flubendiamide  by Nihon Nohyaku and Bayer 
Crop Science in 2007, followed by chlorantraniliprole by DuPont a year later [24], 
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led to the creation of a new mode of action group (Group 28) by the Insecticide 
Resistance Action Committee (IRAC) [22]. 
 Since the introduction of these novel insecticides to the global market a number of 
other diamide derivatives have been developed such as anthranilic isophthaloyl 
amides and anthranilic diamides containing alkyl ether group, some showing high 
insecticidal potency [24-26].  
 
Figure 2 Chemical structures of diamide insecticides: A: Flubediamide (phthalic diamide), 
B: Chlorantraniliprole, C: Cyantraniliprole (anthranilic diamides) 
The exact site of interaction of flubendiamide, chlorantraniliprole and 
cyantraniliprole with the RyR is unknown but it is thought that they compete for the 
same binding site [27]. However, a radio-labelled binding study of flubendiamide 
and chlorantraniliprole on muscle membranes isolated from the house fly, Musca 
domestica, suggested binding to two distinct but allosterically coupled sites [28]. 
Neither insecticide negatively interferes with ryanodine binding, implying a different 
site of interaction for this well-known pharmacological probe [29]. Analysis of 
binding of flubendiamide to Bombyx mori (silk worm) RyR identified a region close 
to the N-terminus (between amino acids 183-290) important for channel sensitivity 
to flubendiamide; however the actual binding site was identified as being somewhere 
within the C-terminal transmembrane region, between amino acids 4111–5084. This 
was  confirmed by construction of a chimeric RyR containing an insect cytosolic 
region and a rabbit transmembrane region, which did not show responses to 
flubendiamide in calcium release assay but could be activated by caffeine [30].  
A. B. 
C. 
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One of the most interesting features of the diamides is their exceptional activity 
against insects and their very low mammalian toxicity. Studies performed on cell 
lines expressing mammalian RyR isoforms showed a lack of, or very limited, 
response even to high doses of diamides [17, 29, 31]. Both classes of diamides 
(phthalic acid and anthranilic diamides) also exhibit very good eco-toxicological 
profiles, posing only small risks to beneficial insects such as parasitic wasps, 
ladybirds, predatory mites and pollinators at field application rates [32, 33]. Up to 
date  individual case studies looking into impact of chlorantraniliprole on non-target 
organisms showed little or no effect [34]. However more in-depth studies are needed 
of the sublethal effects, of these new insecticides, on the non-target organisms 
including economically important beneficial insects such as pollinators (bees and 
bumblebees). Side effects of insecticidal sprays became important due to recent 
research results into the detrimental sublethal effects of neonicotinoid class of 
insectcides and their potential involvement in colony collapse disordrer in honey bee 
Aphis mellifera [35]. Since the introduction of these novel compounds to the 
worldwide market, a number of field studies analysing the efficacy of diamides have 
been reported [36]. Also baseline susceptibilities in some target pest species, 
including Plutella xylostella (diamondback moth) [37], Tuta absoluta (tomato 
leafminer) [38] and Spodoptera litura (lis) (cotton leafworm) [39] have been 
established. Despite the great success of diamides, their use now appears 
compromised in some situations where there have been reports of resistant insect 
populations. In China, 20 populations of P. xylostella were reported to show 
decreased sensitivity to diamides and 6 populations showed a level of resistance as 
high as 2000-fold when compared to a susceptible laboratory strain [40]. The first 
published report of a strain of P. xylostella with a target-site mutation associated 
with a high level of diamide resistance is detailed in chapter V. 
1.2.1.1 Flubendiamide 
The initial lead to the discovery of flubendiamide (a benzenedicarboxyamide or a 
phthalic acid diamide) came from the pyrazinedicarboxamide herbicide program of a 
Japanese company, Nihon Nohyaku [18]. The compound was then co-developed by 
them and Bayer CropScience, after it displayed excellent potency towards a broad 
range of lepidopteran species. Initial studies of the symptoms of poisoning disclosed 
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gradual contraction of the lepidopteran insect body without convulsions, suggesting 
a novel mode of action manifested outside of the central nervous system and similar 
to symptoms observed for ryanodine [41]. Flubendiamide also demonstrated good 
control of lepidopteran populations already resistant to existing classes of 
insecticides, with bioassays  on P. xylostella larvae resistant to pyrethroids, 
organophosphates, carbamates and benzoylphenylurea (chitin synthesis modulator) 
giving a level of control equal to the susceptible strain, with no cross resistance 
apparent. The novel compound also exhibited very low mammalian toxicity, with an 
acute LD50 in rats of  >2000 mg/kg and a consistent lack of mutagenic properties 
[41]. More detailed investigation of the mode of action of flubendiamide, by analysis 
of its effects on isolated gut muscles from the tobacco budworm Helitothis virescens, 
showed no muscle contraction in response to stimuli, whilst maintaining nervous 
system activity. The molecular target was identified to be the RyR through 
fluorescent calcium release assays done on (i) single H. virescens neurons [29, 31] 
and (ii) CHO cells (Chinese Hamster Ovary) expressing Drosophila melanogaster 
RyR [29, 31]. Additionally, flubendiamide was shown to have a stimulating effect on 
Ca2+ pump activity, revealing a close relationship between luminal calcium 
concentration and activation of calcium pumps, and the negative effect of insecticide 
binding on cellular Ca2+ homeostasis [42]. The high specificity of flubendiamide 
towards insect channels was also confirmed by calcium release assays on different 
mammalian cell lines naturally expressing various isoforms of the receptor [31]. 
There are no reported flubendiamide effects on plants in literature found up to date. 
However since higher plants do not have direct homologues of RyRs [43]; it is 
unlikely any obvious negative effects could be predicted. Thus, flubendiamide 
became first the commercial synthetic insecticide with a novel mode of action 
targeting RyRs, and it entered the market in 2007 [16, 24]. 
1.2.1.2 Chlorantraniliprole and Cyantraniliprole 
Chlorantraniliprole (an anthranilicdiamide), developed by DuPont Crop Protection,  
shows broader insecticidal activity in comparison to flubendiamide, giving good 
control  not only of  Lepidoptera but also Coleoptera (beetles), Diptera (flies) and  
Isoptera (termites) species [18]. Like flubendiamide, chlorantraniliprole has an 
excellent toxicological profile, with an LD50 value of acute oral toxicity of 
Chapter I 
8 
 
>5000mg/kg of body weight for vertebrates, and has a high efficacy on insects 
resistant to other classes of insecticides [18]. In cellular assays it was not active 
against mammalian RyR1 and RyR2 isoforms and showed up to 2000-fold decreased 
potency towards RyR2 in comparison to insect channels [18]. Apart from the high 
potency of chlorantraniliprole towards larval stages of many important lepidopteran 
pests it also exhibits mating disruption at sub-lethal doses, as demonstrated in the 
codling moth Cydiapomonella L. Male insects exposed to the insecticide’s residues 
exhibited significantly reduced activity leading to smaller number of successfully 
mated females [44]. Identification of the molecular target of chlorantraniliprole was 
described in detail by Cordova et al [17]. The dorsal vessel (heart) and skeletal 
muscles from Manduca sexta (tobacco hornworm) showed an adverse contractility 
effect on exposure to diamides. Plasma membrane calcium channels were ruled out 
as a potential diamide target by analysis of the change in intracellular Ca2+ 
concentrations in Periplaneta americana (American cockroach) neuron preparations 
in calcium-free conditions during exposure to anthranilamides. The RyR was 
identified as the actual target by calcium release imaging done on Sf9 cells 
expressing D. melanogaster RyR and by radiolabeled ryanodine and diamide binding 
studies on P. americana leg muscle membrane preparations [17, 45]. 
Cyantraniliprole belongs to the same family of compounds as chlorantraniliprole but 
its insecticidal activity is much broader, affecting both chewing and sucking pests 
from  the Orders Coleoptera, Lepidoptera and Hemiptera [46]. Its modified structure 
improves its mobility through the plant xylem, so it can be applied as a systemic 
insecticide [24, 47]. Both chlorantraniliprole and cyantraniliprole bind to a site on 
the RyR distinct from the binding site for ryanodine and their presence increases the 
likelihood of ryanodine binding [28]. 
1.3 Vertebrate ryanodine receptors – genes, proteins, distribution, function and 
role in calcium homeostasis 
1.3.1 Overview of Ca2+ homeostasis in cells 
Maintenance of low levels of free Ca2+ in the cell cytosol is crucial in maintaining 
normal cell function (Figure 3). In mammalian cells at normal resting state the free 
cytosolic Ca2+ concentration is approximately 100 nM and cells use a lot of energy, 
and a number of specialized proteins, to maintain this [48, 49]. There are precise and 
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diverse mechanisms enabling Ca2+ to enter the cytosol, involving chemical signals or 
changes in the membrane potential. The two main sources of entry for free Ca2+ into 
cells are via the extracellular space and from internal stores [49].  
Differences in Ca2+ concentration across the cell membrane creates an 
electrochemical gradient which is exploited by various types of calcium channels 
located on the plasma membrane. The best characterised channels are voltage 
operated channels (VOCs) such as L-type channels (described in more detail in 
section1.4.2) and receptor operated channels (ROCs), which respond to various 
external signals. There are also other less well characterised entry mechanisms such 
as via store operated channels (SOCs) [50].  When the Ca2+ channels open there is a 
rise in cytosolic Ca2+ concentration, which triggers various physiological responses. 
Upon entry into the cytosol the  Ca2+ binds to a wide array of calcium binding 
proteins, for example in humans there are approximately 200 genes encoding such 
proteins which act as Ca2+ buffers and effectors [51].  
Release of Ca2+ from internal stores in the ER/SR is regulated mainly by two channel 
proteins, inositol -1,4,5 triphosphate receptors (IP3Rs) and RyRs. IP3Rs rely on the 
secondary messenger molecule inositol 1,4,5 triphosphate (IP3) for activation [48, 
52] and  play numerous roles in cells during development. RyRs are closely related 
to IP3Rs, however their regulation and function differs substantially [53, 54]. The 
IP3Rs, like RyRs, are homomeric tetramers, however they are smaller than RyRs, 
with approximately 2700 amino acids per sub-unit [55]. There is a high degree of 
conservation between IP3Rs and RyR transmembrane regions, with over 30% amino 
acid identity [56]. RyRs are also essential for normal body development and function 
[57] (described in more detail in section 1.3.3). 
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Figure 3 Diagrammatic representation of the main components involved in free Ca2+entry 
into, and removal from, the cell cytosol. NCX –sodium calcium exchanger, VOCs- voltage 
gated channels. PMCA – plasma membrane calcium pump, ER/SR-endoplasmic / 
sarcoplasmic reticulum, cADPr - cyclic adenosine diphosphate ribose. 
The removal of Ca2+ from cells is facilitated by a number of pumps and exchangers 
and is a crucial step to maintain the low resting Ca2+ concentration required for 
activation of different cellular processes like exocytosis, contraction, transcription, 
metabolism, and proliferation. There are four mechanisms which facilitate this,  the  
Na+/Ca2+ exchanger (NCX), the plasma membrane Ca+2 ATPase pump (PMCA), 
Ca2+ ATPase located on the sarco(endo)plasmic reticulum (SERCA) and the 
mitochondrial uniporter [49]. The high concentration of Ca2+ inside the ER/SR 
lumen is maintained by SERCA and Ca2+ sequestering proteins located inside the ER 
such as calsequestrin (CSQ) [58].  
Because free Ca2+ is an important secondary messenger, micro and macro changes of 
local, or global, concentrations, as well as the spatial distribution of Ca2+ triggers 
different physiological responses which are essential for a number of cellular 
functions, such as the activation of ion channels, neurotransmitter release, neuronal 
degeneration, gene transcription, cell apoptosis and cell proliferation [22, 48, 58]. All 
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of these functions exhibit different response dynamics ranging from less than a 
millisecond (in the case of exocytosis) to hours (transcription or proliferation). The 
kinetics of ion transport for proteins involved in the Ca2+ mediated processes are 
tailored to the required rates, and the  level of expression of individual protein 
components is important as well as the types of isoforms present. For example 
various types of PMCAs respond differently to a sudden increase in Ca2+ [59]. Most 
of our knowledge of Ca2+ homeostasis comes from studies of vertebrates, but some 
aspects of calcium signalling have been studied in insects, predominantly the model 
organism D. melanogaster, which offers a simpler system with a wide range of 
genetic and molecular tools for manipulation of different components of calcium 
signalling. Unlike mammals, D. melanogaster tends to have only one homologue for 
each of the major calcium signalling components [60]. 
1.3.2 Overview of RyR isoforms  
There are 3 RyR isoforms in mammals, with tissue specific distributions. RyR1 
(skeletal) is highly expressed in striated skeletal muscle cells in the gap between the 
transverse tubule of the sarcolemma and the sarcoplasmic reticulum (SR) [61], RyR2 
(cardiac) is found in cardiac muscle cells and  RyR3 (brain) is present at relatively 
low levels (no more than 5% of the total number of RyRs in the cell) in striated 
muscles as well as neurons and other tissues [58]. The receptors were first identified 
on electron micrographs of frog twitch fibres  as ‘foot’ structures located in the triads 
between the T-tubules and the SR [62]. Since their discovery, they have been 
isolated and purified from muscle membrane fractions and their Ca2+ release channel 
properties verified experimentally [63, 64]. Advance in molecular biology has 
allowed the cloning and expression of genes encoding RyRs [65] and an overview of 
methods and published records of the first successful attempts to clone various RyR 
genes is described in chapter III section 3.1. Non-mammalian vertebrates have only 
two isoforms known as α-RyR and β–RyR whose functions can be compared to 
RyR1 and RyR3 respectively and are expressed in equal amounts in muscle cells [66, 
67]. 
In humans the 3 RyR genes are present on different chromosomes, RyR1 on 19q13.2, 
RyR2 on 1q43 and RyR3 on 15q13.3-14. All 3 are complex genes with over 100 
exons (104-RyR1, 102-RyR2, 103-RyR3) encoding the full-length cDNA of 
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approximately 15Kb [68]. The three mammalian RyRs share approximately 65% 
amino acid identity. It is well established that RyR1 and RyR2  are essential for 
normal body function and development, with knockout mice lacking the gene 
encoding either of the receptors either dying in embryonic development (in the case 
of RyR2) due to heart abnormalities [69] or immediately after birth (RyR1), due to 
muscle defects [61, 70]. Interestingly RyR3 does not seem to be critical for normal 
body function, since knockout mice do not exhibit developmental abnormalities and 
are able to reproduce normally [54]. All the RyRs are also expressed in non-muscle 
related body tissues such as the liver or nerve cells [58] and the different isoforms of 
RyR have different properties depending on which tissue they are expressed in. In 
addition splice variation can occur within isoforms, and these also show tissue 
specific expression [52]. All this leads to receptor diversity and variability in the 
response of different cells to the same factors, which may cause variable results in 
studies of RyRs.  
1.3.3 Excitation contraction coupling (ECC) 
Excitation contraction coupling is the process linking the electrical stimulation of 
skeletal and cardiac muscle to muscle contraction. The mechanisms of ECC vary 
between skeletal and cardiac muscle but both involve the release of free Ca2+ into the 
cytosol from SR stores via RyRs. Free Ca2+ is directly responsible for the activation 
of the myo-filaments that cause contraction [65, 71].  
In skeletal muscle cells, ECC occurs by a "mechanical coupling" mechanism 
involving protein-protein interaction between RyR1 and L-type Ca2+ channels (also 
called dihydropyridine receptors DHPRs) located on transverse (T-) tubules of the 
plasma membranes. Action potential leads to activation of voltage sensing DHPRs 
[72] and direct interaction of DHPR α-subunit intracellular loops II and III with the 
cytosolic domain of RyR1 during successful depolarisation triggers a release of 
luminal Ca2+ by RyR1. This increases the speed of receptor response to exogenous 
stimuli leading to faster muscle contraction [58]. In the case of RyR2 a significant 
Ca2+ elevation in the cytosol, is required for its activation [52]. There is substantial 
experimental evidence that apart  from free Ca2+ cyclic adenosine diphosphate 
(ADP)-ribose is also an endogenous RyR activator, regulating sensitivity threshold 
for CICR, a phenomenon fist described in sea urchin eggs [49, 73]. 
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 In cardiac muscle cells there is no association of L-type Ca2+ channels and RyRs 
and activation occurs via calcium induced calcium release (CICR). Small amounts of 
Ca2+ enter the cell through DHPRs, bind to the nearest RyR2 channel and result in 
activation. Two to four calcium ions are enough to trigger a full RyR2 response and 
neighbouring channels are activated either by elevated local Ca2+ concentrations or 
by a coupling/gating within the RyR2 array (see more section 1.3.5.4) [71].  
There is still no consensus regarding the termination of Ca2+ release during ECC. 
Various mechanisms have been proposed but none have been proven experimentally 
to be correct. The shutting down of Ca2+ release is imperative for muscle relaxation 
and in the case of the heart, the diastole phase [65] 
1.3.4 Role of RyRs in disease 
To date the majority of research on RyRs has focused on mammalian isoforms, 
particularly RyR1 and RyR2, due to their involvement in human disease and the 
search for potential therapeutic agents. Mutations and small in-frame deletions in 
genes encoding these RyRs are associated with an array of clinically distinct 
diseases. It has been shown that these are clustered in 3 major hot spots on both 
RyRs: the N-terminus, the central domain and the C-terminus [74]. Although RyRs 
are also expressed in neurons and smooth muscles, in these they control Ca2+ release 
in tandem with IP3Rs, and their dysfunction does not appear to lead to adverse 
effects [75]. 
1.3.4.1 RyR1 
In humans, point mutations in the RyR1 gene can cause severe myopathies such as 
malignant hypothermia (MH), central core disease (CCD), multi-minicore disease 
(MmD), core-rod myopathy (CRM) and centronuclear myopathy (CNM) [70]. The 
most widespread and best characterized are MH and CCD. MH is a disorder 
triggered by volatile anaesthetics, resulting in sustained and uncontrolled Ca2+ 
release from SR, which leads to elevated muscle metabolism causing lactate 
accumulation and heat production [76]. CCD, a rare disorder resulting in a various 
degree of muscle weakness during infancy which may persist through adolescence, is 
recognised by altered morphology of muscle fibres containing “core” lesions, which 
can vary in intensity and localization [77]. A considerable number of mutations, over 
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160 for MH and over a 100 for CCD, have been identified and linked to the clinical 
onset of the disorders, and some are linked with the onset of both MH and CCD. It 
has been hypothesized that mutations in genes encoding RyR accessory proteins, 
such as calsequestrin, can also lead to a disease phenotype [78]. There are no clear 
molecular mechanisms which explain the effects of mutations on RyR1 function in 
MH, or with the abnormalities in muscle structure seen in CCD [75]. Recently, a 
number of these mutations have been mapped in silico onto known RyR1 alternative 
splicing sites, domains involved in channel gating regulation, accessory protein 
binding sites and regions involved in inter-domain interactions, helping to link 
disease phenotype with particular RyR regulation mechanisms [79]. Also, knock-in 
mouse models with mutations inducing both the MH and CCD disorders have been 
developed and analysed. Various hypotheses regarding the underlying causes of 
these diseases have emerged from these studies, including oxidative stress due to 
RyR1 Ca2+ leak [80] and ‘mechanical’ stress from abnormal Ca2+ release created by 
formation of wild type/mutant heterotetrameric RyRs [81]. 
1.3.4.2 RyR2 
Mutations in genes encoding RyR2 cardiac channels lead to exercise- and emotional 
stress- induced Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) 
[82]. CPVT causes arrhythmias, which if not treated promptly lead to sudden cardiac 
death (SCD); the mutations responsible are mainly autosomal and recessive [83]. 
The main mechanism underlying CPVT is the increased likelihood of delayed after-
depolarisations (DADs). During heart relaxation (diastole) DADs can be initiated by 
a Ca2+ leak from the SR through RyRs. If sufficient Ca2+ is released into the cytosol 
after repolarization, but before the next action potential, it causes the sodium calcium 
exchanger  NCX  to operate in reverse leading to depolarization, which can spread to 
neighbouring cells and results in an unsynchronised beat [65].  
Heart failure is also caused by dysfunctional RyR2, however the mechanism of Ca2+ 
leak differs from CPVT and it is proposed to be associated with altered Ca2+ 
sensitivity and hyperphosphorylation of the RyR2 [65]. There have been over 150 
mutations identified to date in RyR2 associated with CPVT 
(http://www.fsm.it/cardmoc/).  As in the case of the skeletal RyR channelopathies 
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there is no consensus on the exact molecular mechanism that leads to the clinical 
manifestations and several hypotheses are proposed [75].  
1.3.5 RyR protein structure and function 
For the purpose of clarity, the remaining part of Sections 1.3 and 1.4 relate to 
functional aspects of RyRs and are described collectively for all mammalian 
isoforms. The available information on invertebrate RyRs is discussed separately in 
section 1.5. 
RyRs form homotetramic channels, with each individual monomer having a 
molecular mass of approximately 560kDa (depending on the isoform and species), 
making them the largest ion channels known to date, with approximately 5000 amino 
acids per subunit. In comparison its close relative IP3R has only approx. 2600 amino 
acids per suunit and an entire sodium channel consists of approx. 2000 amino acids 
[84].  
Due to the large size and the intrinsic association with membranes, the crystal 
structure of an entire receptor has not been resolved. However, there are single 
particle electron microscopy (EM) density maps at 14Å resolution of an entire RyR1 
channel available [85], which were based on results from previous lower 20-30Å 
resolution  studies [86]. Also, a cryo-EM study of the closed state of the RyR1 pore 
forming domain at 10Å resolution identified some of the secondary structures, 
although it did not allow the assigning of individual amino acid side chains [87]. 
Although RyR1 remains the most extensively analysed isoform, there are also 
electron density maps for RyR2 and RyR3 isoforms [88]. Despite potential structural 
differences resulting from the 65% amino acid identity between all 3 isoforms, low 
resolution (23-30Å) EM density maps of all 3 mammalian RyRs look virtually 
identical [89]. A number of small crystal structures of individual domains were 
solved which were recently summarized in the attempt to map a 3D model ryanodine 
receptor macromolecular complex [90]. A more recent  crystal structure became 
available for larger cytosolic domain of of RyR which is associated with 
diseasecausing mutations [91].  
1.3.5.1 Cytosolic domain  
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It is established that the cytosolic part of RyRs is responsible for the regulation of 
calcium release; however the precise mechanisms involved in linking cytosolic 
regulatory sites with modulation of channel gating are yet to be fully determined. 
Mutations associated with MH in RyR1, especially in the N-terminal and central part 
of the protein, lead to “unzipping” of the channel and leaky openings, suggesting that 
these two regions come together in the 3D structure and may regulate channel gating 
[92]. The cytosolic part of RyRs does not form a rigid structure; instead it has groups 
of individually folded domains, separated by solvent-filled cavities. In the receptor, 
the cytosolic parts of four RyR subunits co-assemble to create a central cavity 
leading to the channel pore [93]. Although RyRs do not bind IP3, there are structural 
similarities between the N-terminal part of RyR and the IP3 binding and the 
suppressor domains in IP3Rs, suggesting a conserved regulatory mechanism [94]. It 
has been demonstrated that co-expression of the transmembrane region of the RyR2 
protein with a series of separate regulatory cytoplasmic parts restored some of the 
channel’s regulatory ability [95]. The cytosolic part acts as scaffold for a number of 
regulatory proteins and it contains many binding sites for small molecular weight 
modulators, described in more detail in sections 1.4.1 and 1.4.2 
1.3.5.2 The transmembrane domain 
RyRs are internal membrane-embedded proteins with a majority of their mass 
(approximately 4/5ths) found in the cytosol, with the transmembrane (TM) domain 
accounting for the last 1/5th of the full-length protein [65]. The cytosolic region 
functions as a regulatory domain with multiple binding sites for various ligands, 
whilst the TM region incorporates the channel pore (see more detail in the following 
section) [96]. The TM region of skeletal RyR can be expressed autonomously and 
forms a functional Ca2+ channel sensitive to ryanodine and activation by Ca2+; 
however the regulation of the truncated protein is impaired, for example the channel 
does not close at high Ca2+ concentrations [97]. The functioning and regulation of 
the TM region of cardiac RyR2 has also been studied by  expressing two truncated 
proteins  [95]. 
The lack of a solved crystal structure for RyR means that the exact number of TM 
helixes has not been confirmed and the precise topology is still disputed. It has been 
shown that RyRs have an even number of TM helixes, since both the N- and C-
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termini lie in the cytosolic domain [53, 98]. Different topology models have been 
proposed with a varying number of TM helixes (Figure 4). Early studies suggested 
that a RyR  subunit  had 4 TM helices [99]. Subsequently up to 12 TM helices were 
proposed [100]. A more complicated model with one of the predicted helixes 
forming a loop and the total number of TM helixes being 6-8 was also suggested 
[98]. The most recent cryo-electron microscopy study of a single receptor identified 
only 5 TM helices and suggested that the additional helices predicted in previous 
studies are closely associated with the membrane but not integrated within it [53, 
87]. It is currently accepted that 6 TM helices are most likely present, making the 
RyR comparable to IP3R. Such a 6 TM model was also hypothesised with the first 
isolation of a cDNA encoding human RyR2 [101]. The TM helices of 4 monomers 
arranged within a functional tetrameric unit create a central ion-conducting pore 
through which ions are transported from the SR lumen to the cytosol [99].  
The extreme end of the C-terminus of the TM region is important in the formation of 
fully functional tetrameric channels and expression of the last 100 amino acids of 
RyR2 shows  an ability to create tetramers [102]. Furthermore,  deletion of the last 
15 amino acids of RyR1 abolishes the ability to form stable channels in lipid 
bilayers, most probably due to lack of tetramerization [103].   
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Figure 4 Progress of TM helix prediction in mammalian RyR from (1) the four 
transmembrane helices in Takeshima et al. 1989 [99] (2) much less stringent TM helix 
assignment in Zorzato et al [100] (3) the most complex model in Du et al. [98] (4) High-
resolution electron microscopic images of single channels identified 5 main TM helices in 
the channel [87, 96]. TM1 is inconsistently predicted in various models. 
1.3.5.3 The pore forming domain 
Most experiments to understand RyR structure-function relationships have been 
done on RyR1, due to its high expression levels in skeletal muscles and relative ease 
of purification [104]. The first characterization of purified rabbit skeletal RyR 
showed that the channel is selective toward divalent cations [105]. More detailed 
studies of RyR2 indicated that the channel was permeable to a wide range of both 
monovalent and divalent cations, with an approx. 6.5-fold greater preference for 
divalent [106]. Although direct comparison of different isoforms is difficult, it is 
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considered that the pore forming regions are largely the same and that they all 
exhibit a remarkably high rate of ion translocation, approximating to 1ns for 
monovalent cations [104]. The pore forming region forms an autonomous part of the 
protein; in the case of RyR1 it was possible to successfully expresses the pore 
peptide on its own (amino acids 4829-5037) to generate a functional tetrameric 
cation channel, albeit lacking regulatory elements [107].  
The pore forming domain of RyRs is believed to be made up of the last 3 helixes of 
the TM region of each monomer. In the TM model of Du et al [100], helices 8 and 
10 correspond to the inner and outer pore lining helices, whilst helix 9 forms a P-
loop with a selectivity filter sequence GGGIGD. The selectivity filter was first 
identified in RyR1 through investigation of an I4898T substitution linked with CCD. 
The amino acid region surrounding this substitution has distinct similarities to the 
selectivity filter of  bacterial potassium channels such as KcsA [108]. The 3D 
structure of KcsA has been solved (PDB accession 1BL8), enabling direct 
comparison with RyRs and allowing a pore homology model for RyR to be produced 
[109]. Although the overall structures of the RyR and the K+ channel pore are 
somewhat comparable, the ion selectivity mechanisms seem to work in different 
ways. The selectivity filter of the K+ channel is able to distinguish between similar 
ions like Na+ and K+, whilst RyR is permeable to various cations. However, such 
comparative modelling needs to take account of other studies, based on single 
particle cryo-EM imaging, that suggest that the RyR pore is more similar to another 
bacterial potassium channel MthK (pdb 1LNQ) [87]. The mechanisms of pore 
opening and closing are not fully understood. In a recent study, a series of mutations 
were introduced to pinpoint critical amino acids responsible for the channel gating 
without altering ion permeation [110]. 
The importance of other amino acids in the P-loop and neighbouring helices for ion 
conductance has been studied extensively in RyR1 and RyR2, using site directed 
mutagenesis. The terminal aspartic acid (D) in the selectivity filter plays a crucial 
role in ion selectivity [111]. As in potassium channels, the luminally-orientated part 
of the RyR pore is negatively charged; however the net potential is much higher in 
RyRs which may contribute to the very high unitary conductance rate (1nS for RyR 
against 50-250 pS for K+ channel)  [70, 109].  
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1.3.5.4 RyR arrays 
Electron microscopy of skeletal and cardiac mammalian muscle tissue reveal that 
RyR1 and RyR2 form organized 2D arrays; for RyR1 this leads to the formation of 
tetrads of voltage gated L-type Ca2+ channels (DHPRs), through physical interaction 
with RyR1 receptors. The RyR2 isoform is not physically coupled with plasma 
membrane Ca2+ channels, although it forms 2D arrays, whilst RyR3 fails to create 
any arrays at all. An absence of RyR1 in the cell stops the organization of DHPRs 
into tetrads, which implies that RyR1 is an essential component of this structure [58, 
112]. The function of array formation is not fully understood but it has been 
suggested that a specific pattern of organization helps with the regulation and 
coordination of RyR function. It was speculated that monomers of one channel are 
allosterically coupled with neighbouring channels [58, 113, 114]. RyR2 forms 
regular arrays made up of approximately 70-260 individual channels, the number 
depends on the type of organism; species with a faster heart rate have larger arrays, 
as was shown in the case of rat and human cardiac myocytes [65, 115]. 
1.4 Modulation of RyRs 
1.4.1. Ryanodine receptor macro molecular complex components  
RyRs act as a target and a scaffold for a number of regulatory proteins which interact 
with the receptor by either direct binding, anchoring other proteins, or covalent 
modification of the receptor itself (Figure 5). These regulatory proteins can be 
localized to different parts of the cell including the intra-lumenal space 
(Calsequestrin-CSQ), ER or SR membrane (Triadin and Junctin) and cytoplasm 
(Calmodulin, FKBP12, protein kinases and phosphatases). The large number of 
different regulatory proteins creates a very complex picture of RyR regulation and 
studies of individual components often lead to contradictory results.  
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Figure 5 Ryanodine receptor macromolecular complex (adapted from Song et al [90]) 
showing the predicted sites of protein interaction with the closed rabbit RyR1 superstructure 
(seen from the side). PP1/SP- Protein phosphatase 1/Spinophilin; DHPR – dihydropyridine 
receptors, CLIC2 -Chloride intracellular channel 2. D1-D3 represent divergent regions 
associated with RyR channelopathies, red numbering indicate individual domains, described 
in detail in Song et. al. The TA indicates transmembrane domain. For further information on 
proteins not mentioned in the text (PR130, CLIC2, HRC, Homer, SA100A1, mAKAP, 
PP1/SP, Calumenin) see [90]. 
 
1.4.1.1 Protein kinases and phosphorylation of RyR1 and 2 
Phosphorylation of RyRs by different protein kinases has important regulatory 
functions. Phosphorylation by Protein Kinase A (PKA) leads to an increase in 
binding of ryanodine [116],  and increases the probability of the channel being in the 
open state by decreasing the binding affinity of FKBP (in RyR1 and 2) [117, 118]. 
One PKA phosphorylation site (S2809) has been identified in RyR2 and there is a 
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similar site (S2843) in RyR1 [70, 118].  It is proposed that PKA and CaMKII (Ca2+ 
and CaM dependent) kinases are associated with RyRs through specialized 
anchoring proteins such as mAKAP (A-kinase anchoring proteins), SP (spinophilin) 
and PR130 and conserved leucine zippers on the surface of the receptor [52]. 
Activation of PKA is the outcome of a signalling pathway which begins by 
activation of β-adrenergic receptors [70]. The CaMKII kinases can phosphorylate 
both RyR1 and RyR2 at S2843 and S2809 respectively, but there is also a unique site 
on RyR2 at S2814 [93]. Research suggests that a cardiac isoform CaMKIIδ, like 
PKA, is associated with the RyR2 isoform through accessory proteins and conserved 
leucine zipper domains [119, 120]. The effects of CaMKII kinases are not fully 
understood; studies of RyR2 phosphorylation by CaMKIIδ showed that it is a potent 
channel activator,  however unlike PKA it does not abolish binding of calstabins 
(FKBPs) to the receptor [70]. PKA and CaMKII phosphorylation can also protect 
RyR1 channels from Mg2+ inhibition, but also decrease the open state probability of 
the channel [119]. There is considerable controversy regarding mis-regulation of 
phosphorylation and its involvement in the symptoms of heart failure. Transgenic 
mice which overexpress PKA develop cardiomyopathy and arrhythmias [121]. Some 
studies found that the RyR2 is hyper-phosphorylated in the heart failure animal 
models; however some found that it remains unchanged. There is also no clear 
explanation how phosphorylation by PKA and CaMKIIδ actually modifies RyR2 
gating [65]. 
1.4.1.2 Calstabins and calmodulin 
RyRs have binding sites for the calstabins (FKBP12 and FKBP12.6) and binding of 
these proteins to the receptor ensures proper transition of the channel from open to 
closed states. Abolishing FKBP12 binding leads to a prolonged channel sub-
conductance state and Ca2+ leakage [122]. Unlike RyR1 and RyR3, which interact 
with both FKBP12 and FKBP12.6, RyR2 binds selectively to the latter [123] and 
deficiency of FKBP12.6 in heart tissue causes severe cardiac myopathy [119]. 
Cellular toxicity, caused by expression of RyR2 protein, can be rescued by co-
expression of FKBP12.6, further indicating an inhibitory effect of the protein on 
spontaneous Ca2+ release through deregulated RyR2 [124]. It was shown that co-
expression of rabbit RyR1 and FKBP12 in insect Sf9 cells leads to stabilisation of 
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the channel into closed or open states, abolishing the sub-conductance states, whilst 
also decreasing the channels’ sensitivity to caffeine activation. FKBP inhibitors such 
as rapamycin and FK506 lead to dissociation of FKBPs from the RyRs and reversal 
of the FKBP effects on channel gating [125].  
Calmodulin (CaM) is a 17kDa Ca2+ binding protein which regulates a number of 
proteins including RyRs, where one CaM molecule binds to one RyR subunit [126]. 
Calcium-free calmodulin (apoCaM) act as a channel activator whilst calmodulin with 
Ca2+ bound (CaCaM) is an inhibitor. CaM enhances channel activation at low Ca2+ 
(nanomolar) concentrations and increases channel inhibition as levels of cytosolic 
Ca2+ rise (micromolar) [127]. The calmodulin binding domain on the RyR is located 
in the cytosolic region, spanning amino acids 3614–3643 in RyR1 and 3583–3603 in 
RyR2. Mutations in these regions abolish CaM binding [128]. Calmodulin also 
regulates RyR1 indirectly by binding to DHPR, leading to dissociation of the α-
subunit from RyR1 [52]; scorpion toxins also disrupt DHPR-RYR interactions by 
binding to the same site [70]. Calmodulin binding to RyR2 is important for normal 
channel function, as demonstrated in a mouse model with mutations within the CaM 
binding domain where the mice died prematurely due to abnormalities in heart 
function [129]. Increased dissociation of calmodulin was also found to be one of the 
mechanisms responsible for heart failure in dogs [130]. 
1.4.1.3 Triadin, Junctin, Calsequestrin and Sorcin  
Triadin (Tr) and Junctin (Jn) bind to the luminal region of RyRs and are involved in 
anchoring them to Calsequestrins (CSQ), the main Ca2+ binding proteins in the SR 
lumen [131]. CSQs are potent Ca2+ chelators; in skeletal muscle one molecule of 
CSQ-1 is capable of binding 40-50 calcium ions [132]. In vertebrates there are two 
genes encoding CSQs, associated with skeletal (CSQ-1) and cardiac (CSQ-2) 
muscles respectively [133].  Interaction between Tr, Jn and RyR is Ca2+ independent 
[134]. CSQs have regulatory effects on RyR channel function; increasing 
concentration of Ca2+ in the lumen leads to saturation of Ca2+ binding sites on CSQ 
and dissociation of the CSQ protein from the RyR complex, which then leads to an 
induction of free calcium efflux from the SR to the cytosol upon RyR channel 
activation. At low luminal Ca2+ concentrations (<100µM) some CSQ remains bound 
to the Tr/Jn complex, decreasing RyR activity [131, 135]. It is hypothesised that Tr, 
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Jn and CSQ are all vital for RyR channel regulation and the failure of CSQ to 
interact with RyR leads to regulation abnormalities. For example, when exposed to 
isoproterenol a CSQ-2 (cardiac) deficient mouse model displays CPVT-like 
symptoms, with unchanged basal heart function, increased diastolic Ca2+ leak and 
arrhythmogenic beats [136]. Similarly a CSQ-1 (skeletal) null mutant exhibits 
malignant hypothermia symptoms upon exposure to anaesthetics [137]. Interestingly, 
studies of mouse models showed that CSQs are not required for luminal Ca2+ 
sensing, which is contradictory to one of the proposed RyR regulation hypotheses 
[138].  
Another protein involved in RyR2 regulation is Sorcin, which interacts with both 
RyR and L-type Ca2+ channels (DHPRs). The exact site of interaction is unknown, 
but Sorcin seems to have an inhibitory effect on the channel and it only interacts 
with cardiac RyRs when free Ca2+ levels in the cytosol are high. Calcium binding to 
Sorcin induces conformational changes in the protein which may increase its 
interaction with RyR2, leading to channel closure [52, 139]. PKA phosphorylation of 
Sorcin reverses its effect on cardiac RyRs [140]. 
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1.4.2. Low molecular weight modulators 
RyRs are also modulated by a number of low molecular weight compounds (Table 
1). 
Table 1 Summary of low molecular weight pharmacological modulators 
affecting RyRs  
Chemical Effect Comments 
Caffeine and its 
derivatives e.g. 
sulmazole 
Agonist Well known channel activator, 
increasing sensitivity to free Ca2+ [141].  
Ryanodine Modulator of ion 
translocation 
Complex effect depending on 
concentration, encompassing activation 
(at nM levels) to closure (at µM levels) 
[141]. Has insecticidal activity. 
Ruthenium Red Channel blocker Acts in a voltage-dependent manner, 
blocking the pore 
Dantrolene SR calcium release 
inhibitor 
Muscle relaxant used to treat malignant 
hypothermia [142]. 
Heparin SR calcium release 
activator 
Activates the channel, possible by 
causing a local increase in Ca2+ [143]. 
Peptide toxins Channel gating 
modulators 
Different effects depending on the 
toxin, for example, IpTxa inhibits 
DHPR-RyR1 interaction [144]. 
4-Chloro-m-
cresol 
Agonist RyR1 agonist, with evidence of similar 
effects on other isoforms [145]. 
1.4.2.1 Common RyR modulators 
Caffeine, a RyR activator, is found in leaves and seeds of certain plants including 
coffee and tea, and is used as a popular mild stimulant. It induces Ca2+ release by 
increasing sensitivity of the channel toward Ca2+ even at nanomolar concentrations 
[146], and is responsible for increasing channel open probability in a dose-dependent 
manner [141]. Some other compounds like sulmazole and its derivatives, e.g. EMD 
41000 affect RyRs in a similar way, but their potency is much higher [141]. 4-
Chloro-m-cresol (4-CMC) also activates Ca2+ release via RyRs. Detailed effects of 
this ligand have been studied mainly in RyR1, although there is evidence it can 
modulate other isoforms as well [141, 145]. Like caffeine, it increases the frequency 
and duration of the channel open state and ryanodine binding, however its potency is 
approximately 10 times lower, and unlike caffeine it has an ability to modulate the 
channel from both the luminal and cytosolic sides [145]. Adenine triphosphate 
(ATP) is also known to be an activator of RyR1 in the presence of micro-molar Ca2+, 
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as shown in single-channel bilayer experiments [147].  Recently, 3 regions of the 
RyR protein were identified to be involved in ATP binding; the N-terminus, central 
region and C-terminus [148]. In RyR2 it was possible to express the central region 
independently while retaining the ATP binding capabilities [149]. The only currently 
used clinical drug targeting RyR is Dantrolene, which is used to treat patients with 
symptoms of MH.  These include sustained uncontrolled release of Ca2+ triggered by 
certain anaesthetics, leading to rapid increase in body temperature, contracture and 
degeneration of muscles leading to death if untreated. At therapeutic concentrations 
dantrolene inhibits the uncontrolled release of Ca2+ from SR mediated via RyR, and 
relieving the symptoms of the MH episode [150].   Dantrolene appears to 
preferentially bind to RyR1, however its lack of apparent effect on other RyR 
isoforms is inconclusive [141]. It was demonstrated that it can inhibit the activation 
of RyR1 via Ca2+ and CaM [142] and that it has the ability to rescue RyR1 channels 
containing the R615C MH mutation [151]. 
1.4.2.2 Ryanodine and its analogues 
Ryanodine (figure 6) is the best characterised pharmacological probe binding 
specifically to RyRs. The dissociation kinetics of ryanodine binding are slow enough 
for the binding to be considered irreversible in most experimental channel recordings 
[152]. It has complex effects on channel function, either decreasing or increasing 
Ca2+ permeability depending on concentration [141].  At nanomolar concentrations it 
increases channel open probability and causes the continuous leak of Ca2+ from 
ER/SR lumen into the cytosol. At micromolar concentrations it causes the channel to 
close and inhibits the release of calcium [141]. Synthetic ryanodine derivatives 
(which were an attempt to create insecticides based on the natural product - see 
Section 1.2.1)  resulted in the discovery of compounds with altered association and 
much faster dissociation kinetics to RyR channels [153]. 
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Figure 6 Chemical structure of ryanodine  
The binding of ryanodine to RyRs relies on the presence of Ca2+ as it can only bind 
to the open state, and its binding is enhanced by agonists propagating opening of the 
channel such as caffeine [154], whilst binding is inhibited by Mg2+ and Ruthenium 
red [155]. The investigation of ryanodine binding using radio-labelled ligand has 
suggested the presence of both high- and low- affinity sites [156], and experiments 
with photo-affinity probes and proteolysis have located the high-affinity site to the 
transmembrane region of the protein. Modification of cardiac RyR2 by site directed 
mutagenesis around the predicted TM 10 region of the Zorzato model (see Section 
1.3.5.2) abolished ryanodine binding whilst maintaining sensitivity to caffeine. The 
alanine to glutamine substitution at position 4863 did not significantly alter the 
single channel sensitivity to physiological ligands and ion handling properties but 
did change the affinity of ryanodine and the synthetic ryanoids [157, 158]. Despite 
an extensive amount of experimental data the exact sites of the ryanodine binding 
sites remain unknown. 
1.4.2.3 Free Ca2+ ions 
Free Ca2+ ions are primary regulators of RyRs and are responsible for calcium 
induced calcium release (CICR), a phenomenon observed in all isoforms of RyRs, 
with low (µM) Ca2+ concentration stimulating opening of the channel and high 
(≤0.1mM) concentrations shutting down open channels [159]. There is evidence that 
RyRs contain two types of Ca2+ binding site; stimulatory high affinity sites and 
inhibitory low affinity sites [160]. However there is much controversy regarding 
exactly how CICR is regulated [71]. Inhibitory concentrations of free Ca2+ differ for 
various RyRs, being higher for RyR2 and RyR3 (5mM) compared to RyR1 ( 0.6-
1mM) [58]. Some evidence suggests that termination of CICR does not occur via 
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elevated levels of cytosolic free Ca2+ but by decrease of free Ca2+ and Ca2+ 
disassociation from SR luminal facing sites on the receptor and associated proteins 
[70, 161].  
1.5 Invertebrate RyRs 
There is very little information regarding the organisation of invertebrate RyR within 
muscle cells, although one electron microscopy study concluded that the 
organisation within invertebrate dyads is similar to the vertebrate ones [162].  
1.5.1 Gene 
In contrast to the wide range of literature available on vertebrate RyRs, there is 
considerably less information available on the RyR in invertebrates. What is known 
is that all the invertebrates studied to date have only one gene encoding RyR, with 
the translated RyR protein having approximately 45% similarity (at the amino acid 
level) to mammalian homologues [163]. However, the C-terminus region of the 
invertebrate receptor, containing the TM domain and the channel pore, is much more 
conserved, sharing around 70%  amino acid similarity with mammalian RyRs [164]. 
The overall level of sequence conservation is much higher between different insect 
species (see Table 2); thus B. mori and D. melanogaster RyRs show 79% amino acid 
identity [30], with similar values found for the P. xylostella isoforms (78%) [165]. A 
RyR gene has also been identified and cloned from the nematode Caenorhabditis 
elegans [166]; it has approximately 47% identity to the D. melanogaster RyR and 
approximately 40% identity to mammalian isoforms [167].  
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Table 2 Comparison of RyR protein sequences of various insects shown as % 
identity  
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D. melanogaster X 77.8 78.9 75.6 82.4 77.1 79.3 78.9 78.8 
P. xylostella1  x 91.2 77.0 78.5 78.7 92.0 92.1 80.7 
B. mori2   x 77.7 79.6 79.3 93.8 94.6 81.7 
A. pisum2    x 76.9 82.3 78.3 78.3 79.7 
A. gambiae     x 77.9 80.2 80.0 79.4 
B. tabaci      x 79.9 79.9 82.4 
C. medinalis       x 95.0 82.3 
S. exigua        x 82.3 
A. mellifera2          X 
1First published sequence; 2 Automatic computational prediction done by NCBI 
There is a considerable variation in the number of exons found in insect RyR genes. 
The D. melanogaster gene has 26 exons making up the coding sequence [168]. 
However, members of other insect orders such as Acyrthosiphon pisum (pea aphid) 
and B. mori have over 100 exons within the RyR gene, similar to the number present 
in human RyR genes (Davies TGE, unpublished). There is evidence of alternative 
gene splicing in insect RyRs, although the function of this is unknown. Alternative 
splicing often appears to be associated with tissue distributions or different stages of 
insect development. Analysis of the C-terminal part of the H. virescens RyR 
confirmed the presence of at least two splice forms [169], and more recent 
sequencing of RyRs from the economically important pests P. xylostella and the rice 
leafroller Cnaphalocrocis medinalis (Guenee) detected the presence of multiple 
splice forms (as well as  a number of single nucleotide polymorphisms) [165, 170]. 
1.5.2 Functional studies  
Expression and functional analyses of an insect RyR has been best described in 
detail for  D. melanogaster, showing that the RyR is expressed both during early 
embryonic development and in the muscle cells, digestive tract and nervous system 
of adult flies [171, 172]. It has also been demonstrated that ryanodine sensitive 
internal calcium stores located in D. melanogaster photoreceptors are essential for 
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phototransduction [173]. Analysis of a D. melanogaster RyR deletion mutant, 
lacking the entire first exon of the gene, showed that the receptor is essential for 
correct insect development, since the first instar larvae died 4 to 7 days after 
hatching. Lack of the correct protein resulted in reduced heart rate, body wall 
contraction and impaired feeding and digestion; however the function of the 
photoreceptor cells and  the development of the larval brain were not impaired [174]. 
Interestingly the RyR is not essential for ECC in nematodes and  the null mutants of 
the channel, although exhibiting impaired motility and partial flaccid paralysis, are 
able to develop to adults and reproduce [175]. Electrophysiological measurements of 
transiently expressed D. melanogaster RyRs have shown fast opening and closing 
kinetics similar to the rabbit skeletal RyR, but with a much larger conductance [22, 
163]. More detailed characterization of the functionally expressed carboxyl-terminal 
calcium release channel part of the protein confirmed a much larger conductance of 
inward and outward currents through the insect channel when compared to its 
mammalian counterparts under the same experimental conditions [163]. Single 
channel recordings of insect RyR were also obtained from sucrose gradient purified 
native membrane preparations from the thoracic muscles of H. virescens. Like its 
mammalian counterpart, this channel showed an irreversible modification with 
ryanodine and was sensitive to ruthenium red and to ATP [176]. The role of RyR in 
halothane-mediated anaesthesia has also been investigated using D. melanogaster 
and it is thought that the fly glial and neuronal specific RyR protein is responsible 
for halothane sensitivity and may have a significant role in the anaesthetic effects 
observed in vivo [177]. The presence of RyRs has also been confirmed in P. 
americana neurons through radio-labelled ryanodine binding studies [178] and  
antibody detection has localized RyR to photoreceptors and muscle tissue in the 
honeybee Apis mellifera [179, 180].  
ECC studies on muscle have also been used to demonstrate different activation 
kinetics  between A. mellifera, D. melanogaster  and vertebrate RyRs  [179], and  
electron microscopy of flight muscles from dragonflies (unknown species) and tail 
muscles from Centuroides sculpturatus (Arizona bark scorpion) suggests an indirect 
activation of RyRs during ECC, similar to that seen in mammalian cardiac muscle 
[181]. Calcium currents during EC coupling have been measured in isolated muscle 
fibres from A. mellifera, D. melanogaster and other insect species, where it was 
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shown that the Ca2+ current kinetics were much faster (5-20ms at Vmax) when 
compared to vertebrate skeletal muscle (>100ms) [179]. Also the myotoxic effects of 
ryanodine and a synthetic pyrethroid allethrin have been characterized in adult A. 
mellifera, showing that differences in EC function may be related to structural 
differences between vertebrate and invertebrate muscle fibres, and the expression 
patterns of RyRs [179]. There is limited evidence on how many of the vertebrate 
accessory proteins (section 1.4.1) are conserved in insects and if their role in 
regulation of the invertebrate RyR channel is comparable to the mammalian models. 
Similarly, there is very little information on the impact of  differences between insect 
and mammalian RyRs on channel function; studies with diamide insecticides, which 
are highly specific for certain insect RyRs, suggests that channel differences do 
affect ligand binding and may play a key role in the specificity of these new 
insecticides [30].  
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1.6 Aims of this project 
The overall aims of this project were to better understand the mode of action and 
selectivity of diamide insecticides, and to determine the molecular basis of any 
resistance occurring in pest insects. This would be achieved by:  
1) The creation of a database of DNA sequences encoding RyRs, and a separate 
database of RyR protein sequences, from a range of insect and mammalian 
species. To use these databases to identify divergent regions within the insect 
RyR receptors that could account for the specificity of the diamides towards 
certain insect species and the contradictory action of different diamides 
towards sucking and chewing pests.  (Chapter 3) 
 
2) Using these RyR cDNA sequences to design primers to amplify RyRs from a 
sucking pest (Myzus persicae) and a chewing pest (Plutella xylostella), and to 
clone these into expression vectors. (Chapter 3) 
 
3) Expressing full-length cDNAs encoding the M. persicae and P. xylostella 
RyRs in cell lines. (Chapter 4) 
 
4) Using the expressed RyRs for binding studies with RyR modulators in order 
to identify their site(s) of interaction. (Chapter 4) 
 
5)  Site-directed mutagenesis of the insect RyR cDNAs to identify amino acids 
involved in ligand binding. (Chapter 5) 
 
6) Determining the molecular basis of any resistance to diamides arising in field 
populations of pest insects (potentially mutations in RyR genes). (Chapter 5) 
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Chapter II: General methods 
This chapter describes the standard methods used routinely in the project. Additional 
methods, developed for specific tasks, are presented in the research chapters (III-V).  
2.1 General  
All centrifugations were done in either a model 5415D, 5415R (when temperature 
control was needed) or a 5810R (for volumes larger than 50ml) table top centrifuge 
(Eppendorf, Hamburg, Germany).  
All enzyme reactions were set up on ice and incubations for restriction digests and 
reverse transcriptions were done in a G-Storm GS-482 thermo cycler (Labtech 
International, UK).  
All PCR reactions were set up on ice and done in a G-Storm GS-1 thermo cycler 
(Labtech International, UK). Room temperature was 22 ± 2oC. 
2.2 Insect material  
Myzus persicae clones 4106A and 4191A were reared in Blackman boxes on 
Chinese cabbage (Brassica rapa spp.) leaves at 18±1oC with 16h light / 8h dark 
photoperiod and 70% relative humidity. 4106A is a susceptible population collected 
in Scotland and 4191A is a neonicotinoid-resistant strain collected in Greece.  
The Rothamsted (Roth) strain of Plutella xylostella originated in the UK and has 
been reared in the laboratory for over 30 years on Chinese cabbage (Brassica rapa 
spp.) plants in fan-ventilated Perspex cages with 16h light / 8h dark photoperiod, 
70% relative humidity and a constant room temperature of 21 ± 1oC. 
Mixed populations of P. xylostella larvae and adults were collected in 1.5ml 
Eppendorf tubes and flash frozen in liquid nitrogen prior to RNA extraction. Frozen 
insect stocks were kept at -80oC. 
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2.3 RNA extraction 
2.3.1 E.Z.N.A® mollusc RNA kit 
RNA extractions from insects were carried out using an E.Z.N.A® Mollusc RNA kit 
(Omega Bio-Tek, GA, USA) on no more than 35mg of flash frozen M. persicae or P. 
xylostella, following the manufacturer’s recommended protocol.  
Flash frozen insects were ground up in a 1.5ml eppendorf tube kept on dry ice using 
a pre-cooled plastic pestle. 350µl of MRL buffer/β-mercaptoethanol was 
subsequently added to the insect powder and the tube vortexed. 350µl of  
chloroform : isoamyl alcohol (24:1) was added to the homogenate, the tube contents 
mixed thoroughly and centrifuged at 10,000g for 2 minutes at room temperature. 
Following centrifugation the upper aqueous layer was collected and transferred to a 
fresh tube. RNA was precipitated by adding 1 volume of isopropanol, the tube 
contents mixed and centrifuged at 10,000g for 2 minutes. The supernatant was 
carefully removed and the pellet briefly air dried (1 minute) and then re-suspended in 
100µl of pre-heated (65oC) RB buffer. 350µl of RB buffer/β-mercaptoethanol and 
250µl of absolute ethanol were added to the re-suspended RNA and the mixture 
loaded onto aHiBind® RNA column assembled in a 2 ml collecting tube. Resin 
bound RNA was washed twice with 500µl of wash buffers I and II and 
centrifugation at 10,000g for 1 minute and the RNA subsequently eluted from the 
column in 50µl DEPC-treated water.  
Potential DNA contamination was removed from the RNA eluate using a DNA-
free™ DNAse kit (Ambion®, Life Technologies, CA, USA), following the 
manufacturer’s recommended protocol. A 0.1 sample volume of 10x reaction buffer 
was added to the RNA together with 1µl of DNase I enzyme (2u/µl), the solution 
mixed gently and incubated at 37oC for 30 minutes. The reaction was terminated by 
adding 0.1 sample volume of Stop solution and incubating for 2 minutes at room 
temperature with occasional mixing. The mixture was then spun at 10,000g for 2 
minutes in a bench top micro-centrifuge. After centrifugation the RNA solution was 
transferred to a fresh 1.5ml eppendorf tube. 
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2.3.2 Isolate RNA mini kit 
For RNA extractions from individual M. persicae or P. xylostella, an Isolate RNA 
mini kit (Bioline, London, UK) was used, following the manufacturer’s 
recommended protocol.  Flash-frozen insects were ground in 450µl of Lysis Buffer 
in a 1.5ml eppendorf tube, centrifuged at max speed for 1 minute and the supernatant 
transferred to a spin column R1.  Eluate was retrieved from the column by a 2 
minute centrifugation at 10,000g and the column discarded. One volume of 70% 
ethanol was added to the filtrate supernatant, mixed, transferred to spin column R2 
and centrifuged for 2 minutes at 10,000g. The column was then washed by a 1 
minute centrifugation at 10,000g with 500µl of buffer AR followed by a second 
wash with 700µl of buffer BR. The column was then further centrifuged at 10,000g 
for 2 minutes to remove any residual liquid. RNA was eluted from the column into a 
1.5ml eppendorf tube using 40µl of RNase-free water and 1 minute centrifugation at 
6,000g. 
2.3.3 TRiazol® reagent RNA extraction 
TRIzol® reagent extraction was employed for RNA isolation from larger pools of 
insect material, following the manufacturer’s recommended protocol. Flash frozen 
samples where homogenised as described previously (2.3.1) and 1ml of TRIzol® 
reagent (Life Technologies, CA, USA) was added per 50mg of insect material. The 
homogenized mixture was centrifuged at 12,000g for 10 minutes at 4oC to remove 
parts of the insect exoskeleton and other insoluble materials. The supernatant was 
transferred to a fresh centrifuge tube, chloroform added in a ratio of 0.2ml per 1ml of 
TRIzol®, the tube shaken and incubated at room temperature for 3 minutes and then 
centrifuged at 12,000g for 15 minutes at 4oC. The upper phase was collected into a 
new tube (approximately 50% of the original volume) and 0.5ml of isopropanol 
added per 1ml of TRIzol® used, the solution mixed and incubated at room 
temperature for 10 minutes followed by centrifugation at 12,000g, 4oC for 10 
minutes. The RNA pellet obtained was washed with 1ml of ice-cold 75% ethanol per 
1ml of initial reagent volume and centrifuged at 7,500g for 5 minutes. The 
supernatant was then removed, the RNA pellet briefly air-dried and re-suspended in 
50µl of RNase-free water.  
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All RNA samples were stored at -80oC. The quality of RNA was checked using a 
NanoDrop1000 spectrophotometer (Thermo scientific, MA, USA). Samples were 
considered pure if the A260/A280 and A230/A260 ratios were above 1.8. RNA 
degradation was checked for by incubating 1µl of the RNA mixed with 1µl RNA 
loading dye (New England Biolabs, MA, USA) and 4µl of RNase free water at 65oC 
for 5 minutes and then running the sample on a 1% (w/v) TAE agarose gel at 
70V/200mA for 50 minutes using buffers made up with double distilled water. 
2.4 Synthesis of cDNA 
2.4.1 SuperScript® III 
SuperScript® III Reverse Transcriptase (Life Technologies, CA, USA) was used to 
synthesize cDNA to be used as a template for PCR amplification of RyR fragments 
for cloning. The cDNA synthesis was carried out in 20µl reactions in 0.2 ml thin 
walled PCR tubes as follows: 4µg of total RNA (various concentrations), 2µl dNTPs 
(10mM), 1µl OligodT25 (100pmol, Thermo-Fermentas, MA, USA) and up to 13µl of 
RNase free water. For synthesis of M. persicae cDNA, 1µl of a gene specific primer 
(20pmol) was occasionally added to the reaction. Reaction mixtures were pre-
incubated at 65oC for 10 minutes to resolve any RNA secondary structure and then 
the following reagents were added: 1µl of DTT (0.1M), 1µl of RNaseOUT™ 
(40U/µl Life Technologies, CA, USA), 4µl of 5x first strand Buffer and 2µl reverse-
transcriptase enzyme (200U/µl). The tube contents were mixed and incubated at 
55oC for 1 hour. The reactions were terminated by incubating the tubes at 70oC for 
15 minutes. To remove any DNA/RNA hybrids, 1µl of RNaseH (2U/µl Life 
Technologies, CA, USA) was added and the reactions incubated at 37oC for 20 
minutes. The synthesised cDNA was subsequently used as a template in downstream 
PCR reactions.  
2.4.2 RevertAid™  
RevertAid™ Premium Reverse Transcriptase (Thermo-Fermentas, MA, USA) was 
used to synthesize cDNA to be used as a template for PCR amplification of 
fragments close to the 5’end of genes. The cDNA synthesis was carried out in a total 
volume of 20µl with the reaction set up similar to SuperScript® III: 4µg of total 
RNA (various concentrations), 2µl dNTPs (10mM), 1µl OligodT25 (100pmol) 
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(Thermo-Fermentas, MA, USA) and up to 14µl RNase free water. The tube contents 
were mixed and incubated at 65oC for 10 minutes, to resolve any RNA secondary 
structure, and then the following reagents added: 4µl of 5x RT buffer, 1µl of 
RiboLock™ RNase inhibitor (40U/µl) and 1µl reverse-transcriptase enzyme 
(200U/µl). The reactions were mixed and incubated at 55oC for 45 minutes, then heat 
inactivated at 85oC for 5 minutes. 
2.5 Polymerase Chain Reaction (PCR) 
2.5.1 Primer design 
All gene specific primers were designed according to the sequence to be amplified. 
At least one Guanine or Cytosine was present at the 3’ end of the primer and the 
properties of the primers, including melting temperature (Tm) and secondary 
structures, were checked using an online service OligoCalc 
(http://www.basic.northwestern.edu/biotools/oligocalc.html) [182]. Primers were 
synthesised by Sigma–Aldrich (Haverhill facility, UK) and shipped desalted and dry. 
Primers for mutagenesis reactions were ordered with further purification using 
HPLC or reverse phase cartridge purification. 100µM primer stocks were stored at -
20oC. Before use primer stocks were diluted to give 20pmol working concentrations.  
2.5.2 PCR with proof reading enzymes 
All PCR reactions using cDNA as a template were set up in thin walled 0.2ml PCR 
tubes with 25µl reaction volumes, unless stated otherwise. The enzymes used for 
amplification of fragments for cloning were Pfu (Promega, WI, USA) and Long 
Range PCR mix (Thermo-Fermentas, MA, USA). A typical reaction mix included: 
2.5µl 10x Buffer with MgCl2, 0.5µl dNTPs mix (10mM), 0.5µl forward primer 
(20pmol), 0.5µl reverse primer (20pmol), 0.5µl DNA polymerase enzyme (2-3 u/µl), 
1-2µl of template cDNA, nuclease free water to 25µl. Cycling conditions were 
individually tailored according to the fragment to be amplified by varying the 
annealing temperatures and extension times. Further details are provided in 
appropriate sections of the research chapters. 
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2.5.3 Colony PCR 
Prior to propagation of E. coli transformants in liquid cultures, PCR was used to test 
for the presence of inserts in the bacterial plasmids using small samples taken from 
colonies of the plasmid containing bacteria (colony PCR). PCRs were usually done 
with gene specific primers where there was existing sequence information. Primers 
based on vector sequences were used when there was no sequence information for 
the cloned fragment and the insert did not exceed 2Kb. For large inserts only a small 
portion was PCR amplified to avoid false negative results. No colony PCRs were 
designed to amplify fragments that exceeded 3Kb in length.  
The PCR reactions used one of two standard x2 taq master-mixes 
REDtaq®mastermix (Sigma, MO, USA) and Dreamtaq™mastermix (Thermo-
Fermentas, MA, USA). Both of these contain a dye which can be seen in agarose 
gels. The templates were cells remaining on a pipette tip following colony transfer 
on to a fresh LB agar plate containing antibiotic. Cells were re-suspended in 5µl of 
DHCP treated water. The PCR reactions were set up in a total volume of 25µl as 
follows: 12.5µl of 2x mastermix, 0.5µl of forward primer (20pmol), 0.5µl of reverse 
primer (20pmol), 9.5µl of sterile water and 2µl of template. Typical PCR cycling 
conditions were: 95oC for 5 minutes followed by 28-35 cycles of 95oC for 20 
seconds, 50oC for 30 seconds and 72oC for 1-4 minutes, with a final extension step 
of 72oC for 5 minutes. The extension time used was dependant on the anticipated 
size of the PCR product allowing 1minute per 1kb. The number of cycles was also 
dependant on the size of the colonies on the plate; small colonies needed more 
amplification cycles to avoid false negatives. 5µl of product from each PCR reaction 
was run on a 1% (w/v) TAE agarose gel to confirm the presence of the product. 
Typically 8 colonies were screened for small inserts and 12-16 colonies for larger 
inserts. If the clones screened showed no positive results additional clones were 
tested.  
2.5.4 Analytical agarose gel electrophoresis 
All PCR reactions were checked for the presence of the desired product by analytical 
TAE agarose gel electrophoresis. Gels were made from molecular grade agarose 
(Fisher Scientific, Loughborough, UK). Typically 0.8% w/v (for large fragments 
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>4kb) or 1.1% w/v (for smaller fragments <1Kb) gels were cast. A 1Kb 
GeneRuler™ DNA ladder (Thermo-Fermentas, MA, USA) was typically loaded 
onto a single lane of each gel, in a total sample volume of 6µl (1µl of ladder, 1 µl 6x 
DNA loading dye, 4 µl water). 5µl of each PCR reaction mixed with 1µl of 6x DNA 
loading dye (containing bromophenol blue), or 5µl of PCR master-mixes which 
included the dye, was loaded onto gels. Typical voltage and current settings were 
70V/200mA for 50ml gels and 100V/ 200mA for 100ml gels. Average run times 
were between 50 to 70 minutes. All cast gels were pre-stained with 2.5µl (50ml gels) 
or 5µl (100ml gels) 10mg/ml ethidium bromide and then visualised on a 302nm UV 
trans-illuminator (Syngene, MD, USA) using the Gene Genius Bio-Imaging System. 
2.6 Purification of PCR products  
2.6.1 Gel purification 
PCR products were run on either a 0.75% or 1% w/v 50ml TAE-agarose gel 
(depending on the fragment size) in TAE buffer at 50V/200mA for at least 1hour. 
DNA fragments were subsequently purified from excised gel slices using 
QIAquick® (Qiagen, Hilden, Germany) or GeneJET™ (Thermo-Fermentas, MA, 
USA) gel extraction kits. Gel slices were excised quickly under low emitting UV 
light to avoid excess DNA damage and the gel slices weighed. Extraction of DNA 
was carried out following the manufacturer’s recommended protocols. Binding 
buffer was added to a gel slice placed in a 2ml eppendorf tube in 3:1 (QIAquick®) or 
1:1 (GeneJET™) w/v ratios. Samples were mixed, incubated at 60oC until the 
agarose was completely dissolved, then 10 µl of 3M NaOAc (pH 5.5) was added to 
adjust the solution pH. A volume of isopropanol equivalent to the volume of the gel 
slice was then added and the whole mixture was transferred to a DNA binding 
column (pre-assembled in a 2 ml collection tube) and centrifuged at 10,000g for 1 
minute. 0.7ml of wash buffer was added to the column and the column re-
centrifuged at 10,000g for 1 minute. The flow-through was discarded and the column 
spun again at max speed for 1 minute to remove any residual ethanol. DNA was 
eluted from the column after a 5 minutes pre-incubation of the column resin with 
30µl of pre-warmed (at 50oC) EB buffer (provided in the kit), followed by a 1 
minute centrifugation at 10,000g.  
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2.6.2 Column purification  
For PCR fragments which did not need gel purification (single products) a 
MinElute® PCR purification kit (Qiagen, Hilden, Germany) was used to recover the 
DNA following the manufacturer’s protocol. Five volumes of Buffer PB were added 
to each PCR reaction and mixed. If the resulting mixture did not turn yellow in 
colour then 10 µl of 3M NaOAc (pH 5.5) was added to adjust the solution pH. The 
entire sample was then loaded onto a MinElute® column and the column assembly 
centrifuged for 1 minute at 10,000g. Column bound DNA was washed with 0.75 ml 
of PE buffer, centrifuged for 1 minute at 10,000g and then the column re-centrifuged 
at max speed again for 1 minute to remove any residual wash buffer. DNA was 
eluted in 10µl of EB buffer following a 1 minute pre-incubation of the column. 
2.6.3 Phenol-chloroform purification 
For RACE products and for column-based purifications which did not give entirely 
clean DNA preparations,  an adaptation of the phenol-chloroform extraction method 
described by Sambrook et al. [183] was used to remove unwanted contaminants. 
Each DNA sample was mixed with 0.1 volume of 5M EDTA and 1 volume of water, 
then 1 volume of phenol and 1 volume of chloroform was added. After thorough 
mixing, the sample was spun at 12,000g for 4 minutes at room temperature. The 
upper aqueous phase was then carefully collected and transferred to a fresh 1.5ml 
eppendorf tube for further extraction with 1 volume of chloroform. The sample was 
mixed and centrifuged at 12,000g for 4 minutes at room temperature. The upper 
aqueous phase was again collected and transferred to a fresh eppendorf tube. 0.1 
volume of 3M NaOAc and 2.5 volumes of absolute ethanol were added to precipitate 
the DNA and the mixture was incubated at -20oC for a minimum of 1hour. The 
sample was then spun at 12,000g at 4oC for 20 minutes and the pellet washed with 
ice-cold 70% ethanol. The recovered pellet was briefly air dried and then re-
suspended in DEPC-treated water. The quality of the DNA was checked by 
measuring the A260/280 absorbance ratio using a NanoDrop1000 (Thermo 
Scientific, MA, USA).  
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2.6.4 Precipitation with NH4OAc 
This protocol was mainly used for the purification of large PCR products (over 4Kb) 
for direct sequencing.  20µl of a PCR reaction was transferred to a 1.5ml eppendorf 
tube and 1 volume of 4M NH4OAc and 200µl of absolute ethanol were added, the 
tube contents were mixed well and immediately centrifuged at max speed for 20 
minutes at room temperature. The supernatant was removed, the DNA pellet washed 
with 250µl of 70% ethanol and the tube re-centrifuged at max speed for 5 minutes. 
The majority of the supernatant was again removed and the DNA pellet briefly air 
dried. The DNA pellet was then re-suspended in 30µl of EB buffer (provided in 
Qiagen kits) and the quantity of DNA checked by measuring absorbance ratio 
A260/280 using NanoDrop1000 measurements (Thermo Scientific, MA, USA). 
2.7 Molecular cloning and Bacterial transformation 
2.7.1 pCR-XL TOPO kit 
Ligations with the pCR-XL TOPO vector (Life Technologies, CA, USA) were done 
following the manufacturer’s recommended protocol. 4µl DNA (with TA overhangs) 
and 1µl pCR-XL-TOPO vector were mixed and incubated for 5 minutes at room 
temperature then 1µl of 6X TOPO cloning Stop solution was added and the reaction 
placed on ice.  
One vial of competent TOP10 E. coli cells supplied with the TOPO kit was thawed 
on ice then 2µl of the prepared ligation reaction was added to the cells and incubated 
on ice for a further 30 minutes. Cells were then heat-shocked for 30 seconds at 42oC 
and immediately put on ice for another 2 minutes. 250µl of room temperature S.O.C. 
medium (supplied with the kit) was added to the cells and the cells were allowed to 
recover by shaking at 250rpm for 2 hours at 30oC. The cells were then plated onto 
two (75µl/150µl) LB agar plates containing 50µg/ml kanamycin and placed in an 
incubator overnight at 30oC. 
2.7.2 CloneJET™ PCR cloning kit 
Most DNA fragments were ligated into the pJET1.2 blunt vector, which is a part of 
the CloneJET™ PCR cloning kit (Thermo-Fermentas, MA, USA). PCR products 
generated with pfu enzyme were ligated directly into the vector in 20µl reactions as 
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follows: 10µl of 2x reaction buffer, 1µl of pJET vector (50ng/µl), 1µl of T4 DNA 
ligase (5U/µl), 150ng of insert DNA, and nuclease-free water up to 20µl. A 3:1 
insert:vector molar ratio was used in each reaction, as recommended by the 
manufacturer. Where only small quantities of insert DNA were available the amount 
of vector used in the reaction was halved. PCR products produced by enzymes 
generating TA overhangs were incubated at 70oC for 5 minutes with 1µl of blunting 
enzyme (provided with the CloneJET kit) before the DNA ligase was added. 
Ligations were incubated at room temperature for 30 minutes and then subjected to 
bacterial transformation as described below (2.7.3). 
2.7.3 Bacterial transformations 
35µl of XL-1 blue super-competent cells or 25µl of XL-10 gold ultra-competent 
cells (Agilent, CA, USA) were used per reaction. Cells were thawed on ice in 14ml 
Falcon tubes, gently mixed with 0.59µl of 1.72M β-mercaptoethanol (XL-1 blue kit) 
or 1.2µl of XL-gold β-mercaptoethanol and incubated on ice for a further 10 
minutes. Typically 2µl of ligation reaction was added to the cells and the mixture 
incubated on ice for a further 30 minutes. Cells were then heat-shocked at 42oC for 
45 seconds (XL-1 blue) or 30 seconds (XL-10 gold) and immediately placed on ice 
for a further 2 minutes. 250µl of pre-warmed S.O.C. medium was then added to each 
tube and the tubes placed in a shaking incubator for 2 hours at 30oC and 250 rpm. 
150µl (XL-1 Blue) or 100µl (XL-10 gold) of cells were then plated onto two LB 
agar plates containing 50-100µg/ml of antibiotic for colony selection and incubated 
at 30oC for approximately 30 hours. 
2.7.4 Propagation of expression vectors 
Empty pcDNA3.1(-) and pIZ/V5-his expression vectors (Life technologies) were 
propagated in E. coli XL-1 blue competent cells (Agilent, CA USA) to provide large 
quantities of vector DNA. 0.42µl of 1.72M β-mercaptoethanol was added to 25µl of 
thawed XL-1 blue competent cells and the cells incubated on ice for 10 minutes. 1µl 
of vector DNA (20µg in TE buffer, pH 8.0) was then added to the cells, which were 
incubated for a further 30 minutes on ice, followed by a heat shock at 42oC for 45 
seconds. Cells were allowed to recover for 2 minutes on ice, then 250µl of S.O.C. 
medium added and the transformations incubated at 37oC, 250rpm for 1 hour. 50 µl 
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of transformed cells were plated out onto two (75µl/150µl) LB agar plates containing 
100µg/ml of ampicillin (pcDNA) or Zeocin™ (pIZ) and incubated at 37oC 
overnight.  Vector DNA from 4ml liquid cultures was later purified using mini prep 
kits. 
2.8 Analysis of transformants 
2.8.1 Plasmid purification (mini-preps) 
QIAprep® Spin Miniprep Kit (Qiagen) or GeneJET™ mini-prep kit (Thermo-
Fermentas) were used for purification of plasmid DNA from small volumes of liquid 
culture. Both kits follow a similar protocol involving alkaline lysis of bacterial cells 
and binding of DNA to silica membrane columns. Prior to plasmid DNA 
purification, liquid cultures of E. coli containing plasmid DNA were set up in 15 ml 
Falcon tubes containing 4ml of low salt LB broth and 50 µg/ml of appropriate 
antibiotic and incubated for at least 18 hours in a shaking incubator at 250rpm, 30-
37oC. 
Cells were harvested by centrifugation at 4000g for 15 minutes at 10oC, the 
supernatants removed and the pellets re-suspended (by pipetting and vortexing) in 
250µl re-suspension buffer. Cell suspensions were transferred to sterile 1.5ml 
eppendorf tubes and cell lysis was performed by adding 250µl of lysis buffer to each 
tube followed by gentle mixing until a homogenous solution was obtained. Each 
lysis reaction was terminated by adding 350µl of Neutralisation solution. The 
mixtures were then centrifuged for 8 minutes at 10,000g at room temperature to 
pellet the cell debris and denatured proteins. Supernatants were then transferred to 
DNA binding columns. A brief 1 minute centrifugation at 10,000g allowed DNA to 
bind to the column resin which was then washed once with 700µl of wash buffer 
(QIAGEN) or twice with 500µl of wash buffer (Thermo-Fermentas). Columns were 
then spun for a further 1 minute at max speed to remove any residual wash buffer. 
DNA was eluted from the columns with 50µl of EB buffer. The quality of the DNA 
was checked by A260/A280 measurements using a NanoDrop1000 (Thermo 
Scientific) spectrophotometer. For inserts over 8Kb analytical agarose gel 
electrophoresis was used to check the recovered DNA (see 2.5.4). 
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2.8.2 Restriction digests 
All plasmids containing inserts larger than 8Kb were checked for possible 
rearrangements using restriction enzyme digests. Expected restriction fragment sizes 
were predicted in silico using Vector NTI v10.5 (Life Technologies) or Geneious 
v.6.6.5 (Biomatters Ltd., Auckland, NZ) software. Typical diagnostic BglII or SalI 
(Promega, WI, USA) digests were set up in a 20µl reaction as follows: 2µl 10x 
buffer D (Promega), 2µl 10x BSA, 1µl BglII or SalI (10U/µl), 1µg of plasmid DNA, 
nuclease free water up to 20µl. Reactions were briefly vortexed and then incubated 
in a PCR block at 37oC for at least 1 hour, 15 minutes.  Products were run on 0.8-1% 
w/v agarose TAE electrophoresis gels for visualization and analysis. 
2.8.3 Sequencing 
Sequencing done in-house at Rothamsted utilized the Big Dye Terminator v1.1 kit 
(Applied Biosystems®-Life Technologies, CA, USA) and an ABI 3100 genetic 
analyser (Hitachi, Tokyo, Japan). A typical 20µl sequencing reaction was set up as 
follows: 4µl Big Dye v1.1 reaction mix, 2µl 5x BigDye Sequencing buffer, 1µl 
sequencing primer (20pmol), 500ng Plasmid DNA (or 100ng purified PCR product), 
nuclease-free water up to 20µl. The PCR block cycle conditions were 25 cycles of: 
96oC for 30 seconds, 50oC for 30 seconds 60oC for 4 minutes with the temperature 
ramp set at 1oC per second. 
Dye labelled DNA was precipitated from the reaction mix by the addition of 2µl of 
125mM EDTA, 2µl of 3M NaOAc (pH 5.5) and 71µl of absolute ethanol, brief 
vortexing, then incubation at room temperature for 15 minutes. The precipitated 
DNA was pelleted by 20 minutes centrifugation at 10,000g, the supernatant removed 
and the pellet washed with 100µl of 70% ethanol. Following another centrifugation 
at 10,000g for 5 minutes, as much of the supernatant as possible was decanted by 
inverting the tube, and the DNA pellet was allowed to air dry in the dark until all the 
residual ethanol had evaporated. The DNA was then re-suspended in 20µl of Hi-
Di™ formamide (Life technologies) and transferred into an individual well on a 96 
well plate. Prior to sequencing all reactions were briefly incubated at 90oC for 2 
minutes.  
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In some cases sequencing was done commercially by MWG ERUOFINS DNA 
(Eurofins Scientific group, Brussels, Belgium). 
2.8.4 Maxi preps  
2.8.4.1 Liquid cultures 
A colony of E. coli with desired plasmid was inoculated into a 2.5ml starter culture 
of LB broth (containing 50µg/ml of antibiotic) and propagated in a shaking incubator 
at 30oC, 250rpm. After approximately 8-10 hours, 1ml of the starter culture was used 
to inoculate two 200ml LB broth cultures (containing 50µg/ml of antibiotic) and 
incubated with shaking overnight at 30oC, 250rpm.  Before harvesting the OD of the 
culture at 600nm was checked and if the absorbance value was approximately 1.0 the 
cells were transferred to 250ml Beckman centrifuge bottles and spun down at 6000g, 
4oC for 15 minutes in a JA-14 rotor / Avanti 28 Centrifuge (Beckman, CA, USA). 
2.8.4.2 DNA purification  
The pelleted E. coli cells were processed with a Plasmid Plus maxi kit (Qiagen, 
Hilden, Germany) using a modification of the manufacturer’s protocol. Pellets were 
re-suspended in 8ml of Qiagen kit resuspension buffer P1, containing lysate-blue and 
RNase A. Cells were lysed by adding 8ml of lysis buffer P2 and gently mixing the 
solution until the colour of the lysate turned blue. 8ml of neutralization buffer S3 
was then added to stop the lysis reaction and the contents of the tube gently mixed 
until all the blue colour disappeared. The mixture was then centrifuged at 4500g and 
10oC for 5 minutes and the supernatant from two 200ml cultures was transferred into 
one QIAfilter cartridge. The lysate was gently pushed through the cartridge filter 
(using the plunger provided) and collected in a fresh sterile 50ml tube. 10ml of 
binding buffer was added to the filtrate, the solution mixed, and the entire contents of 
the tube applied to a DNA binding column placed on a vacuum manifold. After all 
the liquid had passed through the column, it was washed with 0.7ml of ETR buffer to 
remove endotoxins, centrifuged for 1 minute at 10,000g and then washed with 0.7ml 
of buffer PE and re-centrifuged for 1 minute at 10,000g. The column was then spun 
again at max speed for 1 minute to remove any residual wash buffer. DNA was 
eluted from columns using 400µl of EB buffer and a 2 minutes centrifugation at 
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8,000g. The quality and quantity of the DNA was checked by NanoDrop1000 
spectrophotometry and by restriction digests (see 2.8.1 and 2.8.2 for details). 
2.9 Site-directed mutagenesis  
All mutagenesis experiments were carried out using the Quikchange Site-directed 
mutagenesis (SDM) kit (Agilent, CA, USA) and the manufacturer’s recommended 
protocol. Primers for the PCR reaction were designed so that the target / primer 
mismatch was at least 10 base pairs from either end of the primer with a determined 
Tm for each primer of over 75oC, calculated using the following formula: 
 
𝑇𝑚 = 81.5− 0.41(𝐺𝐶%)− 675𝑁 −%𝑚𝑖𝑠𝑠𝑚𝑎𝑡𝑐ℎ 
 
Where N= number of bases  
SDM reaction conditions were: 5 µl pfu 10x Turbo buffer, 1 µl dNTPs (kit mix), 1 µl 
forward primer (125ng), 1 µl reverse primer (125ng), 1 µl plasmid DNA (diluted to 
50ng/ µl), 41 µl nuclease-free water, 1 µl pfu Turbo (2.5U/µl). PCR thermo-cycler 
conditions were initial denaturation at 95oC for 30 seconds followed by 16-18 cycles 
of: 95oC for 30 seconds, 55oC for 1 minute, 68oC for 2 minutes, 30 seconds per 1Kb 
of plasmid.  The number of cycles depended on the type of modification: 16 cycles 
for a single mutation and 18 cycles for multiple mutations. 
PCR products were treated with 1µl of DpnI (provided with the kit) for 1 hour at 
37oC to remove template DNA. After the digest, 2µl of the reaction was transformed 
into competent E. coli (either XL-1 blue or XL-10 gold) cells following standard 
procedures (see, 2.7.3). The success of each mutagenesis reaction was checked by 
direct sequencing of isolated plasmid DNA. 
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2.10 Insect cells 
2.10.1 Starting insect cell cultures from frozen stocks 
Frozen stocks of Sf9 cells (Life Technologies) were stored under liquid nitrogen in 
1.5ml aliquots of approximately 1.5x107 cells suspended in Sf-900 II SFM media 
containing 10% FBS and 10% DMSO. In order to initiate new cultures, a frozen 
stock aliquot was gently thawed at 37oC and transferred to T-25 culture flasks. 
Flasks were placed in a 27oC incubator and left for 1 hour for cells to attach to the 
bottom surface. The SFM medium containing DMSO was then removed and 
replaced with 5ml of fresh pre-warmed SFM media containing 10% FBS and 50µl of 
a penicillin-streptomycin cocktail (50U/100µg/ml). The cells were kept in the flask 
until they reached confluence. The cells were then passaged as described below, 
halving the FBS concentration until it reached 0.6% and the cells were ready to use 
for downstream applications. Sf9 cells were maintained in a sterile dedicated 
incubator at a constant 27oC.  
2.10.2 Propagation of insect cell cultures 
Media in near confluent (90-95% cell coverage) T-25 flasks was removed and 4ml of 
fresh Sf-900 II™ media added. Cells were detached from the bottom of the flask by 
sloughing and tapping the side of the flask.  1ml of detached cells was transferred to 
a new T-25 flask containing 5ml of fresh media containing 0.6% FBS. Near 
confluent cell cultures were passaged every 2-3 days, with the typical number of 
passages not exceeding 30. To scale up the cell cultures 3ml of detached cells from 
the T-25 flask were seeded into a T-75 flask containing 12ml of fresh Sf-900 II SFM 
media and the desired concentration of FBS. 
Stocks of low passage cultures were made by collecting cells from near confluent T-
75 flasks into fresh media and transferring the detached cells from each flask into a 
50ml tube (Greiner Bio-One, Kremsmünster, Austria). The number of cells present 
was determined by transferring 10µl of the cell suspension to a hemocytometer for 
counting. The 50ml tube was then centrifuged at 500g for 5 minutes, the supernatant 
removed and the cell pellet gently re-suspended in Sf-900 II media containing 10% 
FBS and 10% DMSO, at a density of 1x107cells/ml. These cells were split into 1.5ml 
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aliquots and placed in a -80oC freezer for 24 hour before being transferred to liquid 
nitrogen in a storage container for long term storage.  
2.11 Propagation of HEK 293 cell cultures 
All experiments with HEK 293 cells were done at Cardiff University with cultures 
initiated and maintained by members of Alan Williams’ research group. The HEK 
293 cultures were maintained in complete high glucose Dulbecco's Modified Eagle 
Medium (DMEM) (Gibco®-Life Technologies, CA, USA) containing 10% FBS and 
penicillin-streptomycin (50U/50µg/ml), in a sterile dedicated 37oC, 5% CO2 
incubator. For cell propagation, the media surrounding cells grown to near 
confluence in T-75 flasks was removed from the flask and the cells washed once 
with 3ml of phosphate-buffered saline pH 7.4 (PBS). To detach the cells from the 
flask, 2ml of DMEM media (containing 0.05% trypsin-EDTA (Life Technologies), 
pre-warmed to 37oC was added, spread out to coat all the cells and left for 2 minutes. 
10ml of DMEM at 37oC was then added to stop the reaction; cells were pipetted up 
and down to break up any clumps and the cells transferred to a 50ml sterile 
centrifuge tube. The total number of cells was determined using a hemocytometer. 
Cells were centrifuged at 500g for 5 minutes at 18oC, the supernatant removed and 
the cells re-suspended in fresh complete DMEM at a density of 1x106 cells/ml. One 
ml of cells was then seeded into a new T-75 flask in a total volume of 15ml complete 
DMEM. 
 
 
 
 
 
 
 
Chapter III 
49 
 
Chapter III: Molecular cloning and characterization of 
insect ryanodine receptors 
3.1 Introduction  
The main challenge posed for cloning the full-length ryanodine receptor (RyR) is the 
size of its mRNA. The average length of its coding sequence is approximately 
15,000 base pairs, depending on the organism and, in the case of vertebrates, the 
isoform. Despite this, RyRs have been cloned successfully from a range of 
organisms. The first was a full-length rabbit skeletal muscle isoform (RyR1), 
obtained by cDNA library screening, with the final expression construct being made 
through a series of ligations of digested fragments from the library into the vector 
pRRS7 for expression in CHO cells [99]. This was followed by the cloning of the 
rabbit cardiac receptor (RyR2) [184] and brain isoform (RyR3) [185].  All 3 
isoforms have now been cloned successfully from various mammals including mice 
and humans [186]. 
In peer reviewed publications there are only two reports of successful attempts to 
clone and express insect RyRs. The first full-length insect channel was cloned from 
the common fruitfly, Drosophila melanogaster (a model organism). The coding 
sequence was obtained through a combination of RT-PCR (to give six overlapping 
cDNA fragments) and cDNA library screening. Final assembly of the full-length 
cDNA was made in the mammalian expression vector pcDNA3.1, using a series of 
specific restriction digests and ligations. However, only two deletion mutants, 
lacking most of the cytosolic domain, were sufficiently expressed in CHO cells to 
allow detailed functional analysis [163]. The second insect RyR successfully cloned 
and expressed was isolated from the silkworm, Bombyx mori. Again, the RyR cDNA 
was obtained by a combination of RT-PCR (to give overlapping fragments) and 
cDNA library screening, with the final full-length cDNA being assembled in the 
expression vector pcDNA3.1 using PCR-based techniques [30]. For both constructs 
an N-terminal eGFP tag was added to monitor protein expression. A patent 
WO/2004/027042, filed by the DuPont Corporation in 2004, gave details of the 
isolation and expression of four additional insect RyR genes; from peach-potato 
aphid (Myzus persicae), corn planthopper (Peregrinus maidis), cotton melon aphid 
Chapter III 
50 
 
(Aphis gossypii) and tobacco budworm (Heliothis virescens). Each of the four genes 
were amplified as a single large cDNA in a two-step nested PCR, sub-cloned into 
pCR-XL-TOPO vector and then transferred into the insect expression vectors 
pIBV5His and pFastBac1 [187]. Since the beginning of this project a number of 
additional studies have been published detailing the sequencing of RyR genes from 
economically important pests such as the rice leaf folder, Cnaphalocrocis medinalis 
(Guenee) [170] and the diamondback moth, Plutella xylostella [165, 188, 189]. 
These papers will be discussed in more detail towards the end of this thesis. 
This chapter presents a detailed strategy for the successful amplification and cloning 
of two insect RyRs. In silico analysis of the obtained sequences, and comparison to 
other insect and mammalian RyRs is also described.  The RyR cDNAs isolated were 
from the two economically important pest species, Myzus persicae and Plutella 
xylostella.  Both of these insects have the potential to cause damage to commercial 
crops resulting in severe yield losses, and both can be controlled with diamide 
insecticides. Both species are also notorious for developing resistance to insecticides 
[190, 191]. M. persicae is the most economically important agricultural pest in the 
UK and a major pest in temperate climates. It is polyphagous, feeding on a wide 
range of plants including potatoes, tomatoes and fruit trees. It causes damage through 
both feeding and, more importantly, the transmission of over a hundred different 
plant viruses [192]. P. xylostella is one of the most widely distributed lepidopteran 
species on the planet [190]. Its larval stage is a major pest of cruciferous crops, 
causing feeding damage to the leaves, decreasing the quality of the produce and in 
extreme cases may be responsible for up to 100% loss in yield [193]. 
3.2 Methods and results 
3.2.1 Creation of databases of available RyR protein and cDNA sequences  
A database of invertebrate and mammalian RyR sequences was constructed, to help 
identify conserved domains and regions of interest within the insect RyRs as well as 
to pin point regions of dissimilarity between vertebrate and invertebrate channels 
which could be important for the selectivity of diamide insecticides. The cDNA 
database was also used as a guide for primer design for the amplification of P. 
xylostella RyR. The database was updated during the project to include newly 
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published invertebrate RyRs. Table 3 lists all of the sequences currently present in 
the database. Sequence alignments were made initially using VectorNTI 10.1 and 
later using Geneious 6.1.4. The database does not include all the available 
mammalian RyR sequences. 
Table 3 List of species with available RyR protein and DNA sequence 
Species 
(invertebrates) 
GenBank 
Accession 
number 
cDNA size 
(bp) 
Protein 
size (aa) 
Heliothis virescens2 DuPont patent1 15429 5142 
Myzus persicae DuPont patent1 15845 5101 
Aphis gossypii  DuPont patent1 15315 5099 
Peregrinus maidis DuPont patent1 15384 5127 
Acyrthosiphon pisum3 XP_003246190.1 15306 5101 
Drosophila melanogaser2 NM_057643.3 15384 5127 
Aedes aegypti4 XP_001657320.1 15357 5118 
Bombyx mori3 XP_004924916.1 15375 5124 
Bemisia tabaci AFK 84957.1 15429 5142 
Apis mellifera3 XP_392217.4 15426 5082 
Anopheles gambiae3  XP_318561.3 15330 5109 
Nasonia vitripennis3 XP_003425568.1 15240 5079 
Cnaphalocrocis medinalis AFI80904.1 15264 5087 
Plutella xylostella4 AET09964.1 15576 5164 
Spodoptera exigua AFC36359.1 15357 5118 
Nilaparvata lugens KF306296.1 15423 5140 
Pediculus humanus4  XP_002424547.1 15177 5058 
Laodelphax striatella AFK84959.1 15348 5115 
Pieris rapae AGI62938.1 15324 5107 
Brugia malayi XP_001900491.1 15219 5072 
Caenorhabditis elegans BAA08309.1 15146 5071 
Daphnia pulex3 EFX89429.1 15471 5119 
Species 
(vertebrates) 
   
Homo sapiens RyR1 AAC51191.1 15117 5038 
Homo sapiens RyR2 CAA66975.1 14904 4967 
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Homo sapiens RyR3 CAA04798.1 14613 4870 
Mus musculus RyR2 AAG34081.1 14904 4967 
Oryctolagus cuniculus RyR1 CAA33279.1 14907 5037 
1DuPont patent US2007/0105098A1; 2Four splice variants available; 3cDNA 
obtained from genome sequence by Dr TGE Davies at the beginning of the project; 4 
Sequence published during the project and was not used during amplification and 
assembly of P. xylostella RyR 
3.2.2 Amplification of Myzus persicae RyR gene fragments 
A reference cDNA sequence for M. persicae RyR was sourced from DuPont patent 
US2007/0105098A1 [187]. However, it proved to be impossible to re-amplify the 
full-length M. persicae RyR cDNA using a single nested PCR reaction as described 
in the patent. A new strategy was therefore employed, whereby short fragments 
which could be easily amplified were obtained by PCR, sub-cloned and joined 
together by overlap extension PCR to create a full-length coding sequence for 
insertion into expression vectors for protein production in cell lines. 
Initially, five overlapping fragments were amplified in a single round of PCR (Figure 
7, Gel1), using pfu proofreading polymerase (Promega) and primer pairs matching 
the patented sequence (Table 4).  All reactions were set up as described in Chapter 
II, section 2.5.2. The PCR reaction involved an initial incubation in the temperature 
cycler at 94oC for 2 minutes, followed by 35 cycles of: 94oC for 10 seconds, 50oC 
for 30 seconds, 68oC for 20 minutes, with a final 20 minutes extension step at 68oC. 
The N6a and N6b fragments were amplified using cDNA made with RevertAid® 
premium reverse transcriptase (Thermo-Fermentas); this enzyme is capable of 
producing cDNA products of up to 20Kb, and this considerably improved the yield 
of PCR reactions covering the 5’ end of the RyR gene.  All other fragments, C4Kb, 
LNK1 and LNK2, covering the remaining portion of the gene, were amplified from 
Superscript™ III (Life Technologies) generated cDNA. The RNA used for the 
cDNA synthesis was a pooled sample of RNA extracted from various life stages of 
two aphid clones (4601a and 5191a) using an E.Z.N.A mollusc® RNA kit (Omega 
bio-Tek), as described in Chapter II, section 2.3.1. 
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Table 4 List of primers used for amplification of M. persicae RyR fragments  
Primer 
Name 
Sequence 5’-3’ name Length 
(bp) 
FLn-F* GCGATGGCCGACAGCGAGGGCAGTTCG N6a 3140 
N3Kb-R2 GTGCGGACTGTTTCGCTTGCTGTATCTC 
N3Kb-F GCTAATAGAGATACAGCAAGCGAAAC N6b 2684 
6Kb-R* CCCCCAATGGGATCTCTATTATGAACC 
LNK1-F CTTGAGGAAGCCGTATTAGTTAACCAGG LNK1 3056 
LNK1-R CCTCTATTGTTCAAAGGTGCATCGTTC 
LNK2-F GGATGGAGTATTGAACATTCAGAGAACG LNK2 2522 
LNK2-R GCGTGGAGTGAGAGTTGTCGGAAACA 
C4Kb-F2 GCCGTAATTGCTTGTTTCCGACAAC C4Kb 4083 
FLn-R TCAGACGCCTCCTCCGCCGCCGAGCT 
*Primers used for N6Kb overlap extension PCR 
 
Figure 7 left- Five overlapping PCR fragments of the M. persicae RyR run on a 1% (w/v) 
TAE-agarose gel. Lanes: A) GeneRuler™1Kb DNA ladder, 1) N6a 2) N6b 3) C4Kb 4) 
LNK1 5) LNK2 right – N6Kb overlap extension PCR. Lanes: A) GeneRuler™ 1Kb DNA 
ladder, 1) N6kb. 
The N6a and N6b PCR fragments were excised from a 1% (w/v) TAE-agarose gel 
(Figure 7, Gel1) and purified using a QIAquick® gel extraction kit, as described in 
Chapter II, Section 2.6.1. Both fragments had a 33bp overlap which was utilized in 
an overlap extension PCR reaction to create a single large product, N6Kb (Figure 7, 
Gel2).  The primers used to make the fusion were Fln-F (a forward N6a primer) and 
6kb-R (a reverse N6b primer). Gel purified N6a and N6b PCR fragments were 
combined in a 1:1 w/w ratio, and the template DNA (not exceeding 20ng) added to a 
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25µl reaction utilizing pfu enzyme. The temperature cycler conditions were an initial 
incubation at 94oC for 2 minutes followed by 35 cycles of: 94oC for 10 seconds, 
50oC for 30 seconds 68oC for 20 minutes, and a final 20 minutes extension step at 
68oC.   
3.2.3 Sub-cloning M. persicae RyR fragments 
Two sub-cloning vectors were used for propagation of the final 4 RyR fragments: 
pCR XL-TOPO (Life Technologies) for C4Kb and LNK1 fragments and pJET1.2 
(Thermo-Fermentas) for LNK2 and N6kb. Vector maps are included in Appendix B. 
Both are positive selection vectors and are able to propagate large inserts of up to 
10Kb. Successful insert ligation disrupts a lethal gene within the vector and allows 
propagation of the recombinant plasmid; as a result only bacteria containing the 
insert are able to grow on the antibiotic selective media and blue/white colony 
screening is not required. pJET1.2 carries a lethal restriction enzyme eco47IR and 
ligates blunt-ended products. pCR XL-TOPO carries a lethal E. coli ccdB gene [194] 
and has 3’ end thymine (T) overhangs for TA cloning. It was the vector of choice for 
the sub-cloning described in the DuPont patent US2007/0105098A1.  LNK2 and 
N6kb were ligated into pJET1.2 (as described in Chapter II, section 2.7.2) and 
transformed into XL-1 blue super-competent cells following the protocol described 
in Chapter II, Section 2.7.3. Products generated by pfu amplification are blunt ended; 
therefore, an additional step to create 3’ end adenine (A) overhangs was required for 
the LNK1 and C4Kb PCR products prior to ligation with the pCR XL-TOPO vector. 
After gel purification both fragments were incubated at 72oC for 20 minutes with a 
standard DNA polymerase; a 50µl reaction was set up containing: all the recovered 
DNA, 10µl of 5x reaction buffer, 1µl dATP (100mM), 6µl MgCl2 (25mM), 0.25µl 
Flexi® taq enzyme (5U/µl, Promega), and nuclease free water up to 50µl. After 
incubation, DNA fragments were ethanol precipitated and used in TOPO ligation as 
described in Chapter II, Section 2.7.1 and transformation into E. coli TOP10 cells. 
Positive colonies were checked for the presence of inserts via colony PCR (Chapter 
II, section 2.5.3), and liquid cultures were set up for purification of plasmid DNA 
using the protocol described in Chapter II, section 2.8.1. Plasmid DNA (isolated 
from at least two colonies for each RyR fragment) was checked by sequencing using 
the primers listed in the Appendix C, section 2. 
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3.2.4 M. persicae RyR fragment assembly 
Due to the lack of suitable restriction sites, it was decided that the four cloned RyR 
PCR products would be joined together to create larger fragments through overlap 
extension PCR. All fragments had an overlap of at least their original primer length. 
In the first step towards creating a full-length cDNA, all 4 fragments were 
individually PCR amplified using pfu, in 50µl reactions using the original 
amplification primers, and plasmid DNA containing the relevant insert as a template. 
The temperature cycler conditions were an initial incubation at 95oC for 2 minutes 
followed by: 20 cycles of 95oC for 10 seconds, 50oC for 30 seconds, 68oC for 14 
minutes, and a final 10 minutes extension step at 68oC. The number of cycles was 
reduced to 20 to minimize the possibility of PCR errors during the amplification. All 
of the products from the first step PCR were gel purified using a Qiagen gel 
extraction kit following the protocol described in Chapter II, Section 2.6.1. Four 
overlap extension PCR reactions were then set up to create fusions of two or three 
fragments (Table 5). An attempt was also made to create a full-length M. persicae 
RyR by simultaneous fusion of all four RyR fragments in a single PCR.  The 
reactions were set up using pfu in a total volume of 25µl, with 50ng of each gel 
purified fragment and 5’ and 3’ primers corresponding to the ends of the desired 
final product. The new assemblies were named: N6L1, N6L2, L2C4 and L1C4 
(Figure 8).  Temperature cycler conditions were 95oC for 2 minutes followed by 25 
cycles of: 95oC for 10 seconds, 50oC for 30 seconds, 68oC for 20 minutes, and a final 
10 minutes extension step at 68oC. It was possible to create fusions of up to 3 
fragments, all of which were gel purified using this approach; however, the 
subsequent assembly of a full-length M. persicae RyR coding sequence cDNA 
through overlap extension PCR was not possible when using pfu. Other taq blends 
were also tried including a Long PCR mix (Thermo-Fermentas) and Extensor PCR 
mix (Sigma), but did not yield positive results. Overlap extension PCRs were also set 
up with an increased number of PCR cycles (up to 35) and altered timings, using 
different combinations of existing fusions and fragments as templates: N6L1 with 
L2C4, N6L2 with C4Kb, N6kb with L1C4, but none produced satisfactory products. 
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Figure 8 1% (w/v) TAE agarose gel of 4 
overlap extension PCR products (as 
described in Table 2).  
 
 
 
 
 
Table 5 Summary of M. persicae RyR fusion PCRs 
3.2.5 Sub-cloning and analysis of M. persicae RyR PCR fusions 
Two fusion fragments, N6L1 and L1C4 (Figure 8 were individually ligated into 
pJET1.2 and transformed into XL-1 blue super-competent cells, following the 
protocol described in Chapter II, Section 2.7.3. At least 12 colonies from each 
transformation were screened using colony PCR. Plasmid DNA was purified from at 
least 5 colonies for each fusion fragment. To check for possible rearrangements of 
inserts within the plasmid, 1µg of plasmid DNA from all of the samples was 
restriction digested with BglII and run on a 1% (w/v) TAE-agarose gel to check that 
the expected restriction digest fragments were obtained. Orientation of the inserts 
within each plasmid was checked by sequencing using vector specific primers (see 
Appendix C, section 1). Additionally, one clone for L1C4 and one clone for N6L1 
were fully sequenced and analysed before the final full-length RyR cDNA assembly.  
Sequencing of L1C4 revealed the presence of 268bp of the pCR-XL vector, 
positioned immediately after the RyR STOP codon. The 268bp comprised the 5’ end 
Assembly 
name Templates Primer pair 
Gel 
lane 
Product 
size (bp) 
N6L1 N6kb and LNK1 Fln-F/ LNK1-R 4 8865 
N6L2 N6kb, LNK1, LNK2 Fln-F/ LNK2-R 3 11387 
L2C4 LNK2 and C4Kb LNK2-F/ Fln-R 2 6605 
L1C4 LNK1, LNK2, C4Kb LNK1-F/ Fln-R 1 9661 
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of the multiple cloning site (MCS), containing a number of restriction sites including 
EcoRI, the M13 reverse primer binding site, and a portion of the Lac Z promoter. 
The origin of this 268bp was difficult to explain, since only insert-specific primers 
were used to amplify the fragment from the vector for the overlap extension PCR. In 
silico analysis of this portion of pCR-XL, using Vector NTI, gave a 92.6% match to 
the Fln-F primer sequence at the 3’ edge of the 268bp carry over. It is possible that 
contamination of the PCR reaction with the Fln-F primer occurred and this, coupled 
with low annealing temperatures during the thermal cycling, gave a partial 
amplification of the vector sequence. However, the inadvertent presence of this 
268bp was fortuitous as the EcoRI site was later utilized for the assembly of the full-
length RyR in the mammalian expression vector pcDNA 3.1(-). Further sequencing 
of L1C4 also revealed an insertion of a thymine (T) at position 9717 (of the 
predicted full-length M. persicae RyR) which was not present in the original 
fragments used for making L1C4. This thymine insertion caused a frame-shift, 
resulting in the premature termination of the protein coding sequence, and had to be 
removed by site directed mutagenesis using the primer pair: Mz.mutdel-F / 
Mz.mutdel-R and the protocol described in Chapter II, section 2.9, before assembly 
of the full-length RyR could be attempted. Successfully mutagenized (corrected, in-
frame cDNA) clones of L1C4 were identified through plasmid DNA sequencing. 
3.2.6 Assembly and propagation of the M. persicae RyR in pcDNA 3.1(-) 
The overall strategy for cloning the full-length RyR is shown in Figure 9. The 
expression vector pcDNA 3.1(-) (vector map in Appendix B) was chosen for 
propagation of the full-length M. persicae RyR, as it gives constitutive high-level 
protein expression using the immediate-early human cytomegalovirus promoter 
(CMV), and has been used successfully to express a number of RyR proteins in 
mammalian cell lines [186]. Empty vector was propagated in XL-1 blue E. coli as 
described in Chapter II, section 2.7.4. A strategy was devised to accommodate the 
full-length RyR into pcDNA 3.1(-), based on the M. persicae RyR sequence in the 
DuPont patent (US2007/0105098A1) and data from sequencing of the individual 
fragments and the two large fusions N6L1 and L1C4 generated in this work. In silico 
analysis showed that the M. persicae RyR contained only a single ApaI site (at 
position 7352), and that this ApaI site was present in both N6L1 and L1C4 fusion 
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fragments so could be used for ligating together the full-length sequence. NotI and 
EcoRI sites within the pcDNA 3.1(-) MCS were used to incorporate the fusion 
fragments into the vector. Both of these restriction sites were also present in the sub-
cloned fusion fragments.  The NotI site was located at the 5’end of the MCS of the 
pJET1.2 vector which was used to sub-clone N6L1, and the EcoRI site was present 
immediately after the STOP codon in the L1C4 pCR-XL carry over (as discussed in 
3.2.5) (Figure 9). Some modifications of N6L1 and L1C4 were required before final 
ligation was possible. The correctly orientated N6L1, with a translation initiation 
START codon close to the MCS NotI site, had to have a 5’-ACG-3’Kozak 
consensus sequence created by site-directed mutagenesis. An additional START 
codon, which was created during ligation of the insert’s 5’ end and the vector, also 
needed to be removed. A single G to A substitution was introduced 3 base pairs 
upstream of the native RyR START codon using Mz.N12-F / Mz.N12-R primer pair. 
The final mutagenized plasmid was named N6L1a. L1C4 had an additional EcoRI 
site present 1067 bp upstream of the STOP codon, which was removed by 
introduction of a silent mutation using Mz.Eco-F / Mz.Eco-R primer pair. This new 
plasmid was named L1C4a. Both mutagenesis reactions were carried out following 
the protocol described in Chapter II, section 2.9. Positive clones containing correctly 
mutagenized inserts were identified and confirmed by DNA sequencing. 
Prior to their ligation, 2µg of N6L1a, L1C4a, and the empty vector, were double 
digested with appropriate restriction enzymes (N6L1a: NotI, ApaI; L1C4a: ApaI, 
EcoRI), and the digested fragments were run on 0.75% (w/v) TAE-agarose gels, 
excised from the gels and purified using a gel extraction kit (see Chapter II, section 
2.6.1). The ligation reaction was set up in a total volume of 20µl including: 40ng of 
each DNA fragment in a 1:1:1 weight ratio, 2µl of ligation buffer and 1µl T4 DNA 
ligase (Thermo-Fermentas), and incubated overnight at 15oC. Before transformation, 
10µl of the ligation reaction was run at 70V/200mA on a 0.8% (w/v) TAE-agarose 
gel for 50 minutes to confirm that successful ligation of all three fragments had been 
achieved. 2µl of the ligation was then used to transform 30µl of XL-10 gold cells, as 
described in Chapter II, section 2.7.3. Transformed cells were allowed to recover at 
30oC for 2 hours, with shaking at 250rpm. The transformation mixture was then 
plated out on low salt LB plates containing 100µg/ml Ampicillin, and incubated at 
30oC for 24 hours, and then at room temperature overnight. This allowed enough 
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time for colony size discrimination to become apparent on the plates; small colonies 
were more likely to contain an intact insert-containing plasmid and these were 
preferentially selected for screening. Positive transformants were identified with two 
separate colony PCR reactions, using primer pairs N1-F / N2kb2-R and C2kbF / C1-
R, amplifying fragments close to the 5’ and 3’ end of the insert respectively. Only 
clones which gave the correct PCR product with both primer pairs were set up as 
overnight liquid cultures, maintained in a shaking incubator set at 30oC and 250 rpm. 
Plasmid DNA was extracted and purified using column-based kits (following 
methods described in Chapter II, section 2.8.1) and checked for possible 
rearrangements by restriction digests with BglII (Promega). The ligation sites and the 
entire RyR cDNA insert were then checked by direct sequencing. The large 
quantities of plasmid DNA required for subsequent transfections were obtained using 
modified maxi-prep purification, as described in detail in Chapter II, section 2.8.4. 
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Figure 9 Summary of the cloning strategy used for assembly of full-length M. persicae RyR in the expression vector pcDNA 3.1(-). 
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3.2.7 Modification of pcDNA 3.1(-) to insert eGFP sequence 
In order to be able to monitor the expression of the M. persicae RyR cDNA in live 
cells, a vector was made with an enhanced Green Fluorescent Protein (eGFP) coding 
sequence incorporated in a position that would allow for the production of N-
terminally tagged protein fusions. Addition of eGFP would also allow detecting 
expressed channels in membrane preparations using anti-eGFP antibody in western 
blots. The eGFP was incorporated into the empty pcDNA 3.1(-) vector by ligation of 
a cassette, made from PCR-amplified and fused vector CMV promoter and eGFP 
coding sequence, between MluI and NotI sites (following a method described for the 
human RyR2 construct [195]). The eGFP sequence was amplified from a human 
wild type (WT) RyR2 construct provided by Prof. Tony Lai, Cardiff University. The 
human RyR2 construct was first propagated in XL-10 E. coli as described for M. 
persicae RyR in section 3.2.6. The forward eGFP amplification primer (eGFP-F) 
contained a 5’ end overhang with a small overlap with the pcDNA 3.1(-) vector 
CMV promoter’s 3’ end, whilst the reverse primer (eGFP-R) had a functional NotI 
site incorporated. The CMV promoter forward primer (pcDNA-CMV F) had a MluI 
site incorporated, and the reverse primer (pcDNA-CMV R) had an overlap with the 
beginning of the eGFP sequence. Both eGFP and the CMV promoter were PCR 
amplified separately using pfu. The human RyR2 plasmid was used as a template in 
the eGFP reaction and the empty pcDNA3.1(-) vector was the template for obtaining 
the CMV promoter. After successful PCR amplification, both products were gel 
purified and used in a second round of PCR to create a single fused CMV - eGFP 
cassette (using pfu and pcDNA-CMV-F / eGFP-R primer pair), which was ligated 
into pJET1.2 vector and transformed into E. coli. Following the selection of 
successful transformants, the fusion cassette was sequenced to check for potential 
PCR errors. The cassette was then cut out of the p.JET1.2 vector, using the 
restriction enzymes MluI and NotI, and ligated (using T4 DNA ligase) into empty 
pcDNA3.1(-) plasmid previously digested with the same restriction enzymes. 
Successful transformants were selected by colony PCR using eGFP-F / eGFP-R 
primer pair. Stocks of purified plasmid DNA were made for future use. The new 
plasmid was called pcDNA3.1-eGFP. 
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3.2.8 Modification of M. persicae RyR and assembly of eGFP fusion in pcDNA 
3.1(-) 
Direct NotI / EcoRI ligation of the digested, untagged RyR construct with the 
modified pcDNA3.1-eGFP vector would be expected to give a 36 base pair linker 
between the end of the eGFP sequence and the RyR START codon, consisting of 
residual pJET1.2 vector sequence. Additionally, the ACG Kozak consensus sequence 
from the untagged RyR construct would also be present, and could potentially 
interfere with eGFP-RyR protein expression. It was therefore decided that the linker 
would be shortened to remove the Kozak and pJET1.2 vector sequences. The new 
construct would have only 3 amino acids between the eGFP and the RyR sequence 
(Figure 10). In order to achieve this, site-directed mutagenesis was used on the 
pJET1.2 plasmid containing the N6L1 fragment, to introduce a novel AfeI site 204bp 
downstream of the RyR START codon. The mutagenesis involved a silent 
substitution which would not alter the predicted amino acid sequence. The reaction 
was done with primers Mz.Afe-SDM-F / Mz.Afe-SDM-R, following the protocol 
described in Chapter II, section 2.9. The mutagenized plasmid, named N6L1-Afe, 
was identified by sequencing and used as a template for amplification of a short 
cassette using pfu and primers Mz.NotI-F / Mz.AfeI-R (primers sequence in 
Appendix C, section 3). The forward primer contained a functional NotI site 
immediately upstream of the RyR START codon and the reverse primer contained 
the newly introduced AfeI site. The cycling conditions were an initial denaturation at 
95oC for 1 minute followed by: 35 cycles of 95oC for 20 seconds, 50oC for 35 
seconds, 72oC 1 minute 30 seconds, and a final extension of 72oC for 2 minutes. The 
product was gel purified, double digested with NotI and AfeI restriction enzymes 
and purified again using a Qiagen PCR purification kit (Chapter II, section 2.6.2). 
The cassette was then ligated into pJET1.2 N6L1-Afe plasmid, pre-digested with 
NotI and AfeI, using T4DNA ligase. The ligation product was transformed into XL-
1 blue E. coli and the modification of the plasmid was confirmed by sequencing. The 
new plasmid was named N6L1b. The final assembly of the full-length M. persicae 
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RyR was performed as described in section 3.2.6, using pcDNA3.1-eGFP, N6L1b 
and L1C4a plasmids (Figure 9). 
 
Figure 10 Summary of techniques used to remove the Kozak sequence and generate a short 
linker between the M. persicae (mRyR) START codon and eGFP sequence in the pcDNA-
eGFP fusion construct.  
3.2.9 Assembly of eGFP tagged M. persicae RyR construct in a vector for 
expression in insect cells 
A pIZ/V5-His (Life Technologies) plasmid was used to accommodate the M. 
persicae eGFP tagged RyR coding sequence. This vector gives constitutive 
expression of a target protein, through baculovirus immediate-early promoter OpIE2, 
in a range of insect cell lines. Unlike a baculovirus expression system it does not 
cause cells to lyse, and gives an option to use Zeocin™ (Life Technologies) selection 
to isolate stable cell lines. The vector contains a single Zeocin™ resistance gene, 
used for selection of both E. coli clones and successfully transfected insect cells. The 
pIZ/V5-His has two tags for protein purification, both on the 3’ end of the MCS, 
meant to be used as C-terminal fusion tags.  
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Figure 11 Summary of the strategy used to introduce insect RyRs into a modified pIZ vector 
for expression in insect cell lines. The NruI site had to be engineered into the empty pIZ 
vector. 
Removal of the full-length RyR insert from the pcDNA3.1-eGFP vector requires the 
use of NotI and PmeI restriction sites. This is not ideal because PmeI digestion 
creates a blunt ended product. There is no site present in the pIZ/V5-His vector 
which would give a blunt end and allow insertion of the RyR in the correct position 
and desired orientation. The pIZ/V5-His vector was therefore modified prior to use 
for propagation and expression of insect RyRs through the introduction of a novel 
restriction site, NruI. The NruI site was engineered in such a position as to allow the 
removal of most of the V5 tag from the vector upon restriction digest and insert 
ligation. The site was created by site-directed mutagenesis of the thymine (T) at 
vector position 694 to guanine (G), using primer pair pIZ/His-NruI SDM-F and 
pIZ/His-NruI SDM-R (Appendix C, section 1), following the protocol described in 
Chapter II, section 2.9. Successfully mutagenized clones were identified by 
sequencing and the modified vector, named pIZ/NruI, was propagated in XL-1 blue 
cells. The eGFP sequence was then inserted into the modified vector: the eGFP 
sequence was amplified from pcDNA3.1-eGFP using pfu and primer pair eGFP-
EcoRI–F / eGFP-R. The forward primer had a 5’end overhang with an EcoRI site 
and the insect 5’-CAAA-3’ Kozak consensus sequence incorporated. The cycling 
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conditions were 95oC for 2 minutes followed by: 30 cycles of 95oC for 10 seconds, 
50oC for 30 seconds, 72oC for 2 minutes, and a final extension at 72oC for 5 minutes. 
Amplified product was gel purified, double digested with EcoRI / NotI and purified 
again using a Qiagen PCR purification kit. The cassette was then inserted between 
the EcoRI and NotI sites of the pIZ/NruI vector. The new vector was propagated in 
XL-1 blue cells, and successful transformants were selected by colony PCR and 
sequencing. The final assembly of the M. persicae RyR was then attempted: the 
entire insert was cut out from the eGFP tagged pcDNA3.1 construct using NotI / 
PmeI, and ligated overnight at 15oC into the NotI / NruI digested pIZ/eGFP vector in 
1:1 weight ratio, using T4DNA ligase (figure 11). Prior to E.coli transformation, 
10µl of the ligation reaction was run on a 0.8% (w/v) TAE agarose gel to confirm the 
success of the ligation. XL-10 gold cells were used for transformation following the 
standard protocol described in Chapter II, section 2.7.3, and positive transformants 
were selected exactly as described previously for the two pcDNA3.1 constructs (see 
3.2.6). The integrity of ligation sites within the plasmid DNA containing the RyR-
eGFP insert were checked by sequencing, and the integrity of the construct as a 
whole was checked by BglII restriction digest. 
3.2.10 Quantitative RT-PCR 
Quantitative RT-PCR was used to examine the relative levels of expression of the 
RyR in four different life stages of M. persicae clone 4106; apterous adults, winged 
adults and nymphal stages L1/L2 and L3/L4.  The primers were designed to amplify 
a fragment of 90-150bp, and are listed in Table 6.  
 
Table 6 M. persicae qPCR primers 
Primer Sequence 5’-3’ Expected amplicon 
size 
Mz.qPCR3-F CGAACTTGCATTAGCGTTGA 125bp 
Mz.qPCR3-R CTGGATCCCAGCCTAAATCA 
Mz.qPCR4-F CAATTGGGAATCGCAGTTCT 127bp 
Mz.qPCR4-R CGCTGCACGAGTTCATTAAA 
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Total RNA was prepared as described (Chapter II section, 2.3.2) and 750ng used for 
cDNA synthesis using Superscript III (Life Technologies) and random hexamers 
(Life Technologies, CA, USA), according to the manufacturer’s recommended 
protocol. PCR reactions (15µl) contained: 4µl cDNA (20ng), 7.5µl SensiMix SYBR 
Kit (Bioline, London, UK) and 0.25 µM of each primer. Samples were run on a 
Rotor-Gene 6000™ (Corbett Research) using temperature cycling conditions of 10 
minutes at 95°C followed by 40 cycles of: 95°C for 15 seconds, 57°C for 15 
seconds, 72°C for 20 seconds. A final melt-curve step was included post-PCR 
(ramping from 72°C-95°C by 1°C every 5 seconds) to confirm the absence of any 
non-specific amplification. The efficiency of PCR for each primer pair was assessed 
using a serial dilution of 100ng to 0.01ng of cDNA. Each qRT-PCR experiment 
consisted of three independent biological replicates with two technical replicates for 
each. Data were analysed according to the ΔΔCT method [196], using the geometric 
mean of two selected housekeeping genes (actin and the para gene which encodes 
the voltage-gated sodium channel) for normalisation according to the strategy 
described previously [197]. In this analysis the reference life stage was adult 
apterous aphids. 
3.2.11 Amplification and cloning of Plutella xylostella RyR fragments 
At the start of this project there was no P. xylostella RyR sequence published, or 
available in online sequence depositories, so attempts were made to amplify small 
fragments of P. xylostella RyR using degenerate PCR primers designed to conserved 
regions of other Lepidopteran (Bombyx mori and Heliothis virescens) RyR genes, 
near to their 5’ and 3’ ends and also around the middle of the coding sequence. Four 
primers per fragment were designed (two forward and two reverse, see Table 7) to 
amplify fragments of less than 1kb in length. All possible primer combinations were 
used in PCRs. 
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Table 7 List of degenerate primers used for amplification of P. xylostella RyR 
fragments 
Primer Name Sequence 5’-3’ Description 
Px.NAdf TTYYTNCGDACSGAAGAYATGG Forward primers for 
5’end N fragment Px.NBdf GAAGGHTTYGGHAAYCGDCAYTG 
Px.N1dr GGTWTNGTNARRCAYTCRTCDCC Reverse primers for 
5’end N fragment Px.N2dr CCNGCCCAYTTDGTNCKVGCBAG 
Px.CAdf GGARTTYGACGGNCTGTWCATYGC Forward primers for 
3’ end C fragment Px.CBdf AAYHTGYTBGGBATGGARAAGAC 
Px.C1dr TCWCCNACNGGGAARAAGTCCC Reverse primers for 
3’ end C fragment Px.C2dr GGTCACGVAGCTCDCCGAAVGC 
Px.MAdf GARAARTTGATCCABTACATNGAYAGDGC Forward primers for 
middle M fragment Px.MBdf GACTTCCTGAGVTTYTGYGTTTGGG 
Px.M1dr CCAGHARBTGCCAGTCTTCTTGTATCTG Reverse primers for 
middle M fragment Px.M2dr GCRTAGTTCTCRGCYTCGTTGTAGA 
Degenerate residues are underlined. 
 All degenerate PCRs were done in 25µl reactions with: 1µl cDNA (made with 
RevertAid premium transcriptase), 12.5µl of REDtaq® master mix and varying 
amounts of primers and nuclease free water. During reaction optimisation, 10 to 40 
pmole of each primer were tested. The cycling conditions tested were 95oC for 2 
minutes followed by: 35 cycles of 95oC for 20 seconds, 45-50oC for 45–60 seconds, 
and 72oC for 2-3 minutes, with a final extension time of 72oC for 5 minutes. This 
gave 3 fragments: CA-1 (3’end), MB-2 (middle) and NA-1 (5’end), obtained when a 
long annealing time (1minute) at 50oC was used in combination with high primer 
concentrations. Bands of the expected size were purified by gel extraction and 
ligated into p.Jet1.2 vector, using the insert’s sticky-ends protocol. All 3 fragments 
were transformed into XL-1 blue cells following the protocol described in Chapter 
II, section, 2.7.3.  Positive transformants were selected by colony PCR using vector 
specific primers, the plasmid DNA purified, and the insert sequenced (using the 
same vector specific primers) to confirm the identity of the cloned fragments. The 
RyR sequences obtained were then used to design P. xylostella gene specific primers 
to amplify fragments covering the large gaps (approximately 7Kb) between the CA-
1, MB-2 and NA-1 fragments (Figure 6).  A long PCR mix (Thermo-fermentas) was 
used to successfully amplify both 7Kb fragments after initial attempts with pfu 
failed. Two sets of PCR reactions were set up following standard protocols (Chapter 
II, section 2.5.2), but with additional amount of 10mM dNTPs (1µl) included in the 
reaction mix and gradient cycles with different extension times. Primer pair Px.M1f / 
P.C2R was used to amplify between CA-1 and MB-2 to generate fragment N7Kb. 
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Primers Px.N1f / Px.M1r were used to amplify between NA-1 and MB-2 to generate 
fragment C7Kb. The cycling conditions for both PCR reaction sets were an initial 
denaturation at 94oC for 2 minutes followed by: 35 cycles of 94oC for 10 seconds, 
45-55oC for 20 seconds, 68oC for 14 or 25 minutes, followed by a final extension of 
68oC for 15 minutes. The best amplification results were obtained with a 50oC 
annealing temperature and a 25 minute extension time for C7Kb, and 45oC annealing 
with 25 minutes extension time for N7Kb. Both PCR fragments were then gel 
purified, cloned into p.Jet1.2 vector following the sticky ends protocol (Chapter II, 
section 2.7.2), and transformed into XL-1 blue cells. Transformation reactions were 
recovered at 30oC for 2hours, and then transferred to low salt LB 100µg/ml 
ampicillin plates. The LB plates were also incubated at 30oC for 24 hours to increase 
the likelihood of getting intact, non-rearranged plasmids. Due to the large insert size 
and lack of sequence information it was impossible to select positive clones by 
colony PCR. Instead 16 colonies for both fragments (C7Kb and N7Kb) were taken 
and grown overnight in 4ml of LB broth with 50µg/ml ampicillin, their plasmid 
DNA purified using a mini- prep kit, and 400ng of the undigested plasmid DNA run 
on a 1% (w/v) TAE-agarose gel, which allowed a size discrimination of plasmids 
containing the insert to be visualized. Two positive clones for C7Kb and N7Kb were 
chosen for sequencing; initially vector specific primers were used to sequence the 
insert ends, and then this new sequence data was used to design the initial forward 
and reverse primers to allow for sequential sequencing through the whole insert, as 
illustrated in Figure 14. Primer sequences are in Appendix C, section 4. 
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Figure 12 Summary of the amplification of P. xylostella RyR in order to obtain sequence of 
the receptor to device cloning strategy. Top: The 3 initial small fragments amplified by 
degenerate PCR, which were cloned and sequenced to provide information for gene specific 
primer design for. (Bottom) 2 large fragments spanning the gaps between the initial small 
fragments. The extreme 5’ and 3’ ends missing approximately 100bp were obtained through 
RACE. 
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Figure 13 Diagram of the sequencing strategy for the two large P. xylostella RyR fragments. 
Fragments were first cloned and initially sequenced using vector specific primers. All 
subsequent overlapping primers were designed based on collected information for the 
sequencing results using upstream (for the 5’ end) and downstream (for the 3’end) primers, 
until entire fragment have been sequenced.  
A consensus sequence for both fragments was then assembled using Contig Express, 
part of Vector NTI 10 (Invitrogen) suite of programs. 
3.2.12 Obtaining P. xylostella RyR gene ends by RACE  
It was estimated that there were between 50 to 100 bps missing between the 
amplified fragments NA-1 and CA-1 and the START and STOP codons of the P. 
xylostella RyR coding sequence, respectively. In order to obtain information on the 
entire coding sequence, a 5’ and 3’ Rapid Amplification of cDNA Ends (RACE) was 
done, using a First Choice® RLM RACE kit (Ambion®-Life Technologies, CA, 
USA). A set of RACE primers was designed according to the kit manufacturer’s 
recommendations (see Table 8).  
Table 8 List of RACE primer sequences 
Primer name Sequence 5’-3’ position 
Px.3’RACE inner-1F GAGTCCAATTGCTTCATCTGTGGC 15103-15126 
Px.3’RACE outer-2F CATCGGAGACGAACTGGAGCC 14928-14948 
Px.5’RACE inner -1R CGCTCAGTAGCGACAGACACGAGG 498-521 
Px.5’RACE outer-2R GTACCGCTCAGTAGCGACAGACAC 502-525 
Px.5’RACE F GATATGGTGTGCCTGTCCTGCACG 63-84 
 
Freshly extracted P. xylostella RNA was used for both 5’ and 3’end reactions. For 5’ 
end RACE, 8µg of total RNA was first treated with calf intestine alkaline 
phosphatase (CIP) at 37oC for 1 hour to remove free 5'-phosphates. The reaction was 
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terminated with ammonium acetate, the RNA extracted with phenol:chloroform and 
precipitated with isopropanol. The RNA was then treated with tobacco acid 
pyrophosphatase (TAP) at 37oC for 1 hour, to remove the 5’ end caps from the full-
length mature messages. The 5’ end RACE adapter was then ligated to CIP/TAP 
treated RNA in a 1 hour incubation at 37oC with T4 RNA ligase. The reverse 
transcription reaction was then set up in a total volume of 20µl using: 2µl of treated 
RNA, 2µl random decamers, 4µl dNTP mix (10mM), 1µl RNAse inhibitor and 1µl 
M-MLV reverse transcriptase which was provided with the kit. The 3’end RACE 
used a cDNA synthesis reaction: 1µg of non-treated RNA with 4µl dNTPs (10mM), 
2µl 3’ adapter, 1µl RNAse inhibitor and 1µ of M-MLV transcriptase in a total 
reaction volume of 20µl. Both reactions were incubated at 42oC for 1 hour and were 
terminated with a 5 minute incubation at 70oC. The cDNA was then used for a series 
of gradient PCR reactions, set up in total volume of 25µl using: REDtaq®mastermix, 
RACE outer primer (20pmol) pairs and 1µl of cDNA as a template. The PCR cycle 
was 95oC for 3 minutes followed by 35 cycles of: 95oC for 30 seconds, a temperature 
gradient of 55-65oC for 30 seconds, 72oC for 2 minutes and a final 5 minutes 
extension at 72oC. Results of the first PCR cycle gave no, or very weak 
amplification, therefore 1µl of the first reaction was used as a template for a 
secondary nested PCR using RACE inner primer (20pmol), REDtaq® mastermix 
and the same cycling conditions. Two fragments with the best amplification in the 
secondary reaction (at 65oC for the 5’RACE and 55oC for the 3’ RACE) were gel 
purified, ligated into p.Jet1.2 vector and transformed into XL-1 blue cells. 12 
colonies were tested for the presence of insert using vector specific primers. Four 
clones from each RACE reaction were grown in liquid culture for plasmid DNA 
isolation. Cloned fragments for both reactions were confirmed to be part of the P. 
xylostella RyR gene by sequencing, which also provided information on the 5’ and 
3’ UTR regions of the gene.   
3.2.13 Amplification and sub-cloning fragments of full-length P. xylostella RyR 
The initial sequence information obtained for the P. xylostella RyR facilitated the 
design of a strategy to clone a full-length coding sequence. It was decided that the P. 
xylostella gene would be cloned as 4 overlapping fragments. However, unlike for the 
M. persicae RyR, individual fragments would be joined together by ligation using 
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unique restriction sites. It was assumed that the initial P. xylostella RyR sequence 
contained an unknown number of introduced errors, due to the use of a low-fidelity 
taq in the PCR. Therefore, for amplification of the 4 overlapping fragments a high 
fidelity proofreading polymerase enzyme was used.  
Initially, a set of P. xylostella gene-specific primers were designed to amplify four 
fragments named Nterm, M1, M2 and Cterm, using pfu in a standard reaction set up 
as described in Chapter II, section 2.5.2. PCR conditions were 95oC for 2 minutes 
followed by 35 cycles of: 95oC for 10 seconds, 50oC for 20 seconds, 68oC for 20 
minutes and a final extension at 68oC for 10 minutes. This strategy gave a good yield 
of products for M1 and M2, which were gel purified and cloned into p.Jet1.2 vector 
(Chapter II, section 2.7.2). Despite attempts to optimise the PCR reactions for the 
other fragments (by increasing the amount of dNTPs and extending the annealing 
and extension times to 35 seconds and 25 minutes, respectively) PCR reactions to 
amplify Nterm (4kb) gave only very weak amplification, not suitable for purification 
and cloning, and PCR reactions to amplify Cterm (6Kb) did not produce any product 
of the expected size. Replacing pfu with other high fidelity enzymes such as fusion® 
(New England Biolabs) did not improve this; in fact fusion taq failed to amplify any 
large RyR fragments, following the manufacturers recommended protocols (data not 
shown). 
Four additional primers were designed to sub-divide PCR amplification of Nterm 
and Cterm into smaller overlapping fragments which could be easily amplified using 
pfu and joined together in an overlap extension PCR (Figure 15). Primers Px.Ntm2F 
and Px.Ntm1R were designed to amplify (in conjunction with the two previous 
primers - see above) two 2Kb fragments named N1 and N2, and primers Px.Cv1-F 
and Px.Cv2-F to amplify two 3Kb fragments, C1 and C2. Extended temperature 
cycler conditions were used (50oC annealing for 35 seconds and a 25 minutes 
extension step at 68oC) to amplify all 4 sub-fragments (see Figure 7). These were gel 
purified and used as a template (in 1:1 weight ratios) for two secondary overlap 
extension PCRs using primers Px.NtermF / Px.NtermR for the Nterm fragment and 
Px.CtermF / Px. CtermR for the Cterm fragment. The secondary PCR cycle was 
95oC for 2 minutes followed by 35 cycles of: 95oC for 10 seconds, 50oC for 35 
seconds, 68oC for 24 minutes and final extension at 68oC for 15 minutes. The fused 
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N and C fragments were then cloned into p.Jet1.2 as described in Chapter II, section 
2.7.2. 
 
Figure 14 Summary of P. xylostella RyR fragments used for the full-length assembly. 
Nterm and Cterm fragments were generated as initial sub-fragments fused together using 
overlap extension PCR to give the final product. Gel images: L - GeneRuler 1Kb ladder.  
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Gel 1: lanes 1 and 4 = positive controls (REDtaq®), lane 2 = fragment M1, lane 3 = 
fragment C2. Gel 2:  lane1 = fragment M2, lane 3 = fragment C1, lane 5= fragment N1, lane 
6 = fragment N2 
Positive transformants were selected by colony PCR, using insert specific primers. 
Four clones for each of the sub-cloned fragments were grown in liquid culture for 
purification of plasmid DNA and sequencing (using already existing primers from 
section 3.2.11, Appendix C, section 4) to confirm the presence of the required 
restriction sites within the constructs and to rule out the presence of any possible 
PCR errors. 
3.2.14 Modification of sub-cloned P. xylostella RyR fragments 
Sequencing revealed significant sequence diversity in the cloned P. xylostella RyR 
fragments (see discussion section, 3.3.2), including the presence / absence of 
alternative splice sites (table 9).  It was therefore decided that the full-length P. 
xylostella RyR would be assembled from fragments which had the best alignment to 
the B. mori RyR cDNA which had previously been functionally expressed [30]. 
Unfortunately the number of SNPs present in the different fragments made it 
difficult to use the restriction site cloning strategy originally planned to ligate 
together the full-length cDNA. 
Table 9 List of sequenced splice sites 
Name Position (cDNA) Length (bp) type 
Nterm-1 261-276 15 insertion 
Nterm-2 2596-2896 300 deletion 
M1-1 4065-4197 132 deletion 
Cterm-1 13536-13578 42 insertion 
 
For the four C6 clones, all four clones had a Kpn1 site, two had an EcoRI site and 
one of these also had an insertion. For the four M2 clones, only two contained PvuI 
sites and only one had an EcoRI site. None of the clones contained both restriction 
sites. It was decided that the M2 fragment with the EcoRI site would be mutagenized 
to introduce the PvuI site needed for the final ligation, by introducing a silent 
polymorphism that would not change the amino acid sequence. The M2 fragment 
was small enough that the PCR needed to engineer the restriction site was unlikely to 
introduce any new errors. A site directed mutagenesis kit was used with primer pair 
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Px.M2pvu-SDM-f / Px.M2pvu-SDM-r, (Appendix C, section 5) following the 
protocol described in Chapter II, section 2.9. The mutagenized plasmid was 
propagated in XL-1 blue cells and clones carrying the PvuI site were identified by 
sequencing. 
The Nterm fragment was re-amplified twice from the selected plasmid using pfu and 
two modified forward primers. The first fragment generated was amplified with 
primer Px.NotI-F which contained a NotI restriction site overhang immediately 
upstream of the START codon, and was to be used for introducing the Nterm 
fragment into the pcDNA3.1-eGFP construct containing an N-terminal eGPG tag 
and short linker sequence (as seen in the M. persicae RyR plasmids). The second 
fragment generated was to be introduced into the untagged pcDNA3.1 construct, and 
was amplified using primer Px.No-tag-F containing an overhang incorporating a 
NotI site and 5’-ACC-3’ Kozak sequence upstream of the START codon. The PCR 
conditions used for both reactions were 95oC for 2 minutes followed by 35 cycles of: 
95oC for 20 seconds, 50oC for 45 seconds, 72oC for 10 minutes, and a final extension 
at 72oC for 20 minutes. Both fragments were ligated into pJET1.2 vector, 
transformed into XL-1 blue cells, and positive clones were sequenced to confirm the 
presence of the modification and that no PCR errors had been introduced 
3.2.15 Assembly of P. xylostella RyR in expression vectors 
Before the final ligations to generate full-length cDNA containing constructs, 2µg of 
each of the pJET 1.2 plasmids containing the sub-cloned fragments described above 
were double digested using appropriate Fastdigest® restriction enzyme pairs (Figure 
15), run on a TAE gel and purified using gel extraction.  
The first assembly was done in the pcDNA3.1-eGFP vector by simultaneous ligation 
of all four required fragments with the NotI / KpnI digested plasmid. A 30µl ligation 
contained 3µl 10x buffer, 50ng of each cDNA fragment (1:1 weight ratio), 1µl of 
T4DNA ligase, and nuclease free water up to 30µl. The reaction was incubated at 
room temperature for at least two hours, and prior to transformation 15µl of the 
reaction was run on a gel to confirm the success of the ligation (Figure 16). 50µl of 
XL-10 gold cells, treated with 2µl of β-mercaptoethanol, were used for the 
transformation with 2µl of the ligation reaction added, as described in Chapter II 
section 2.7.3. Transformed cells were allowed to recover in 250µl of pre-warmed 
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SOC, in a 30oC incubator with shaking for 2 hours at 250 rpm. The cells were then 
plated out on two LB-agar plates containing 100µg/ml ampicillin. Positive 
transformants were selected after 30 hours incubation at 30oC by double colony 
PCR, as described for the M. persicae RyR (section 3.2.9). Out of the 12 clones 
screened, one clone gave a positive amplification of both PCR fragments and the 
expected banding pattern for a full-length P. xylostella RyR construct using a 
diagnostic Sal I restriction digest. All ligation sites were also sequenced to confirm 
that there were no ligation errors.  Large quantities of the selected plasmid were 
obtained by Maxi-prep following the protocol decribed earlier. 
 
Figure 15 Summary of the restriction enzymes used to recover P. xylostella RyR fragments 
from the pJET1.2 vector (table) and a gel image of a ligation of all 4 fragments with the 
pcDNA-eGFP vector. 
The second construct made was for the expression of P. xylostella RyR in insect 
cells using the modified eGFP-pIZ vector. The full-length coding sequence was cut 
out of the pcDNA-eGFP construct using NotI / PmeI, and the insert was then ligated 
between the NotI / NruI sites in the vector (as for the M. persicae RyR, see 3.2.9). 
The 20µl ligation reaction was set up using T4DNA ligase and a 3:1 insert to vector 
(w/w) ratio. After overnight incubation at 15oC, 10µl of the ligation reaction was run 
on a 0.8% (w/v) TAE gel to check for the presence of a single ligation product, and 
2µl of the ligation was used to transform 35µl of XL-10 gold cells (Chapter II, 
section 2.7.3). Positive transformants were identified by double colony PCR. Out of 
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the 20 clones screened, 2 contained the intact P. xylostella RyR, as confirmed by 
diagnostic SalI restriction digest and sequencing. 
3.2.16 Deletion mutants of the P. xylostella RyR 
Two deletion mutants were made for the expression of the C-terminal pore-
containing region of P. xylostella RyR in both insect and mammalian cell lines. Both 
the pcDNA3.1-eGFP and eGFP-pIZ constructs were digested with XbaI (which only 
cuts within the RyR sequence), which allowed the creation of a fusion of the N-
terminus and the transmembrane domain without introducing a frame shift (Figure 
17). Functional deletion mutants of D. melanogaster and B. mori RyR channels 
which were successfully cloned and expressed were based on similar mammalian 
deletion mutants [97].  
 
Figure 16 Summary of the construction of P. xylostella RyR deletion mutants containing 
963bp of the N-terminus (N-term) of P. xylostella RyR fused to the transmembrane (Tm) 
domain, using digestion with XbaI. 
One of the products of XbaI digestion contained the vector sequence together with a 
portion of the N-terminus of the RyR protein and the entire transmembrane region. 
This fragment was gel purified and re-ligated using T4DNA ligase. Both pcDNA3.1 
and pIZ deletion constructs were transformed into 25µl of XL-10 cells (Chapter II, 
section 2.7.3). After transformation, cells were allowed to recover in 250µl of S.O.C 
medium at 30oC, with shaking at 250rpm for 1 hour 30 minutes, and then plated out 
on two LB plates containing antibiotics (100µg/ml ampicillin for pcDNA and 
50µg/ml of Zeocin for pIZ). Positive clones were selected by colony PCR, using N-
terminus specific and transmembrane-specific primers. The ligation site within each 
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construct was sequenced to rule out the possibility of a frame shift having been 
introduced.  
3.3 Discussion 
3.3.1 M. persicae RyR 
Sequencing of the M. persicae RyR constructs and sub-cloned PCR fragments 
generated in this study highlighted 44 randomly distributed single nucleotide 
polymorphisms (SNPs) compared to the sequence data in the DuPont patent 
(US2007/0105098A1). 27 of these SNPs would be predicted to result in amino acid 
substitutions (Table 10) and might therefore affect the function of the receptor. 
Multiple alignments of 30 available RyR sequences from various organisms (insects 
and vertebrates) indicated that the translation of our sequence has a better match to 
other RyRs than does the DuPont sequence. The presumed PCR errors in the DuPont 
sequence were most likely the result of using a lower fidelity taq and a high number 
of PCR cycles to amplify the entire coding sequence in a two-step nested PCR 
reaction, as described in the patent methods.  
 
Table 10 SNPs in the M. persicae RyR sequence (DuPont data versus 
experimental results) 
Nucleotide 
residue DuPont experimental AA change 
453 C A N---K 
479 C G P---R 
675 C T 
 
1892 A C Q---P 
2137 A G N---D 
2195 G A G---E 
2454 C T 
 
2549 G A G---D 
2712 G A 
 
2972 G A G---E 
3696 C T 
 
3721 G A A---T 
3756 G A 
 
3923 G A G---D 
3943 G A G---R 
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4019 G A R---Q 
4414 C T P---S 
4771 G A G---R 
4854 A G 
 
5531 N A X---N 
5548 T C 
 
6287 G A R---K 
6817 G A V---M 
6830 T C P---L 
7577 A G Y---C 
7842 G A 
 
7938 G T K---N 
7988 G A G---D 
9166 C T H---Y 
9733 G C D---H 
10031 C T T---M 
10592 G A S---N 
10973 G A R---Q 
11004 C T 
 
11347 G A V---M 
11394 A G 
 
12221 T A L---Q 
12546 T A 
 
12819 G A 
 
13227 T C 
 
13398 T C 
 
14241 A G 
 
14414 C T S---L 
15033 G A 
 
 
The full-length coding sequence of the M. persicae RyR is 15,306bp long, which 
corresponds to a 5101 amino acid protein with a mass of 580 kDa. The deduced 
amino acid sequence has 46.2% identity with human RyR2 (accession number: 
CAA66975.1) and 75.5% homology to the D. melanogaster RyR (accession number 
NP_476991). The predicted protein sequence shares features with other invertebrate 
and vertebrate RyRs, including retention of commonly occurring domains such as 
MIR (212-293), SPRY (663-801, 1091-1214, 1539-1682) and RIH (440-648, 2219-
2450). One potential EF-hand Ca2+ binding domain pair (4198-4248) was also 
identified; this domain is also partly conserved in recently characterized P. xylostella 
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RyR sequences [165]. Transmembrane (TM) helix prediction using hidden Markov 
approach [198] indicated 6 potential helixes close to the C-terminal end of the M. 
persicae RyR sequence, with the probable pore forming domain localized between 
TM5 (4897-4919) and TM6 (4977-4996). The selectivity filter motif 
GXRXGGGXGD, critical for RyR ion conductance, is also fully conserved in the M. 
persicae sequence [199]. The amino acid residue Q(4863), found in mouse RyR2 
and thought to be a prerequisite for sensitivity of the channel to ryanodine, is also 
present [200].  Overall, this confirms that a true M. persicae RyR has been obtained. 
Three constructs were made for expression of M. persicae RyR: an untagged and an 
N-terminal eGFP tagged RyR for expression in mammalian (HEK) cells, and an N-
terminal eGFP tagged RyR for expression in insect (Sf9) cells. All 3 constructs were 
stable when propagated in E. coli, and it was possible to obtain large quantities of 
highly pure plasmid DNA for cell line transfections. Attempts were also made to 
clone and express the M. persicae RyR using a Bac to Bac® baculovirus expression 
system (Life technologies), but despite successful cloning of the full-length RyR into 
the pFastbac1 shuttle vector, it proved impossible to isolate recombinant bacmid 
DNA from DH10 Bac E. coli cells (data not shown). 
3.3.1.1 Expression of the M. persicae RyR in different life stages 
The level of expression of the RyR gene was measured in different developmental 
stages of M. persicae (clone 4106A); a mixed pool of first and second instar larvae, 
mixed third and fourth instar larvae, apterous and winged adults, but these showed 
no significant differences (Figure 17).  
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Figure 17 Summary of the relative expression of the RyR gene in different life stages of M. 
persicae clone 4106A. The apterous adult stage was used as a reference. There was no 
significant difference observed between all tested life stages. The data is presented as a mean 
of 3 biological and technical replicates with 95% confidence intervals.   
 
This finding is in contrast with other insect species which have been shown to have 
differential expression of RyR during development. For example, in P. xylostella the 
expression of RyR is significantly different between larval, egg, pupal and adult 
stages, and also in various body parts of the adult moth, being higher in the thorax 
and lower in the abdomen [165]. Differences were also found in expression of RyRs 
in isolated tissues of fourth instar larvae in another P. xylostella study [188]. 
Differential expression of the RyR gene was also found in Nilaparvata lugens (brown 
planthopper) between macropterous female adults and other developmental stages 
[201]. Tissue specific analysis of expression levels of RyR in M. persicae would be 
difficult to examine due to the aphids morphology; tissue dissection in such a soft 
bodied insect being a challenging undertaking.  
3.3.2 P. xylostella RyR 
The cloned P. xylostella RyR cDNA sequence reported here consisted of 15,354bp, 
corresponding to a 5,118 amino acid protein with a molecular mass of 579 kDa. The 
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deduced amino acid sequence has 77.3% identity with the cloned M. persicae RyR, 
91.7% with B. mori (unpublished), 78.3% with D. melanogaster (accession number 
NP_476991) and 45.8% with human RyR2 (accession number CAA66975.1). As 
found for the M. persicae channel, the P. xylostella RyR shares all of the 
characteristics of ryanodine receptors including: the highly conserved 
transmembrane region, the GXRXGGGXGD selectivity filter motif required for 
cation selectivity, RIH (2232-2454), MIR (212-393) and SPRY domains (664-803, 
1091-1214, 1551-1693). It also has a partly conserved calcium binding EF hand 
domain pair (4222-4271). The seven amino acid residues found in the rice leafroller 
(Cnaphalocrocis medinalis) RyR transmembrane region, which are thought to be 
lepidopteran specific, are also found in the P. xylostella RyR sequence at positions 
N(4953), N(4955), N(4966), L(4981), L(5012), N(5044), T(5095) [170]. It is 
speculated that these residues may play a part in diamide insecticide selectivity 
towards Lepidopteran species. Overall this confirms that a true P. xylostella RyR has 
been obtained. 
In contrast to the M. persicae RyR, sequencing of the P. xylostella fragments used 
for full-length cDNA assembly revealed many variations in the RyR coding 
sequence (Figure 18, encompassing: 4 splice sites: - a 15bp insertion and a large 
300bp deletion in one of the Nterm fragments, deletion of 132bp in one M1 
fragment, and a 41bp insertion in one of the Cterm fragments. Additionally, a large 
number (over 200) silent SNPs were found, with a clustered distribution suggesting 
that they are not a result of PCR errors (Figure 18). This P. xylostella RyR sequence 
variability and the presence of alternative splice sites were also reported 
independently [165], with all four of the splice sites identified in this study being 
confirmed, along with another additional 7 sites which were probably not identified 
in this current study due to limited clone coverage. Comparison of this current 
study’s assembled RyR sequence with the reported frequency of all 11 splice sites 
(in 10-20 sequenced clones) suggests that our cDNA construct is most likely the 
most prevalent form of the receptor in P. xylostella.
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Figure 18 Sequence alignment (using Geneious v6.05) of all of the P. xylostella RyR fragments generated for RyR cDNA assembly versus the initial 
sequencing results obtained early in the project. Gray bars represent sequence covered; names of individual cloned fragments are shown on the left. Black 
vertical lines represent individual SNPs, some of these could be attributed to the errors made by a low fidelity taq used to generate the reference sequence. 
Black horizontal lines represent individual splice sites. Top bar shows the scale numbering indviudal positions every 1000bp.
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Initially two constructs were made for the expression of the full-length P. xylostella 
RyR: an N-terminal eGFP-RyR fusion in pcDNA3.1(-) for expression in mammalian 
(HEK) cells, and an N terminal eGFP-RyR fusion in pIZ/V5 for insect (Sf9) cell 
expression.  Two deletion constructs, with only a small portion of the cytosolic 
domain and the entire transmembrane region, were also subsequently made. All four 
constructs were stable in E. coli and easily propagated.  
3.3.3 General remarks  
This chapter reports the successful cloning of RyRs from M. persicae and P. 
xylostella. During PCR initial amplifications ofM. persicae RyR it was found that 
better yields were obtained if the cDNA synthesis reaction was spiked with a gene 
specific primer binding to the 3’ UTR. Spiking had no apparent effect for 
amplification of P. xylostella RyR. It was also noted that PCR reactions using pfu 
polymerase and RyR cDNA as template needed extremely long extension times to 
achieve successful amplification. In the case of the LNK1 and LNK2 fragments, 
extension times as long as 5 minutes per kb were required if the reaction was to yield 
any product. Interestingly, despite the long extension times and the low annealing 
temperatures, primer binding remained specific with little evidence of artefacts. 
Propagation of all insect and mammalian RyRs (and sub-cloned fragments) in E. coli 
was done under lower growth temperatures than normal, in order to avoid plasmid 
rearrangements and colony growth suppression as the cloned fragments were toxic to 
the bacteria at higher temperatures. It was noted that lowering the temperature and 
extending the cell’s recovery time increased the efficiency of cloning for all DNA 
fragments above 2kb. In contrast, maintaining the cells at 37oC greatly decreased the 
chances of selecting successful transformants when cloning large DNA fragments. 
Additionally the density of the liquid cultures was critical for obtaining high yields 
of plasmid DNA. The highest yields of pure plasmids were obtained when the 
optical density measured at 600nm was between 0.8-1. During the expression 
experiments described in Chapter IV, an additional two P. xylostella constructs were 
made (one in pcDNA3.1(-), one in pIZ) without the eGFP tag and with 3 modified 
amino acids (which were potential PCR errors identified by aligning our sequence 
with other reported P. xylostella RyRs (details in chapter IV, section 4.3.3)). 
Chapter IV 
85 
 
Chapter IV: Functional expression of insect ryanodine 
receptors 
4.1 Introduction 
The main challenges for successful expression of RyRs are the complexity of the 
functional unit (a combination of four monomers), the large size of the individual 
subunits, and the intracellular membrane localization. In early studies conducted on 
mammalian RyR channels it was found that the purified RyR tetramers are very 
stable, allowing functional and structural analyses to be carried out [202, 203]. All 3 
mammalian RyR isoforms (isolated from different species, including Homo sapiens, 
Mus musculus (mouse) and Oryctolagus cuniculus (rabbit)) have been successfully 
expressed in various cell lines, including Chinese hamster ovary (CHO), Human 
embryonic kidney (HEK) 293, and Monkey kidney derived COS-1 and COS-7 [186]. 
The ability to achieve a good level of expression in cell lines has proven particularly 
useful for studying RyR mutations associated with different disease states, in 
understanding different domain interactions within the receptor, and in identifying 
the location of the binding sites for various ligands and accessory proteins [186].  
To date there have been very few attempts to express and functionally analyse insect 
RyRs. The first analysis was done on native protein purified from H. virescens 
thoracic tissue [176].  The RyR from D. melanogaster was the first insect channel to 
be successfully expressed in CHO cells, but the level of expression obtained allowed 
only very basic electrophysiological measurements to be made, and a further limited 
electrophysiological analysis of a truncated channel containing only the C-terminal 
TM region to be carried out [163]. The same CHO expression system  was also used 
for confirming that the receptor is the target protein for the diamide insecticide 
flubendiamide, through calcium release assays on full-length RyR using fluorescent 
calcium imaging techniques [31]. More recently the full-length B. mori RyR and a 
series of deletion mutant constructs were expressed successfully in HEK293 cells.  
The expression level was sufficient for in vivo measurements of ER Ca2+ 
mobilisation through the RyR by caffeine, ATP, and by flubendiamide. Functional 
analysis of the deletion mutants pinpointed the binding region of flubendiamide to 
the TM part of the protein (see more detail in Chapter I section 1.2.1, figure 19) [30].  
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Figure 19 Graphical representation of known diamide sites of interaction on the model 
insect ryanodine receptor based on B. mori RyR expression.  
Sf9 and Sf21 are insect cell lines established from pupal ovarian tissue of 
Spodoptera furgiperda (fall army worm) and they are primarily used for protein 
expression using the baculovirus system [204]. Insect cells are often used for the 
production of mammalian proteins since they have eukaryotic processing 
capabilities, being deficient only in the ability to glycosylate the final protein 
products. In many cases this glycosylation deficit has been overcome by modifying 
the cells lines to incorporate mammalian glycosylation genes, which allows the 
production of ‘human-like’ glycoproteins [205]. In the past both Sf9 and Sf21 cells 
have been used to express rabbit skeletal RyRs using the baculovirus system. Both 
cell lines were able to produce large quantities of fully-functional protein, which was 
almost identical to the isolated native channels [125, 206].  So far there have been no 
published reports of invertebrate RyRs being expressed in insect cell lines. 
In this chapter a detailed overview of methods and optimization approaches used to 
successfully express two insect RyRs in mammalian HEK 293 and in insect Sf9 cells 
is described and evaluated.  
4.2 Methods 
In the course of this project various approaches were tested to try and achieve 
optimal transfection and protein expression in two cell lines: insect Sf9 and 
mammalian HEK 293 (growth and maintenance of both cells lines are described in 
Chapter II sections 2.10 and 2.11). Since the primary objectives of this chapter was 
to find optimal expression conditions for both insect RyRs, experiments showing 
poor expression and lack of function were not replicated more than two or three 
times in order to save resources and time. This methods section outlines the general 
protocols used, and the optimised conditions empirically achieved through a series of 
modifications of the initial protocols are discussed in the Results and Discussion 
Chapter IV 
87 
 
section. Experiments which produced poor expression or no receptor function were 
not rigoroulsly quantified and GFP construct expression experiments were compared 
visually to the mammalian RyR2 positive controls, without fluorescent signal 
quantification, since there was no access to appropiate software tools.  
4.2.1 Transfections 
4.2.1.1 Calcium phosphate transfections of HEK 293 cells 
Calcium phosphate was the initial method of choice for transfecting large quantities 
of HEK 293 cells. A typical transfection was done in twenty 90mm cell culture 
dishes (Sigma-Corning, MA, USA). The protocol used was optimised for expressing 
the mammalian RyR2 cardiac channel (Cardiff University), transfecting batches of 
10 dishes at a time. Twenty-four hours prior to transfection, cells were harvested and 
counted (as described in Chapter II, section 2.11), and 1x106 cells were seeded into 
each dish containing 9ml of complete DMEM media (Life technologies, CA, USA). 
The transfection mixture used was:  5ml of 2xHEPES solution pH 6.95 (recipe in the 
Appendix A, section 2) in one 50ml Falcon tube and 1.24ml of 1M CaCl2 together 
with plasmid DNA (12µg per plate) in a second 50ml Falcon tube, the total volume 
of this tube being brought to 5ml using sterile distilled water. The DNA-calcium 
solution was then added drop-wise into the 2xHEPES solution (tube 1) with shaking. 
This ensured the formation of the fine precipitate required for good transfection 
efficiency [207]. 1ml of the precipitate solution was then dispensed into each culture 
dish and the dishes were placed in a 37oC / 5% CO2 incubator.  Fresh complete 
DMEM media was added to the cells 24 hours later and all cells were harvested 48 
hours post transfection. 
4.2.1.2 Cellfectin™ II transfections of Sf9 cells 
Cellfectin™ II (Life Technologies, CA USA) is a lipid based reagent designed for 
transfecting insect cells and is recommended by the supplier as a “superior” method 
of transfection. Initial experiments with Cellfectin were done in 6-well plates and 
later, larger scale, transfections in 60mm cell culture dishes (Sigma-Corning, MA, 
USA). The protocol for the 6-well plates was as follows: 8x105 cells in 3ml of Sf-
900 II medium containing 0.6% FBS (no antibiotic) were seeded into each well and 
left overnight to attach to the bottom of the plate. On the day of transfection at least 
Chapter IV 
88 
 
1µg of DNA was diluted in 100µl of Sf-900 II medium (non FBS supplemented) in a 
1.5ml tube, and 8µl of the Cellfectin reagent was diluted in the same volume of 
medium in a second 1.5ml tube. Both tubes were vortexed and incubated at room 
temperature for 15-30 minutes, then the contents of both tubes were combined, 
vortexed and incubated for a further 5-10 minutes. In the meantime, the FBS-
containing medium was removed from the attached cells in each well, the cells 
washed once with 2ml of fresh medium (to remove any traces of FBS) and the wells 
filled with 2ml of un-supplemented Sf-900 II. After incubation, the transfection 
mixture was added drop-wise to the cells, the plate gently rocked to evenly distribute 
the solution, and left to transfect in a 27oC incubator for 4h. The medium containing 
the transfection solution was then removed and replaced with 3ml of fresh Sf-900 II 
containing 0.6% FBS. 
 For the large scale transfections at least ten 60mm dishes were transfected at a time. 
One day prior to transfection 2.5x106 (approximately 65-70% confluence) cells were 
seeded into each dish containing 5ml of unsupplemented Sf-900II media. The exact 
amounts of DNA, Cellfectin reagent and incubation times for each step were first 
determined in the small scale transfections and are discussed in section 4.3.2.3. The 
transfections were set up similarly to the small scale ones: desired amounts of DNA 
and Cellfectin were first diluted in two tubes containing 500µl Sf-900 II medium (no 
FBS) for each 60mm dish, and after appropriate incubation time, the contents of both 
tubes were mixed together. After further brief incubation, transfection solutions were 
gently (to avoid disturbance of the monolayer) applied to each 60mm dish and cells 
were placed at 27oC for 48-72h.  
4.2.2 Optimization of transfection methods  
4.2.2.1 HEK 293 cells 
For calcium phosphate transfections, the efficacy of using differing amounts of 
plasmid DNA (12µg, 16µg or 20µg per plate) was investigated. The effect of adding 
1.7mM sodium butyrate (a known transfection and translation up-regulation agent 
[183, 208, 209]) 15-25h post transfection was also tested. Other commercially 
available transfection reagents were also assessed, including Effectene® (Qiagen, 
Hilden, Germany) and JetPrime® (PolyPlus™ transfections SA, Illkirch, France), 
following the manufacturer’s recommended protocols. 
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4.2.2.2 Sf9 cells 
In order to achieve the highest possible transfection and expression efficiency, 
various amounts of plasmid DNA and PLUS™ reagent (Life technologies, CA, 
USA) were equilibrated together prior to incubation of the DNA with Cellfectin II 
reagent (see Table 11). Addition of PLUS™ reagent (a transfection enhancer) was 
according to the manufacturer’s recommended protocol (5µl per well in 6 well-
plates). Various DNA / reagent incubation times were also investigated: 15, 30 and 
45 minutes for the DNA / PLUS™ reagent and 5, 10 and 15 minutes for the DNA 
mixture / Cellfectin reagent. The effect on cell viability of maintaining Sf9 cells in 
the transfection medium after 4h incubation was also looked at. The efficacy of 
adding 1-1.7mM sodium butyrate 4h and 24h post-transfection was also assessed. 
Expression efficiencies and expression levels were analysed 24h, 48h and 72h post 
transfection by imaging with a Leica M205 FA microscope using GFP2 filters. 
Table 11 Composition of transfection reactions 
Cellfectin™ (µl) Plasmid DNA (µg) PLUS™ reagent (ul) 
10 20 0 
20 20 0 
30 20 0 
15 8 0 
15 10 0 
15 12 0 
15 15 0 
15 20 0 
15 1 5 
15 8 5 
 
Additionally, different transfection methods were analysed including calcium 
phosphate and FectoFly® (Polyplus-transfection SA, Illkirch, France) reagent, 
following the manufacturer’s recommended protocol. 
4.2.3 Analysis of transfected cells  
4.2.3.1 Mixed-membrane preparation   
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To make a mixed-membrane preparation, cells were collected from the culture dishes 
(60mm-Sf9, 90mm-HEK 293) by gentle tapping and pipetting. Cells were then 
counted using a hemocytometer and then re-suspended in hypo-osmotic buffer (see 
Appendix A section 3) at a density of 1x106 cells (HEK 293) or 2x106 cells (Sf9) per 
ml of buffer. Cell aliquots of 10-15ml were homogenised using a glass homogeniser 
kept on ice (around 10 even strokes), and each aliquot was then passed at least 10 
times through a 23G gauge needle attached to a 10ml syringe. The homogenate was 
centrifuged at 2700rpm (1500g) and 4oC for 15 minutes to remove broken cells and 
nuclei. The supernatant was carefully removed and then centrifuged at 28,000rpm 
(100,000g) in a Beckman Optima–L90K centrifuge, using a 50.2 Ti rotor, for 1h at 
4oC. The pellet was then transferred to a 1ml glass homogeniser kept on ice, 
resuspended in 0.4M sucrose, 20mM HEPES solution (20µl per 1x106 (HEK 293) 
cells or 2x106 (Sf9) cells) and homogenised to give a fine suspension. Mixed-
membrane preparations were first flash frozen in liquid nitrogen and stored in 100µl 
aliquots in a -80oC freezer. 
4.2.3.2 Protein assays 
A micro BCATM (bicinchoninic acid assay) protein assay (ThermoScientific, MA, 
USA) was used to quantify protein. The mixed-membrane sample was diluted 1:50, 
1:100, 1:200 in double distilled water, mixed well, and 100µl of the diluted protein 
was loaded into a 96 well (flat bottom) plate, either in duplicate or triplicate. 200µl 
of working reagent (a mixture of kit reagents A, B and C) was then added to each 
well and the plate incubated in the dark for 15 minutes. The absorbance of each well 
at 595nm was measured using a UV max kinetic micro-plate reader (Molecular 
Devices, CA, USA). The protein concentration of each mixed-membrane preparation 
was then calculated by fitting the average absorbance values of each duplicate or 
triplicate sample onto the BSA (bovine serum albumin) standard curve.  
Alternatively, a Bradford reagent (Bio Rad, CA, USA) assay was used. The mixed-
membrane preparation was diluted 1:2, 1:4, 1:8, 1:16 in double distilled water and 
measured against a set of BSA standards in a 96 well (flat bottom) plate. 200µl of 
Bradford reagent and 5µl of the diluted mixed-membrane sample were added to each 
well. All concentrations were prepared in duplicate. Readings were taken after a 10 
minute incubation by measuring the absorbance at 590nm, using a SpectraFluor Plus 
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(Tecan, Dorset, UK) micro-plate reader, and the protein concentration in each well 
was determined by the Magellan™ data analysis software (Tecan) associated with 
the plate reader. 
4.2.3.3 Radio-ligand binding assays  
Two different methods were used for the radio-ligand binding assay experiments; a 
glass micro-fibre GF/B filter disc (GE Healthcare-Whatman®, Little Chalfont, UK) 
assay, which was used for testing the expression levels of the RyRs, and a 96 well 
GF/B filter plate (PerkinElmer, MA, USA) based assay which was used to determine 
the binding kinetics of ryanodine to the receptors.  
The glass micro-fibre filter disc assay protocol was as follows: The binding buffer 
(recipe in Appendix A, section 5.1) was made up on the day of the experiment. 
Experiments were done in duplicate or triplicate for hot (total binding) and cold 
(non-specific binding) reactions. For the hot reaction, samples were set up in 3ml 
vials (VWR, PA, USA) in a total volume of 500µl, consisting of 100µg of the 
mixed-membrane preparation, 20µl of [3H] ryanodine (0.1mCi/ml) (PerkinElmer, 
MA, USA) (final concentration of [3H] ryanodine 8nM) and binding buffer up to 
500µl. The cold reaction had 100µg of mixed-membranes, 20µl of [3H] ryanodine, 
5µl of cold ryanodine (final concentration 5µM) and binding buffer up to 500µl. 
Samples were thoroughly mixed by vortexing and incubated in a 37oC water bath for 
90 minutes. The filter discs were pre-soaked in binding buffer and, after the sample 
incubation was completed, the samples were loaded onto the glass micro-fibre filters 
using a vacuum manifold. The glass vials were then washed with 500µl of binding 
buffer to recover any residual sample. Following sample binding, filter discs were 
washed with an additional 500µl of binding buffer. After the vacuum pump filtration 
was completed all discs were transferred to individual scintillation vials containing 
5ml of Ultima gold™ MV scintillation fluid (PerkinElmer, MA, USA), and loaded 
onto a Packard Bioscience (now PerkinElmer) 2100TR TriCarb Liquid Scintillation 
Analyzer for counting. Obtained dpm values were then processed to calculate the 
amount of specific binding using Office Excel 2010 (Microsoft, CA, USA). 
The 96 well filter plate assays were carried out as follows: the mixed-membrane 
preparation was diluted in buffer A (all the buffers recipes can be found in Appendix 
A, section 5.2) to a final concentration of 0.25mg/ml. Both total and non-specific 
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reactions were set up in a 96 well flat bottom microtiter plate in a total volume of 
250µl. For each reaction 48µl of Buffer B containing 0.01% Pluronic (Sigma, MA, 
USA) was added together with 2.5µl of DMSO (for total reaction) or 1mM 
ryanodine (final concentration 10µM) in DMSO (for non-specific reaction), 100µl of 
diluted mixed-membrane preparation and 100µl of diluted [3H] ryanodine (to the 
desired final concentration).  Empty wells on the plate were filled with buffer B and 
diluted (old) membrane preparation. The plates were shaken gently and left to 
incubate at room temperature for 2h. The 96 samples were then loaded onto the filter 
plate (with each well pre-soaked with 50µl of 0.1% polyethylenimin in wash buffer) 
using a 96 well plate harvester (Brandel, MD, USA). The filter plate was then 
washed 3 times with 250µl wash buffer and left overnight at room temperature to 
dry. Each well on the plate was then filled with 50µl MicroScint™-O (PerkinElmer, 
MA, USA) and the filter plate loaded into a TopCount NXT™ Micro-plate 
Scintillation counter (PerkinElmer, MA, USA). Specific binding and binding 
kinetics values (equilibrium dissociation constant Kd and Binding capacity/receptor 
density Bmax) were calculated using GraphPad Prism v5.5 (GraphPad, CA, USA). 
4.2.3.4 Western Blotting 
Mixed-membrane preparations from HEK 293 cells transfected with P. xylostella or 
M. persicae RyR-eGFP fusion constructs were run on 5% (w/v) polyacrylamide gels 
(recipe in Appendix A, section 4) and blotted onto nitrocellulose membranes using 
an iBlot 7 minute blotting system (Life technologies, CA, USA) following the 
manufacturer’s recommended protocol. The nitrocellulose membranes were then 
blocked with 5% (w/v) powdered skimmed milk (VWR, PA, USA) in TBS-T (recipe 
in Appendix A, section 4) for 1h at 4oC, washed with TBS-T and then incubated 
overnight at 4oC with primary mouse monoclonal anti-eGFP antibody (Santa Cruz 
biotechnology, TX, USA) at a 1:5000 dilution in 1% (w/v) powdered milk/TBS-T.  
After removal of unbound primary antibody with 3 washes of TBS-T buffer, the blot 
was incubated for two hours with 1:5000 diluted secondary goat anti-mouse 
horseradish peroxidase conjugated antibody (Sigma, MA, USA) in milk/TBS-T  
After a further 3 washes with TBS-T buffer, the antibody attached peroxidase 
activity was detected  by breakdown of a luminol (ECL) substrate (GE Healthcare, 
Little Chalfont, UK) and exposure of the blot to X-ray film. The protein was 
Chapter IV 
93 
 
visualised after a 30 minutes exposure by developing the X-ray film using an X4 
Automatic X-ray Film Processor (Xograph, Stonehouse, UK). 
4.2.4 Microscopy  
The efficiency of transfection was checked by examining fluorescence images of 
transfected Sf9 cells expressing eGFP-RyR fusion constructs using a Leica M205 
LA light microscope with GFP2 filter (Leica, Wetzlar, Germany), and similarly 
transfected HEK 293 cells with a Zeiss Axio Vert fluorescence microscope x10 
objective (Zeiss, Oberkochen, Germany). This step was omitted for untagged RyR 
constructs. High magnification images were taken using either a Leica SP5 x63 oil 
immersion lens or Zeiss 780LSM x63 and x40 water immersion lenses. HEK 293 
and Sf9 cells were imaged both in vivo in culture dishes and fixed onto coverslip 
with 0.4% formaldehyde.  
4.2.4.1 Calcium release assays for HEK 293 cells 
Expression of full-length P. xylostella and M. persicae constructs, and the P. 
xylostella deletion mutant in HEK 293 cells, was determined by monitoring the 
release of calcium from internal stores with a calcium sensitive fluorescent dye after 
addition of RyR agonists. 1x105 HEK 293 cells were seeded onto glass bottom 
dishes (MatTek, MA, USA) (12mm diameter) and transfected with plasmid DNA 
containing the RyR cDNA using Effectene® as follows (protocol to prepare 7 
dishes): plasmid DNA (0.8µg) was diluted with 6.4µl of enhancer in 100µl of EC 
buffer (both supplied with Effectene®) and the mixture was incubated for 5 minutes 
at room temperature. After 5 minutes, 20µl of Effectene® was added and the mixture 
incubated for a further 10 minutes. In the meantime cells were washed with complete 
DMEM medium (cDMEM, containing 10% FBS and penicillin/streptomycin 
100U/100µg/ml). Then 600µl of cDMEM was added to the plasmid DNA / 
Effectene® mixture and thoroughly mixed by vortexing. 100µl of this solution was 
then applied to each dish and the cells were returned to the 37oC / 5% CO2 incubator. 
HEK 293 cells expressing human RyR2 were used as a positive control for the 
calcium imaging experiments and Fluo-3 AM (Life technologies, CA, USA) loaded 
un-transfected HEK 293 cells were used to test for potential excitation of 
endogenous calcium stores. Cells in 200µl DMEM were loaded with 2µl of a 1mM 
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solution (final conc. 10µM) of Fluo-3 AM calcium sensitive dye, 24 and 48 hours 
post transfection, and incubated for 45 minutes at 30oC / 5% CO2 to avoid dye 
compartmentalization. After the loading was completed, cells were incubated for 10 
minutes with 2ml of fresh DMEM media. Calcium release events were imaged using 
an SP5 confocal microscope (Leica, Wetzlar, Germany) with the cells in 200µl of 
fresh DMEM. 60 second recordings were made, one recording per dish per agonist, 
measuring excitation at 488nm and capturing emissions at 525 nm every 70ms.   
4.2.4.2 Calcium release assays in Sf9 cells 
Fura 2-AM dye (Life technologies, CA, USA) was used for monitoring calcium 
release in Sf9 cells transfected with the untagged P. xylostella RyR.  Glass coverslips 
(1cm diameter glass) coated with Poly-L-lysine (Sigma, MA, USA) were placed in a 
4 well plate. Each well was then filled with 500µl of Sf-900 II medium and each 
coverslip was seeded with 2.5x105 cells. Cells were allowed to attach to the 
coverslips for 1h and then they were transfected in 4 well plates using the optimised 
Cellfectin™ II method (discussed later in section 4.3.2.3). 24h, 48h, 72h and 96h 
post transfection cells were loaded with  1mM of Fura 2-AM. Cells on coverslips in 
4 well plates were first put into 500µl of fresh SF-900 II medium and then 2µl of the 
dye stock solution (5mM) was added. Cells were left to incubate at 27oC for 45-60 
minutes, followed by 3 washes with 500µl of fresh un-supplemented Sf-900 II 
medium. Prior to imaging, coverslips with Fura 2 loaded cells were placed in 
standard Ringer’s solution (recipe in Appendix A, section 8). All imaging was done  
using an Axio Vert.A1 microscope with a LD Plan-Neo Fluar x20/0.4 lens (Zeiss, 
Oberkochen, Germany), measuring the ratio of  excitation at 340/380nm (calcium 
free/calcium bound indicator) every 180ms and capturing emission at 510nm for at 
least 60 seconds. Cells on the coverslip were placed into a perfusion chamber of 
approximately 0.5 ml volume mounted on the microscope stage which was 
connected to a peristaltic pump, allowing for a constant fluid exchange (flow rate 3 
ml/min). Test solutions were applied using 3-5 seconds bursts via a glass u-tube 
(Figure 20).  
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Figure 20 Perfusion chamber setup with a glass U-tube applicator for recording of multiple 
agonist applications. Black arrows indicate flow of Ringer’s solution, which allows for a 
constant replacement of solution in the perfusion chamber. Agonist solutions are applied via 
the glass U-tube, where flow is controlled by recording software (VisiView®) or the 
electrical switch on the  the peristaltic pump. When the U-tube flow is stopped, agonist 
present inside the tube diffuses over the cells by seepage through the application hole. 
Experiments were recorded using VisiView® software (Visitron Systems, Puchheim, 
Germany) and the numerical data analysed using Microsoft Excel 2010 and 
SigmaPlot v.12 (Systat Software). The data were normalized using the equation: 
R/R0, where R is a fluorescence ratio value recorded for individual time points and 
R0 is an average fluorescence ratio calculated over the first 5 seconds prior to 
addition of the agonist. Data points on graphs are presented as the mean values of 
individual cell responses for each independent experiment and standard errors 
compared to the mean. The normalized amplitude responses of individual cells were 
calculated by estimating the highest value subtracted from the basal level (Rmax–
R0=∆Rmax) and normalizing with the equation: ∆Rmax/R0. Final amplitude data was 
presented as a mean value of all cells in the individual experiment and the standard 
deviation of the mean. 
 
 
 
Chapter IV 
96 
 
4.2.5 Membrane solubilisation and sucrose gradient purification 
Mixed-membrane preparations of known protein concentration were diluted 1:4 with 
0.4M KCl, and centrifuged at 50,000rpm ( approximately 100,000g) for 30 minutes 
at 4oC using an OPTIMA TLX (100.4 Ti Rotor) Beckman ultra-centrifuge. The 
supernatant was discarded and the pellet was re-suspended in solubilisation buffer to 
a final protein concentration of 2mg/ml (recipe in Appendix A, section 6) and 
CHAPS/PC (3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate 
/ phosphatidylcholine) added to a final concentration of 0.6% (v/v) from the freshly 
prepared stock solution of 10% (w/v) CHAPS in double distilled water. The pellets 
were passaged through a 23G gauge needle attached to a 10ml syringe and 
transferred to 1.5ml eppendorf tubes and the mixture was incubated at 4oC for 1h. 
The membrane lysate was centrifuged in an Eppendorf 5415R centrifuge at 11,500 
rpm for 30 minutes at 4oC and the supernatant collected and kept on ice.  
Sucrose gradients were prepared using two mixing chambers connected to a 
peristaltic pump. 40%, 35% and 5% (w/v) sucrose solutions prepared in gradient 
buffer were incubated in a cold room on a rolling platform for 1h. 5ml of the 40% 
(w/v) sucrose solution was added to 2 high speed 36ml centrifuge tubes (Beckman) 
as a cushion. Chamber A and the chamber connector channel was filled with 40ml of 
the 5% (w/v) sucrose solution, and chamber B was filled with 25ml of the 35% (w/v) 
sucrose solution while being stirred by a magnetic stirrer. Once the two chambers 
were filled, the peristaltic pump was turned on and the tap between the two chambers 
was opened allowing a gradient to form and the sucrose mixture to migrate to fill the 
2 centrifuge tubes.  
4mg of solubilized membrane lysate (2mg/ml) was then gently pipetted as a layer on 
top of formed gradients and the tubes centrifuged at 28,000 rpm for 16 to 18h at 4oC 
using a Beckman OPTIMA L100 XP (rotor 32 Ti) centrifuge. Gradient fractions 
were collected in 2ml aliquots using a fraction collector (Pharmacia Biotech-GE 
Healthcare, Uppsala, Sweden) and their sucrose concentration checked using a 
refractometer. Ryanodine receptors were found in fractions containing 27-29% (w/v) 
sucrose. 
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4.2.6 Single channel recordings 
Both mixed-membrane preparations and sucrose-gradient purified full-length RyR of 
P. xylostella, M. persicae, and the P.xylostella deletion mutant, were tested for 
channel activity in an artificial bilayer system held under voltage clamp. The planar 
phospholipid bilayers were formed from a suspension of synthetic 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphoethanolamine (Avanti Polar Lipids, AL, USA) in n-
decane (35 mg/ml) painted across a 200 μm-diameter hole in a partition separating 
the cis (0.5 ml) and trans (1.0 ml) chambers. The trans chamber was held at ground 
and the cis chamber was clamped at relative holding potentials. Current flow was 
measured using an operational amplifier as a current-voltage converter [210]. 
Bilayers were formed in symmetrical solutions containing 210 or 610 mM KCl, 20 
mM HEPES, pH 7 in cis and trans chambers. To measure single channel currents, 
aliquots of RyR2-containing fractions and 3M KCl were added to the cis chamber 
creating favourable conditions for channel incorporation in a fixed (cytosolic side at 
the cis chamber, luminal face to the trans chamber) orientation [211]. 
Unincorporated channels and the osmotic gradient were removed by perfusion and 
the single channel Po (open probability) was increased following the addition of 
100µM EMD 41000 [212] to the cis chamber. For the deletion mutant mixed-
membrane preparation, a 250mM and 3M Caesium gluconate with 20mM HEPES 
solution was used instead of standard KCl, following methods described for 
characterization of D. melanogaster C-terminal RyR [163].  
4.3 Results and Discussion 
4.3.1 Expression of the Myzus persicae RyR  
Table 12 summary methods of individual transfection experiments done for M. 
persicae constructs in HEK 293 cells 
Construct Trasfection 
method 
Number  of 
experiments 
Analysis of function 
WT M. persicae 
RyR 
Calcium 
phosphate 
3 [3H] ryanodine binding 
artificial bi-layers 
GFP M. persicae 
RyR 
Calcium  
phosphate 
4 Western blot, [3H] 
ryanodine binding 
JetPrime® 3 Calcium release assay 
Effectene® 3 Calcium release assay 
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4.3.1.1 Untagged RyR in HEK 293 cells 
Initial expression of the untagged M. persicae RyR construct in HEK 293 cells gave 
a high yield of protein in the mixed-membrane preparation (between 18-36mg/ml 
when tested with the micro-BCATM assay) from cells harvested 48 hours after a 
standard calcium phosphate transfection, but there was no evidence of specific [3H] 
ryanodine binding. Additionally, no RyR channel activity was detected in artificial 
bilayers, using either mixed-membrane preparations or sucrose gradient purified 
RyR. Lack of an insect RyR-specific antibody or a fluorescent tag on the RyR 
protein made it impossible to determine whether this was due to poor expression of 
the cDNA or protein miss-folding. 
4.3.1.2 eGFP-RyR in HEK 293 cells 
The modified construct with an N-terminally-fused eGFP sequence allowed visual 
monitoring of the expression and efficiency of RyR transfections in HEK 293 cells. 
Localization of fluorescence in individual cells, and the assessment of the amount of 
RyR channels present, was done using high-magnification confocal imaging and 
eGFP-specific antibody detection on Western blots. The M. persicae eGFP-RyR 
construct gave a poor level of expression 48h post transfection using calcium 
phosphate as a transfection reagent, with no more than 5% of the cells displaying a 
GFP signal per field of view (Figure 21).  
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Figure 21 Low magnification images, using a Zeiss Axio Vert microscope (x10 objective), 
showing HEK 293 cells calcium phosphate transfected with A: human e-GFP-RyR2 fusion 
plasmid and B M. persicae eGFP-RyR plasmid. Images on the right are of the bright field 
view. 
After further attempts at optimization (4 independent transfection experiments) it 
was concluded that calcium phosphate transfection does not give satisfactory 
amounts of M. persicae RyR protein. The addition of 1.7mM sodium butyrate, 4h 
and 24h post transfection, did not increase the number of fluorescing cells or the 
strength of the signal in individual cells per field of view. Further experiments using 
JetPrime® or Effectene® did not give a visual improvement over the calcium 
phosphate transfection method. In an attempt to optimise the transfection using 
Effectene®, two concentrations of plasmid DNA (protocol recommended and a 
higher than recommended quantity) were used; however it was apparent that even 
when very high (32µg) amounts of plasmid DNA were added the overall efficiency 
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and expression level was still low in comparison to the human RyR2 control (Figure 
22).  
 
Figure 22 Low magnification images, using Zeiss Axio Vert microscope (x10 objective), 
showing HEK 293 cells Effectene® transfected with A: human eGFP-RyR2 fusion plasmid 
B: M. persicae eGFP-RyR fusion plasmid. Images on the right show the bright field view. 
Transfections with JetPrime® showed a relatively good efficiency compared to 
mammalian RyR2 controls, with approximately 30-40% of cells fluorescing per field 
of view. However, the expression level in individual cells was very low (data not 
shown). Extending the post transfection incubation time from 24 to 48 hours did 
improve eGFP expression; however Western blots of membrane preparations 
showed no protein band of the expected size after labelling with anti-eGFP primary 
antibody, suggesting a very low expression level or miss-targeting of the protein. 
Calcium release assays on HEK 293 cells transfected with Effectene® or JetPrime® 
and M. persicae eGFP-RyR plasmid DNA showed no release of calcium in response 
to 10mM and 30mM caffeine (tested in 3 independent experiments, 6 dishes each). 
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 4.3.1.3 eGFP-RyR in Sf9 cells 
The N-terminal eGFP fusion construct of M. persicae RyR was expressed in Sf9 
cells using two different transfection reagents; Cellfectin™ II and Fectofly®, but as 
in the HEK 293 cells the efficiency of expression (approx. 5-10% of cells) and 
strength of the signal in individual cells were poor. Modifying the amount of reagent, 
plasmid DNA and addition of transfection enhancer (PLUS™ reagent) had no visual 
effect. As for HEK 293 cells, the calcium release assays with Fluo-3 AM dye and 
20mM caffeine showed no activation of calcium release after addition of the agonist.  
4.3.2 Expression of the P. xylostella RyR 
4.3.2.1 eGFP-RyR in HEK 293 cells 
As for the M. persicae RyR, the calcium phosphate transfection method proved to be 
unreliable in achieving a high-level of expression of P. xylostella RyR. Although the 
overall transfection efficiency appeared to be higher when compared to the aphid, it 
did not reach the levels seen in the human RyR2 control. Reagent-mediated 
transfections also did not produce satisfactory results; the reproducibility of 
transfection was greatly increased in comparison to using calcium phosphate, but the 
expression level (assessed visually) was still not as good as the human RyR2 control 
(data not shown).  However, for membrane preparations isolated from P. xylostella 
RyR / JetPrime® transfected cells it was possible to detect both the full-length RyR 
and the deletion mutant proteins on Western blots. For the deletion mutant a 
comparable level of expression to the human RyR2 control was achieved (Figure 
23).  
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Figure 23 Western blot of membrane preparations from HEK 293 cells expressing 1) the P. 
xylostella eGFP-RyR deletion mutant transfected with calcium phosphate, 2) M. persicae 
eGFP-RyR transfected with calcium phosphate 3) P. xylostella eGFP-RyR 4) human eGFP-
RyR2 transfected with calcium phosphate (positive control). Ladder markers are indicated 
with arrows. The result shows a large molecular weight band in lane 3, similar in size to the 
human RyR2 control and the expected molecular weight for the deletion mutant protein in 
lane 1. 50µg of mixed-membrane preparation was loaded onto each lane. 
Fluorescent imaging of fixed HEK 293 cells expressing the P.xylostella eGFP-RyR 
fusion protein, revealed a diffused cytosolic eGFP signal, which was excluded from 
the nucleus and plasma membrane. This contrasts with images obtained for the 
eGFP-tagged human RyR2 channel in HEK 293 cells imaged in vivo, which show a 
more ‘spider web’ like pattern associated with the eGFP expression being targeted 
exclusively into ER membranes (Figure 24). The P.xylostella RyR deletion mutant, 
however, showed a more reticular eGFP expression pattern, comparable to the 
mammalian RyR2 control (data not shown). The cytosolic expression of the full-
length insect eGFP-RyR fusions is comparable to the expression of eGFP protein on 
its own, as was demonstrated in earlier attempts to express D. melanogaster eGFP-
RyR fusion proteins in CHO cells [163].  
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Figure 24 In vivo, high magnification, images, obtained using x63 lenses on a Leica SP5 
microscope, of HEK 293 cells expressing A) P. xylostella eGFP-RyR fusion protein, B) M. 
persicae eGFP-RyR fusion, C) human eGFP-RyR2 fusion (kindly provided by Dr Lowri 
Thomas, Cardiff University) (pictures on the right show  bright field view of imaged cells). 
The eGFP signal is excluded from the nucleus (white arrows) in all 3 images; however the 
cells expressing insects RyRs do not exhibit the “spider-web” like pattern of expression seen 
with the human RyR2 construct (C). 
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4.3.2.2 Functional analysis of P. xylostella eGFP-RyR expressed in HEK 293 
cells 
Out of 8 experiments set up to measure the response of the full-length P. xylostella 
eGFP-RyR to 20mM caffeine, only three cells in one dish gave a positive response. 
This is in direct contrast to the control imaging done on transfected cells not loaded 
with fluo-3 AM dye, showing at least 1-2 eGFP fluorescing cells per field of view at 
high magnification. It appears that the functioning of the channel is abolished or 
severely impaired when expressed in HEK 293 cells. In the case of the P. xylostella 
deletion mutant, it was assumed that the caffeine binding site would no longer be 
present, so caffeine was not used. Out of 8 dishes transfected with the deletion 
construct, half were tested with 20µM ryanodine and the other half with 30µM 
flubendiamide. No responses were recorded for either agonist. It was speculated that 
most cells expressing the deletion protein did not survive the dye loading procedure. 
As in the case of the M. persicae RyR constructs no [3H] ryanodine binding was 
detected for either the P. xylostella full-length or deletion construct RyR and no 
channels were incorporated and recorded in the lipid bilayers. 
4.3.2.3 eGFP-RyR in Sf9 cells 
Expression of the P. xylostella eGFP-RyR fusion construct in Sf9 cells showed lower 
efficiency to eGFP only controls (Figure 25), with the strength of the signal in 
individual cells being significantly weaker. Basic calculation of the efficiency by 
selection of a small portion of the image containg approximately 100-200 cells 
showed values for GFP only of 56-58% and for the P. xylostella approx. 20% 
without PLUS™ reagent and approximately  35% with the reagent.  
Chapter IV 
105 
 
 
Figure 25 Low magnification images of transfection experiments for the expression of the 
P. xylostella eGFP-RyR fusion protein in Sf9 cells (bright field view showed on the right). 
Panels: A) control plasmid carrying only the eGFP sequence (1µg of DNA), B) large 
amounts (15 µg) of plasmid DNA were required to achieve good transfection efficiency, C) 
addition of PLUS™ reagent improved the efficiency and decreased (8 µg) the amount of 
plasmid DNA needed. White sequare indicate the size of the imaged used for counting the 
efficiency. 
After optimisation of transfection conditions the best results were achieved when 10-
12µg of plasmid DNA was used with Cellfectin™ II treated cells. Higher amounts of 
DNA did not improve the success of the transfection, and higher quantities of 
Cellfectin™ II (<15µl) had a detrimental effect on cell viability. Addition of 
PLUS™ reagent to the plasmid DNA mix did improve the transfection efficiency 
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and gave good results with much lower amounts of DNA (1µg), with the best results 
being achieved using 8µg of plasmid (Figure 25). The PLUS™ reagent also reduced 
variability across transfection experiments and seemed to make the procedure less 
dependent on the overall condition of the cells prior to transfection. It was observed 
that when Cellfectin™ II was used exclusively, transfection efficiency fluctuated 
between 5-50%, despite the same batch of media, plasmid DNA and FBS being 
used. In order to scale up the transfection experiments it was decided, based on the 
obtained results, that 3µg of plasmid DNA in the presence of PLUS™ reagent is 
sufficient to achieve the desired level of eGFP-RyR expression in 60mm culture 
dishes.  It was also noted that altering the length of time of incubation of DNA and 
lipid reagent prior to applying to the Sf9 cells had no apparent effect on the 
experimental outcome. Keeping the cells in contact with the transfection mixture for 
longer than 4h also did not have any negative effects. Although most experiments 
were imaged 48h post transfection, it was noted that individual cells were able to 
reach a high level of expression (bright cells) after 24h incubation. Extending the 
post transfection imaging analysis to 72h showed no positive effects on the level of 
expression seen. It was impossible to achieve good expression for the eGFP-RyR 
deletion mutant in Sf9 cells, regardless of the conditions used. In contrast to the 
HEK 293 cells, the expression of the truncated protein seems to cause the insect cells 
to die at an early time point post transfection.High magnification, in vivo imaging of 
Sf9 cells expressing the P. xylostella eGFP-RyR fusion protein, using a Zeiss 
780LSM microscope, confirmed good transfection efficiency. Two populations of 
cells were observed expressing the eGFP-tagged RyR; some cells having a diffused 
cytosolic signal (also seen in the HEK 293 cells expressing both insect RyRs) and 
some a more reticular expression, with a more concentrated ‘globular signal 
(Figure26). 
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Figure 26 High magnification in vivo images of Sf9 cells expressing the P. xylostella eGFP-
RyR fusion protein, using a Zeiss 780LSM microscope (x63 lens). Arrows indicate two 
populations of cells with (1) a diffused cytosolic signal and (2) a more reticular globular 
signal distribution. The image on the right shows a fluorescent-bright field overlay showing 
that the expression efficiency is good, with approximately 46% of cells containing eGFP 
signal. 
 
4.3.2.4 Functional analysis of the P. xylostella eGFP-RyR expressed in Sf9 cells 
Western blots of mixed-membrane preparations obtained from Sf9 cells expressing 
the eGFP-RyR fusion showed no protein band of the expected size. It was speculated 
that the most probable cause for the negative results was that there was not enough 
eGFP-RyR fusion protein to detect on the blot, due to the transfections being limited 
to ten 60mm culture dishes (compared with twenty 90mm dishes for HEK 293s), 
which was dictated by the cost of the transfection reagent and difficulty in obtaining 
sufficient numbers of Sf9 cells for transfection. Unfortunately, the calcium release 
assays using Fluo-3 AM also gave negative results, as for HEK 293 expression, 
despite the good transfection efficiency in Sf9 cells. It was concluded that although it 
was theoretically possible to obtain good transfection efficiency for P. xylostella 
RyR, the expressed protein did not form a functional channel.  
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4.3.3 Modification of the P. xylostella RyR constructs 
Despite a relatively good expression (strong eGFP signal and production of protein 
of the correct size in HEK 293 cells) there was no evidence that the expressed eGFP-
RyR channel was functional, as no specific [3H] labelled ryanodine binding was 
detected (in the filter disc assay from HEK 293 mixed-membrane preparations) and 
transfected cells loaded with a fluorescent calcium sensitive dye failed to evoke a 
calcium release response after exposure to 30mM caffeine in both HEK 293 and Sf9 
cells. This non-functionality was probably due to either the presence of the N-
terminal eGFP tag or errors in the RyR coding sequence. The cloned P. xylostella 
RyR sequence was therefore aligned with newly available P. xylostella RyR 
sequences to look for possible PCR errors (since the beginning of the project 
different groups have published P. xylostella RyR sequences independently; these 
were not available during the initial sequencing and assembly of the P.xylostella 
RyR constructs). An alignment with 5 sequences found in GenBank (accession 
numbers: JF927788.1, JN801028.1, JQ769303.1, JF926694.1 and JF926693.1) 
showed 3 base differences in the cloned sequence which resulted in 3 amino-acid 
substitutions unique to the cloned sequence: S815T, Y2834H and M4291I. It was 
assumed that these 3 substitutions do not occur naturally and were generated during 
PCR amplification. Since the errors were present in different regions of the gene, the 
easiest way to obtain modified (corrected) constructs was to mutate the original sub-
cloned fragments, Nterm, M2 and Cterm, using site-directed mutagenesis (Chapter 
II, section 2.9). Only the Nterm fragment generated for the untagged P. xylostella 
RyR construct, which contained the 5’-ACC-3’ Kozak consensus sequence 
immediately upstream of the START codon, was modified and used in the final full-
length ligation. The assembly of a new modified untagged P. xylostella RyR in 
pcDNA3.1 (-) was done as described in Chapter III, section 3.2.15.  After selecting 
the correct plasmid DNA by colony PCR and sequencing, the full-length P. 
xylostella RyR was excised from the pcDNA3.1- untagged RyR construct with NotI 
and PmeI restriction enzymes and ligated into a modified pIZ vector containing an 
NruI site as described in section 3.2.15. Both new plasmid constructs were tested for 
potential rearrangements, and the ligation sites were sequenced to check for possible 
ligation errors. Large quantities of the plasmids were then prepared for multiple 
transfections in HEK 293 and Sf9 cells. 
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4.3.4 Expression of untagged modified P. xylostella RyR in HEK 293 
Calcium release assays were used to test for functional expression of the modified 
construct in HEK 293 cells. In 5 independent experiments, at least 1-2 cells per field 
of view showed an increase in intracellular calcium in the presence of 20mM 
caffeine, 48 hours post transfection. Normalized to the baseline, individual cell 
responses were consistent with caffeine activation of the RyRs, displaying sharp 
increases in intracellular Ca2+ which returned to basal levels over time (Figure 27).   
 
Figure 27 Responses in individual HEK 293 cells transfected with P. xylostella - untagged 
RyR and loaded with Fluo-3 AM dye, after addition of 20mM Caffeine dissolved in DMEM. 
Data collected from a single experiment represents one field of view using x63 lenses. 
 
Untransfected HEK 293 cells gave no such positive responses (in two separate dishes 
tested, data not shown), indicating that the response seen with the P. xylostella RyR 
resulted from successful channel expression. No positive responses were recorded 
when the transfected cells were challenged with diamide insecticides (10µM 
flubendiamide or 10µM chlorantraniliprole) when using Fluo 3-AM dye. Due to the 
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low solubility of diamide compounds in water, DMSO (Dimethyl sulfoxide) was 
used as a diluent; this proved problematic since DMSO triggers an increase in 
fluorescence in all imaged cells, making it impossible to determine the origin of the 
fluorescent signal following diamide application, even when the final concentration 
of the solvent was not exceeding 1% (v/v) of the total solution. The assays done with 
20mM caffeine confirmed that modifying the constructs had a positive effect on the 
channel function. However, subsequent binding assays with [3H] ryanodine on 
membrane preparations from two large scale transfections (at least 10 plates), using 
JetPrime® or calcium phosphate, showed no specific binding. It was concluded that 
although it is possible to express functional P. xylostella RyR channels in HEK 293, 
the level of expression is insufficient for detailed binding studies to be performed.  
4.3.5 Expression of untagged modified P. xylostella RyR in Sf9 cells 
4.3.5.1 Calcium release assays 
The modified construct pIZ WT P. xylostella RyR was tested first for functionality in 
calcium release assays using cells loaded with fluo-3 AM dye in simple experiments 
without the perfusion system. As with the HEK 293 expression system, it was 
possible to observe responses in 2-3 cells per field of view to 20mM caffeine, 48h 
post transfection. However unlike with the HEK 293 cells, over the course of the 60 
second recordings the signal was not returning to the baseline level, possibly because 
of the high concentration of caffeine remaining in solution or different Ca2+ handling 
capabilities of the insect Sf9 cells (Figure 28). Untransfected cells failed to evoke 
any caffeine mediated responses in the four dishes tested. This result indicates that, 
as for HEK 293 cells expressing the modified P. xylostella RyR construct, the Sf9 
cells were expressing a functioning RyR channel. 
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Figure 28 Activation of individual Sf9 cells expressing  modified P.xylostella RyR using 
20mM caffeine. Cells were loaded with FLUO-3 AM  and the spike in fluorescent 20mM 
caffeine dissolved in Sf-900 II media was added to the dish. Like HEK cells cells did ot 
show fast return of the singnal to the baseline level. Data collected from a single experiment 
represents one field of view using x63 lenses. 
 
In subsequent experiments a perfusion system was employed, such that once a 
suitable patch of caffeine responsive cells was found, the cells could be challenged 
with a number of different agonists. A typical experiment consisted of one or two 
application of caffeine (30mM and/or 10mM) followed by either 30µM of a diamide 
analogue (a reversible agonist capable of being washed out of the binding site) or 
10µM of flubendiamide or chlorantraniliprole insecticide, followed by 30mM 
caffeine. The initial exposure to caffeine resulted in a typical brief elevation of 
intracellular Ca2+ which usually returned to basal level over time. A similar cellular 
response was also seen with 30µM of the diamide analogue. However, the 
fluorescence level remained elevated in the cells exposed to 10µM flubendiamide or 
chlorantraniliprole and it was impossible to evoke any further caffeine responses in 
the same cells, which suggest that the binding of both insecticides was irreversible 
over the time course of the experiment (Figure 29). In contrast, it was possible to 
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record further responses to 30mM caffeine in cells exposed to the diamide analogue. 
Lower concentrations (0.5µM, 1µM, 5µM) of flubendiamide and the diamide 
analogue were also tested, showing no ‘measurable’ responses; however, 
flubendiamide, even at low concentrations (0.5µM and 1µM), abolished further 
caffeine responses even if no Ca2+ mobilization was recorded (data not shown). This 
lack of a recorded response to lower concentrations of insecticide is likely due to 
experimental setup limitations such as a short release time for each compound (3-5 
seconds), or distance to and size of the U-tube aperture. It was previously 
demonstrated that in H. virescens neurons less than 1µM of flubendiamide can evoke 
an EC50 (effective concentration) response [31]. The initial high concentration of 
flubendiamide used (10µM) was previously reported to cause a maximum response 
in calcium release assays in CHO cells expressing D. melanogaster RyR [31].  The 
experimental setup might also have a negative effect on measured responses to 
10mM caffeine, resulting in false negatives during some experiments. 
 The functional expression was also tested at different time points (48h, 72h and 
96h), to determine if channel activity decreased with time, and if cells were showing 
cytotoxic effects typically associated with RyR overexpression [186]. Interestingly, 
receptor activity in Sf9 cells did not appear to diminish over time. Also, unlike with 
the mammalian HEK 293 cells, Sf9 cells did not show cytotoxic effects, and many 
cells expressing the protein were able to divide. In total, from all time points and 
separate transfections investigated, the response of 71 cells to 30mM caffeine was 
monitored in 12 separate recordings; 16 cells (3 recordings) with 10mM caffeine; 43 
cells (8 recordings) with 30µM of the diamide analogue, and 2 recordings for both 
chlorantraniliprole (10 cells) and flubendiamide (13 cells). The average amplitude 
with 30mM caffeine was 0.22 ± 0.095 SEM (∆R/R0), from 8 independent 
experiments (n=30 cells) over different time points. Cells with normalized response 
values lower than 0.05 were excluded from the final calculation. The duration of the 
response (from excitation to return to the resting state) varied between individual 
cells in any given experiment and between different experiments, and ranged 
between 12 to 22 seconds (as seen in Figure 29), or lasted until the end of the 
recording - suggesting a very slow decrease of signal to the baseline (a result also 
seen with fluo 3-AM imaging, Figure 28). As these were preliminary experiments 
designed to assess channel functionality, all of the calcium release assays omitted the 
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initial dye calibration step which allows for Ca2+ quantification. It was therefore not 
possible to assess the resting Ca2+ concentration and to quantify the amount of Ca2+ 
released following agonist exposure in cells expressing P. xylostella RyRs from this 
particular dataset. 
. 
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 Figure 29 Fluorescence ratios measured over time in single calcium release experiment using Fura 2 AM. 
Panels A-D show mean ± standard error responses of the same cells (n=8) to A 10mM caffeine, B 30µM 
diamide analogue, C 10µM flubendiamide and D 30mM caffeine - application of flubendiamide abolishes 
further caffeine responses, suggesting an irreversible binding. The picture on the left shows a snapshot of cells 
during fluorescence ratio measurement, using x40 lens and an excitation wavelength of 380nm. 
E 
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4.3.5.2 Ryanodine binding assays and single channel recordings 
The preliminary filter disc binding assays on mixed-membrane preparations from large scale 
transfection experiments (at least 15 x 60mm dishes) using Sf9 cells, indicated positive 
binding of ryanodine to the P. xylostella RyR receptor in the presence of  800µM of free Ca2+ 
(3 independent experiments, done in duplicate). The calculated average specific binding was 
0.72 pmol/mg of protein, with a standard deviation of ±0.16. The specific binding for all 3 
experiments was greater than 90% of the total binding value (Table 13).  
Table 13 Results for individual filter discs titrated [3H] ryanodine binding assay 
Total 
(dpm) 
Non-specific 
(dpm) 
Specific 
binding (dpm) 
Protein 
(µg) 
Specific binding 
(pmol/mg) 
13714.7 684.12 13030.58 100 0.617855856 
15269.8 624.61 14645.19 100 0.69441394 
16277.2 811.8 15465.4 100 0.733304884 
16974.4 844.82 16129.58 100 0.764797534 
9268.78 1275.4 7993.38 100 0.379012802 
18996.1 1242.24 17753.86 100 0.84181413 
 Grey/white backgrounds highlight experimental duplicates. All discs contain membrane 
preparations from Sf9 expressing untagged P. xylostella RyR. 
Additionally the Sf9 mixed-membranes incorporated into artificial bilayers resulted in 
incorporation and brief recordings of ‘ryanodine-like’ channels (Figure 30). However, it was 
impossible to record responses to any agonists, since the (non-purified) mixed-membrane 
preparation compromised the integrity of the artificial bilayer, causing it to break down upon 
perfusion. Further purification of the channels through sucrose gradient centrifugation will be 
required before more detailed experiments can be done.  
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Figure 30 A single channel trace obtained from a bi-layer experiment showing a ‘ryanodine receptor-
like’ channel incorporated into a membrane. The recording was done in a 4:1 KCl (~850:210mM) 
gradient between cis and trans chambers when a mixed membrane preparation from Sf9 cells 
expressing WT P. xylostella RyR was applied. The currents seen are due to the chemical gradient 
rather than holding potential, no agonists were tested. Histogram analysis of the trace indicated that 
the channel was mostly in a closed state with no visible sub-conductance states. Graph represents a 
single experiment. No further studies were attempted. The graph represents a single experiment; no 
further replications were conducted. 
 
A binding saturation experiment was also done, using the 96 well filter plate format, with a 
minimum of 3 replicates per plate for each ryanodine concentration. Although specific 
binding was significantly lower (only approx. 40% of the total binding) in comparison to the 
previous filter disc assays, binding for 11 ryanodine concentration points was recorded and a 
curve was fitted to the data using GraphPad prism (Figure 31). 
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Figure 31 Binding saturation curve for WT P. xylostella RyR (expressed in Sf9 cells) challenged with 
titrated ryanodine. Each point on the graph represents the average of 3 replicates ± S.E.M.  
The density of binding sites Bmax (2447±425 dpm (244.9±42.5 fmol/mg)) and the dissociation 
constant Kd value (12.89±4.5 nM) for ryanodine binding to P. xylostella RyR were calculated 
using this software. The Kd value is higher than seen for native preparations of rabbit skeletal 
muscle RyR (2.04 ± 0.12nM) and H. virescens RyR (3.82±0.39nM), which also have much 
higher Bmax values;  4.57 ± 0.32 pmol/mg (rabbit)  and 2.41 ± 0.17 pmol/mg (H. virescens) 
[176]. In another study however, the Kd value for H. virescens native membrane preparations 
was 13.9±3.8nM, making it comparable to the Sf9 expressed P. xylostella RyR, while the 
Bmax values were between 1-1.5 pmol/mg [29]. It is apparent that the filter plate experiments 
require further optimization to reduce the non-specific binding, which may influence the Kd 
and Bmax values of the currently obtained binding data. However, these preliminary results 
clearly indicate that there is sufficient functional receptor density in mixed-membrane 
preparations of Sf9 cells expressing the P.xylostella RyR to allow meaningful binding assays 
to be carried out. 
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4.3.6 General remarks 
The work reported here used expression vectors (pcDNA3.1(-) and pIZ/V5-His) with 
constitutive promoters in non-lytic systems for the expression of insect RyRs, with the aim of 
achieving a good level of expression, as has been previously demonstrated for a number of 
mammalian RyR constructs [186]. The pcDNA family of vectors (Life technologies) has 
been used in the past to express insect RyRs from D. melanogaster and B. mori [30, 163].  In 
the case of expression in Sf9 cells, there have been no reports in peer reviewed literature on 
attempts to express RyRs by any other means other than recombinant baculovirus [125, 206]. 
The use of non-lytic vectors is mentioned in the DuPont patent WO/2004/027042, but there is 
very little detail on the associated methodology [187]. Both HEK 293 and Sf9 cell lines have 
been shown by different groups to be able to express functional mammalian RyR channels 
indicating that, theoretically, they may have the capability to express insect RyR channels as 
well. All expression studies were initially done in HEK 293 cells, as the Cardiff University 
laboratories have had considerable success in using these cells for expression and study of 
mammalian RyR2 channels [95, 195, 213]. Calcium phosphate transfection although the most 
cost effective method, gave very variable results across different experiments using HEK 293 
cells and between different plates set up alongside each other on the same day. This method 
also proved unsuitable for transfection of insect Sf9 cells, as the addition of the DNA 
precipitate resulted in complete cell lysis within a few hours. Modifications made to the P. 
xylostella cDNA constructs resolved the lack of function seen early on in both expression 
systems; however, the HEK 293 cells gave inadequate (low level) expression of RyR protein, 
so could not be used for more detailed receptor characterization. It is possible that in the 
mammalian cell line chosen for this study, some insect RyR accessory proteins required to 
overcome the cytotoxic effects of RyR expression are not available. In studies of the 
mammalian RyR2 channel, it was shown experimentally that co-expression of FKBP 12.6 has 
a positive effect on cell proliferation and decreased the cytotoxic effects associated with 
RyR2 over-expression [124].  
In the case of P. xylostella RyR, it is unclear whether the modification (correction) of the 3 
amino acids deduced to be PCR errors within the cDNA sequence or the removal of the N-
terminal eGFP tag restored channel function. In previously expressed insect (D. 
melanogaster, B. mori) and mammalian RyRs, an N-terminal GFP tag had no negative effects 
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on overall channel function [30, 163, 195]. Introduction of the eGFP tag to the modified P. 
xylostella RyR constructs will be required to resolve this matter.  
In the case of M. persicae RyR, it is possibly unlikely that the eGFP tag was the reason for 
poor expression and lack of function, since both untagged and tagged constructs were tested 
in HEK 293 cells and gave the same negative result. However removal of the tag from the 
insect (Sf9) cells expression vector (pIZ-eGFP-RyR) could be explored as a potential way of 
resolving the expression problems, but other factors may also need to be looked at, including 
codon usage. There were no PCR errors detected in the cloned aphid sequence; direct 
sequencing of PCR amplified M. persicae fragments covering portions of the receptor did not 
find any errors when aligned to: - the full-length cDNA incorporated into the expression 
vectors, - the closely related A. pisum RyR sequence - other available insect RyRs.  
4.4 Conclusions 
It was possible to achieve a good level of protein expression for the RyR gene from P. 
xylostella using Sf9 cells, enabling detailed functional characterization of the channel to be 
carried out at a future date. The expressed P. xylostella RyR was shown to be responsive to 
caffeine and diamide insecticides and was able to bind ryanodine. There was also evidence 
that the level of expression is sufficient to conduct single channel recording experiments. 
In summary, expression of insect RyRs proved to be a difficult task and was only achieved 
after modification of the original constructs and optimization of the transfection method. It 
was not possible, however, under any of the conditions so far tested, to achieve good 
expression of the M. persicae RyR cDNA. 
 
 
 
 
 
 
Chapter V 
120 
 
Chapter V: Characterization of diamide insecticide resistance in  
P. xylostella 
5.1 Introduction 
5.1.1 Plutella xylostella 
Plutella xylostella is a small nocturnal moth with a high reproductive rate and short life cycle 
of approximately 3-4 weeks, depending on the ambient temperature (Figure 32). Short lived 
adults mate soon after emergence and females can lay up to 200 eggs over a period of 4 days. 
The emerged first instar larvae mine into leaf tissue while the later, larger larval stages, eat 
whole leaves; 4th instar larvae, after completing feeding undergo pupation which can last up 
to 15 days in cooler temperatures [193]. P. xylostella is a major worldwide pest of cruciferous 
crops (eg. cabbage) and is particularly destructive in sub-tropical parts of the world where the 
climate allows for year round crop production and completion of multiple life cycles of the 
pest [190]. The worldwide cost of control of P. xylostella is estimated to be 4-5 billion US 
dollars per annum [190]. 
 
Figure 32 P. xylostella life cycle. Photographs provided by Mark Mallot. 
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5.1.2 Insecticide resistance in P. xylostella 
Introduction of any new class of chemistry to control pests is often followed by the 
development of resistance to that chemistry, due to the high (unnatural) selection pressure 
applied to the pest population, which is often accelerated by misuse of the insecticide e.g. 
through application of several consecutive treatments with the same compound or by using 
less than the recommended application rate.  
There are 3 main mechanisms of insecticide resistance: 
 a) reduced insecticide uptake, usually resulting from changes in the insect’s cuticle 
 b) ‘metabolic’, which involves an increase in the rate of detoxification of the insecticide, 
usually by over expression and/or modification of enzymes such as cytochrome P450s, 
glutathione S-transferases, and carboxyl-esterases involved in the breakdown of xenobiotics  
c) modification of the target protein due to novel mutations arising in the coding sequence, 
especially in the vicinity of the insecticide binding site  [214].   
P. xylostella was the first agricultural pest to develop resistance to DDT, one of the first 
widely used synthetic insecticides [215], and has subsequently developed resistance to almost 
all chemical classes of insecticide that have been used for its control. This has involved a 
wide array of resistance mechanisms being induced in the pest, including  target site 
modifications  [216], increased detoxification [217] and reduced uptake [218].  
The recent, in many cases exclusive, use of the new diamide insecticides on P. xylostella has 
rapidly selected for resistance in this species, and this chapter focuses on the characterization 
of two such diamide resistant strains. The work, which reports the first target site mutation 
associated with a diamide-resistant phenotype, has recently been published (see Troczka et al. 
2013) [19]. A preliminary characterization of the effect of the target site mutation on 
functioning of the RyR channel, using expression in Sf9 cells (see Chapter IV for 
methodology), is also presented and discussed. 
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5.2 Methods 
5.2.1 P. xylostella strains 
Field samples of P. xylostella were collected from 2 geographically distinct locations where 
control failure with diamide insecticides had been reported. The first strain, Sudlon, was 
supplied by Bayer CropScience AG, and was sourced from Cebu Island in the Philippines. 
The second strain was supplied by Syngenta, sourced from Bang BuaThong, Thailand 
(ThaiR) and was subsequently selected every 2 weeks with chlorantraniliprole. Syngenta also 
supplied a susceptible field strain (ThaiS) which originated in an area near Chiang Mai, 
Thailand. Additionally two laboratory susceptible P. xylostella strains were available to be 
tested, the Roth strain (Rothamsted) and the HS strain (provided by Bayer CropScience AG). 
5.2.2 Sequencing of TM region of P. xylostella RyRs 
RNA from pools of 5 larvae (mixed instar’s) from ThaiS, ThaiR, Sudlon and HS strains was 
extracted as described in Chapter II, section 2.3.2, and cDNA synthesised using 
Superscsript™ III (described in Chapter II, section 2.4.1). Three short (approximately 1Kb) 
overlapping DNA fragments were amplified by PCR in 25µl reactions incorporating: 2x 
Dreamtaq™ PCR master mix (Thermo-Fermentas, MA, USA), 1µl of cDNA, and primer 
pairs (20pmol each primer) covering the entire TM region (assuming the 6 TM model) of the 
channel (Table 14). A portion of the receptor close to 5’ end, which was previously reported 
to be important for channel sensitivity to flubendiamide in B. mori [30], was also PCR 
amplified. The PCR temperature cycle used was 95oC for 2 minutes followed by 35 cycles of: 
95oC for 20 seconds, 50oC for 30 seconds, 72oC for 1 minute 30 seconds, and final extension 
step at 72oC for 5 minutes. All PCR products were purified by selective precipitation with 4M 
NH4OAc (Chapter II, section 2.6.4) and sent for sequencing by EUROFINS DNA. 
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Table 14 Primer pairs used for amplification and sequencing of TM and N-terminal 
regions of P. xylostella RyR 
PCR 
product 
Primers Primer sequence Size 
(bp) 
Position 
(AA)a 
F1 Px.1Kb-F1 GGCTATACTGATCGGGTACTACC 1157 4743-5119b 
Px.Cterm-R1 GAGTTTGGTACCAGTGGCCCTAAGTC 
F2 Px.2Kb-F1 CGGTTTAATGGCGGATGCGGAAG 1087 4387-4749 
Px.2Kb-R1 GGTAGTACCCGATCAGTATAGCC 
F3 Px.3KbF -1 CGGAGAGAAGAACATGCACGACGCAG 1160 4008-4393 
Px.3KbR-1 CTTCCGCATCCGCCATTAAACCG 
N Px.N1-F TCCTACTTCGGCATCTCAACAGTG 1252 104-521 
Px.N1-R GCGGAGATCATCTCCCAGCTCTG 
aPosition based on Accession number JX467684, bReverse primer outside coding region 
5.2.3 DNA extractions and TaqMan assay 
Genomic DNA was extracted from at least 10 individual insects from each P. xylostella 
strain, using DNAzol® reagent. Each larva was ground to a powder in a 1.5ml eppendorf 
tube containing 200µl of DNAzol® reagent on dry ice. The homogenate was then centrifuged 
at 10,000g, 4oC for 20 minutes in an Eppendorf 5415R centrifuge to remove insoluble tissue 
fragments, RNA and polysaccharides. The supernatant was then transferred to a fresh 1.5ml 
tube and the DNA was precipitated by the addition of 100µl of 100% ethanol, the tube 
contents mixed and maintained for 3 minutes at room temperature. The samples were then 
centrifuged for 20 minutes in an Eppendorf 5415R centrifuge at maximum speed to pellet the 
DNA. The supernatant was subsequently removed and the pellet was washed with 200µl of 
70% ethanol, followed by a 5 minute centrifugation at maximum speed. After the wash step 
the ethanol was removed and the pellet left to air dry for 5-10 minutes. The DNA was then 
re-suspended in 20µl of nuclease free water and used straight away in PCRs and TaqMan® 
assays.  
Prior to the TaqMan® assay, small PCR fragments covering the region where the potential 
resistance mutation was identified by sequence analysis (Section 5.2.2) were PCR amplified 
from the genomic DNA isolated from the ThaiS, ThaiR and Roth strains, in 25µl reactions 
incorporating: 1µl of genomic DNA, 2xDreamtaq® mastermix, and primer pair Plut.Mut1-F / 
Plut.Mut1R (20pmol) (sequences in Appendix C, section 5), using the PCR cycle conditions 
described in section 5.2.2. The obtained PCR products were gel purified, and then sequenced 
in order to identify if any introns were present in close proximity to the mutation site. 
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A TaqMan® assay (Life Technologies), using the primers/ fluorescent probes described in 
Table 15, was designed to amplify across the region of interest, i.e. where a resistance-
associated mutation had been found in the RyR gene.   
Table 15 TaqMan assay probe and primer sequences 
Primer/Probe Sequence 
PxTaqMan_F CGCCGCTCATCTGTTGGA 
PxTaqMan_R GCGTGACAGACTGCAAGATAGT 
PxTaqMan_WT VIC-TGGCTGTTGGGTTCAA 
PxTaqMan_Mut FAM-TGGCTGTTGAGTTCAA 
 
The forward and reverse primers, and the two minor groove binding (MGB) probes (Life 
technologies - Applied biosystems), were designed using Primer Express™ Software, Version 
2.0 (Life technologies). Primers PxTaqMan_F and PxTaqMan_R are standard 
oligonucleotides with no modification. The probe PxTaqMan_WT is labelled with VIC® (a 
fluorescent reporter dye) at the 5′ end for detection of the wild type (WT) allele and probe 
PxTaqMan_Mut is labelled with 6-FAM (Fluorescein amidite reporter dye)  for detection of 
the resistant allele. Each probe also had a 3′ non-fluorescent quencher and a minor groove 
binder at the 3′ end. The minor groove binder provides more accurate allelic discrimination 
by increasing the TM differential between matched and miss-matched probes [219]. PCR 
reactions (20 µl) contained: 1 µl of genomic DNA, 10 µl of SensiMix™ Probe DNA kit 
(Bioline), 800nM of each primer and 200nM of each probe. Reactions were run on a Rotor-
Gene 6000™ (Qiagen-Corbett Research) cycler using temperature cycling conditions of 10 
minutes at 95°C followed by 40 cycles of 95°C for 10 seconds and 60°C for 45 seconds. The 
increase in VIC and FAM fluorescence was monitored in real time by recording each cycle 
on the yellow (530nm excitation and 555nm emission) and green (470nm excitation and 
510nm emission) channel of the Rotor-Gene respectively. 
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5.2.4 Modification of the WT P. xylostella untagged constructs 
A full-length WT P. xylostella RyR cDNA has been shown to be functionally expressed in 
both Sf9 and HEK 293 cells (details Chapter IV). This WT cDNA was modified to introduce 
the mutation present in diamide resistant moths. Due to the large size of the expression 
plasmid constructs it was not possible to use SDM on the full-length cDNA insert, so the 
mutation was introduced into a sub-cloned modified C4 fragment (Chapter IV), which was 
used to make the full-length untagged WT plasmid, using the SDM method described in 
Chapter II, section 2.9. The plasmid carrying the mutation (which causes a Glycine (G) to 
Glutamic Acid (E) substitution) was identified by sequencing, and named C4G-E. This 
modified cDNA was used in the assembly of the full-length RyR into  
pcDNA 3.1(-), as described in Chapter III, section 3.2.15 This modified cDNA was also 
transferred across into the pIZ/NruI vector following the procedure described in Chapter III, 
section 3.2.15, and the construct named pIZ-G-E RyR.  
5.2.5 Expression of G-E P. xylostella RyR in Sf9 cells 
The pIZ-G-E RyR expression plasmid was used in subsequent transfections of Sf9 cells, 
using the optimized conditions described in Chapter IV, section, 4.3.5. Functional expression 
of the mutated RyR channel was initially tested 48h, 72h and 96h post transfection with  
calcium mobilization assays using FURA 2 AM dye (Chapter IV, section 4.2.4.2). Mixed-
membrane preparations from large scale transfections of Sf9 cells were prepared as described 
(Chapter IV, section 4.2.1.2). Binding assays with [3H] ryanodine were done in 96 well plates 
as described in Chapter IV, section 4.2.3.3. Data were analysed using SigmaPlot v.12 and 
GraphPad Prism v.5 software, as previously described. 
5.3 Results and discussion  
5.3.1 Bioassays 
The initial bioassays to determine the level of resistance of the P. xylostella field strains to 
diamide insecticides were done by researchers at Bayer CropsScience AG and Syngenta. The 
results of these bioassays are presented in our publication [19], and are reproduced in Table 
16 below. The bioassays indicate that the ThaiR and Sudlon strains are highly resistant (>200 
fold) to diamide insecticides and that both strains display cross resistance between 
flubendiamide and chlorantraniliprole. However, the Sudlon strain has higher resistance 
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ratios (RR) to both diamide compounds; it was speculated that this might be due to more than 
one resistance mechanism being present. 
Table 16 Log-dose probit-mortality data for two diamide insecticides tested against 
2nd/3rd instar larvae of P. xylostella in a leaf-dip bioassay (72h) as presented in [19]. 
Compound Strain LC50-value 
[mg/L-1] 
95% FLa Slope 
(±SD) 
RRb 
Chlorantraniliprole HS 0.048 0.026-0.15 1.3 ± 0.068 - 
 Sudlon >200 - - >4100 
 Thai S 0.30 0.25 - 0.38 5.1 ± 0.83 - 
 Thai R >60 - - >200 
Flubendiamide HS 0.15 0.086-0.30 3.8 ± 0.30 - 
 Sudlon >200 - - >1300 
 Thai S 0.08 0.06 - 0.11 3.8 ± 0.59 - 
 Thai R >60 - - >750 
aFiducial limits, bRR= resistance ratio, LC= lethal concentration (LC50 of Sudlon or Thai R 
divided by LC50 of HS or Thai S, respectively) 
5.3.2 Sequencing of transmembrane region 
PCR analysis of the field collected Thai strains was problematic, possibly due to poor storage 
conditions during transport from Thailand leading to some degradation of the RNA, so the 
cDNA synthesis was not of sufficient quality for subsequent PCR amplification of a single 
large fragment covering the entire TM region. It was therefore necessary to amplify the TM 
region in 4 fragments. In the case of the Sudlon and HS strains, the RNA isolated was of a 
higher quality; however the same 4 fragments were amplified by PCR in order to simplify the 
later data analysis by creation of multiple alignments of individual sets of fragments.  
Direct sequencing of the 4 amplified fragments covering the entire TM region from both 
resistant and susceptible strains of P. xylostella, identified a mutation at position 14,837 of 
the cDNA predicted to cause a glycine (G) to glutamic acid (E) substitution at position 4946 
(based on the first published P.xylostella RyR sequence [165]), or position 4900 in the cloned 
and  expressed RyR described in this study. The mutation appears to be homozygous in all 
pools of individuals sequenced, for both the ThaiR and Sudlon strains. Interestingly, the 
nucleotide changes in the gene sequence giving rise to the G4946E substitution were different 
in the two resistant strains. Thus ThaiR has a single base change GGG to GAG (compared to 
ThaiS and Roth susceptible strains) and Sudlon potentially has an additional silent 
substitution GAA (Figure 33), with only the first base change being responsible for the amino 
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acid alteration. This finding, together with a different profile of silent SNPs (single nucleotide 
polymorphisms) for both resistant strains, suggests that the mutation has most likely evolved 
independently in both strains and has not been found at two geographically distinct locations 
as the result of insect migration. There are no susceptible field strains available from the 
region where the Sudlon strain originated, so we do not know if the susceptible population 
from which the resistant strain evolved carried a GGG or GGA coding triplet. In the two 
laboratory susceptible strains of P. xylostella, Roth and HS, only the GGG coding triplet was 
found. Once again, alignments of sequences from both Roth and HS strains showed a number 
of distinct silent SNPs, suggesting different geographical origins for the susceptible strains 
(Figure 33). Direct sequencing across the region harbouring the mutation, using as template 
PCR products amplified from genomic DNA extracted from at least 10 individual 3rd and 4th 
instar larvae, confirmed that the mutation is homozygous in ThaiR and Sudlon strains. In the 
susceptible Roth and HS strains, only the homozygous WT – GGG allele was found.  
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Figure 33 Nucleotide alignments of the TM region around the mutation site (altered coding triplet highlighted in black) from 4 strains of P. 
xylostella, using the Wang et al [165] RyR sequence (GenBank: AET09964.1) as a reference. The alignment highlights individual SNPs - it is 
clear that the SNP profile is different for the Sudlon and ThaiR strains. 
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5.3.3 In silico characterization of the RyR G4946E substitution 
The glycine to glutamic acid substitution, G4946E, which was found in diamide resistant P. 
xylostella populations, is located in a highly conserved region of the TM domain of RyRs. 
Amino acid alignments of RyRs (Chapter III, section 3.2.1) from different vertebrate and 
invertebrate species revealed that a glycine is present in most species at this position (Figure 
34). More in-depth trawls of on-line databases indicated that only 6 species (to date) have a 
substitution of this glycine for a different amino acid. Two species, Camponotus floridanus 
(Florida carpenter ant) and Daphnia pulex (water flea) have an alanine at this position, and 
two crustaceans, Litopenaeus vannamei (Whiteleg shrimp shrimp) and Homarus americanus 
(Atlantic lobster) [19] along with two nematodes, Caenorhabditis elegans and Brugia malayi, 
have a serine substitution. Both alanine and serine are small uncharged amino acids, unlike 
the glutamic acid found in the resistant P. xylostella, and only one of them is found in the 
relevant position in an insect species. A BLAST search, using the highly conserved protein 
motif FFAAHLLDVAVE which contains the glutamic acid residue rather than glycine, 
returned no hits within NCBI [19].  
The location of the amino acid change associated with resistance to diamide insecticides in P. 
xylostella is perhaps surprising, as the diamides chlorantraniliprole and flubendiamide are 
highly selective towards lepidopteran species and only a few amino acid residues within the 
TM region, localised distal to the immediate vicinity of the mutation, are exclusively found in 
Lepidoptera [170].  
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Figure 34 Amino acid alignments of the region of the RyR channel spanning the resistance-associated mutation G4946E (marked with an arrow). GenBank 
accession numbers for each sequence can be found in Chapter III section 3.2.1. For the purpose of clarity the alignment does not include the alternatively 
spliced isoforms and protein sequences available in the DuPont patent (US2007/0105098A1) and other mammalian RyRs. The glycine (G) residue is found in 
all species apart from nematodes and crustaceans. 
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Prediction of the topology of the TM domain in P. xylostella RyR, using a hidden Markov 
model approach as described in Krogh et al. [220], indicated the presence of 6 TM helixes, in 
line with TM predictions for the human RyR2 channel [101] (Figure 35). The resistance-
associated mutation G4946E was found to be localised close to the pore domain (in the 
primary structure), in the loop region between predicted TM2 and TM3 helices on the 
cytosolic side of the membrane (Figure 35). Since, insects have only one copy of the RyR 
gene, the RyR channel must be made-up of four identical subunits. The mutation appears to 
be homozygous in diamide resistant individuals, so we can presume that the substitution will 
be present in all four subunits that make up a single functional channel. Due to a lack of 
detailed 3D structure for the RyR TM region, it is difficult to speculate what the structural 
implications are for the substitution of a small side chain amino acid (Glycine) with a much 
larger polar one (Glutamic Acid) within the external cytoplasmic loop linking TM2 and TM3 
helices. Mutational studies of the TM region of mammalian RyR isoforms revealed that 
modification of amino acids around the channel pore region usually leads to anomalies in 
channel function [200]. Additionally, a recent study of mammalian RyR1 gating, which 
introduced tryptophan substitutions  at positions V4830 and T4840 (in rabbit RyR1) in close 
proximity (10-20 AA) to the resistance mutation site G4946, resulted in the channel being 
locked in either a permanently open or closed state when modifying H4832 and G4834, 
indicating the potential functional importance of this region in channel gating [110]. 
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Figure 35 P. xylostella RyR TM domain topology map, predicted using a hidden Markov modelling 
approach [220]. Individual TMs are labelled as in the cryo-EM images of the pore and TM region of 
RyR1 [87]. The amino acid residues at each end of the helices are numbered according to the RyR 
cDNA sequence described in this study. The location of the resistance-associated mutation is 
indicated with an arrow. 
5.3.4 TaqMan assay 
A TaqMan assay was developed to allow for screening of individual insects for the presence 
of the resistance-associated mutation G4946E, and was initially done on genomic DNA from 
15 individuals of the ThaiR and ThaiS strains. This mutation was found to be homozygous 
(n=30) in all ThaiR individuals. In the ThaiS strain, 13 individuals were homozygous for the 
WT allele (n=26) and 2 heterozygous for the resistance allele (n=2) (Figure 36). 
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Figure 36 Representative TaqMan traces for the ThaiS strain showing the homozygous WT allele 
(blue), heterozygous resistant allele WT/resistant (green), and homozygous resistance allele (red). 
This indicated that the resistance allele is likely to be present in the susceptible ThaiS 
population at a low frequency (approximately 6.7% based on the number of samples tested). 
The assay was also used on 15 individuals of the Sudlon strain (before direct sequencing was 
done on these Sudlon samples) but these individuals scored very poorly, with many failed 
reactions (no fluorescence signal for either WT or resistance allele). It was later discovered 
(on direct sequencing of the samples) that silent SNPs in the Sudlon sequence, as well as a 
different coding triplet for the resistance mutation, were responsible for the TaqMan failure. 
It was concluded that the  high number of silent SNPs present in different P. xylostella strains 
means that the TaqMan assay is a not a viable tool for monitoring for resistance in field 
samples from diverse regions. 
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5.3.5 Expression of the P. xylostella RyR G4946E in Sf9 cells 
Modification of the WT P. xylostella RyR cDNA to give an expression vector containing the 
resistance-associated mutation G4946E had no apparent effect on the stability of the pIZ 
plasmid, and large quantities of pure plasmid DNA were obtained using the methods 
described previously  (Chapter II, section 2.8.4).  
Insect (Sf9) cells expressing P. xylostella RyR G4946E cDNA incorporated in the pIZ vector 
were used for functional expression analyses. It was expected that the presence of the 
G4946E mutation would most likely have a significant effect on the biophysical properties of 
the channel, due to its location close to the channel pore [19].  Initial imaging experiments 
measuring the release of Ca2+ after exposure to 10mM or 30mM caffeine, showed multiple 
responses as expected for a functioning channel (Figure 6). However, no Ca2+ release was 
recorded in response to application of two diamides (10µM flubendiamide or 30µM diamide 
analogue) (Figure 6). These experiments indicate that the mutation has greatly reduced the 
ability of diamides to activate the modified channel, most likely by decreasing the binding 
affinity. As demonstrated in Chapter IV, the binding of flubendiamide to the WT channel 
expressed in Sf9 cells appears to be irreversible and abolishes any subsequent caffeine 
induced Ca2+ release. The ability of the Sf9 cells expressing the modified G4946E channel to 
respond to caffeine after exposure to flubendiamide supports the reduced binding affinity 
hypothesis.  
There was no significant difference in the calcium signal amplitude of the response to 
caffeine for cells expressing WT or G4946E modified channels following 30mM caffeine 
induced Ca2+ release at different (72 or 96 hours) time points (Figure 6). However, a more 
detailed analysis is required, since the Ca2+ release assays were done without calibration of 
the Ca2+ indicator (Fura2 AM dye), therefore  cytoplasmic Ca2+ concentrations could not be 
calculated.  
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Figure 37 Normalized A340/A380 nm fluorescence intensity ratios measured for Sf9 
cells expressing P. xylostella RyR G4946E in a single Ca2+ release experiment using 
FURA 2 AM. Panels A-C show mean ±standard error responses of the same cells (n=8) 
72h post transfection to A 30mM caffeine, B 10µM flubendiamide, C 30mM caffeine. 
Binding of flubendiamide appears to be abolished by the presence of the mutation.  
Left: Bar chart showing that the average amplitude ±SEM of responses to 30mM 
caffeine in Sf9 cells expressing WT and G4946E P. xylostella RyR remains the same. 
WT (n=30 cells), G4946E (n=30 cells). Data for G4946E RyR collected from 4 
independent experiments. 
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An additional experiment using high concentration of chlorantraniliprole (100µM), 
which is a more water soluble diamide, indicated that it is possible to evoke Ca2+ 
release in cells expressing the G4946E channels whilst also abolishing further 
caffeine induced Ca2+ release (Figure 7), suggesting that the diamide binding is not 
completely abolished.  
 
 
5.3.6 Ryanodine binding assay 
Mixed-membrane preparations from Sf9 cells transfected with the G4946E construct 
were tested for their ability to bind [3H] ryanodine. A saturation binding experiment 
was done to determine the kinetics of ryanodine binding, and the data compared to 
the results for the WT RyR (presented in Chapter IV, section 4.3.5.2). At least 3 
replicates per data point were collected and, as found for WT membrane 
preparations, the specific binding was low (40%). However, the data obtained did 
allow a curve to be fitted (Figure 39) and determination of the Kd and Bmax values for 
the binding of ryanodine. The Kd and Bmax values were 14.69±4.18nM and 
2671±401.1dpm (267±40 fmol/mg) respectively, making them comparable to the 
WT channel (12.89±4.5nM and 244.9±42.5 fmol/mg respectively) and to previously 
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Figure 38 Normalized A340/A380 nm fluorescence intensity ratio measurements for Sf9 
cells expressing P. xylostella RyR G4946E in a single Ca2+ release experiment using FURA2 
AM, 96h post transfection. n=8 cells. Panel A. 100µM chlorantraniliprole, Panel B. 30mM 
caffeine after exposure to chlorantraniliprole. A high dose of chlorantraniliprole is able to 
induce a response in cells expressing the G4946E channel and abolish subsequent release of 
calcium by caffeine. 
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published Kd values for binding of ryanodine to H. virescens native membrane 
preparations (13.9±3.8nM) [29].  Although further optimisation of the binding assay 
protocol is required to reduce the non-specific background, it is clear that the 
presence of the G4946E mutation does not alter ryanodine binding affinity and 
kinetics in the diamide resistant P. xylostella RyR channel. 
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Figure 39 Saturation curve fitted to data obtained for the binding of ryanodine to P. 
xylostella RyR G4946E expressed in Sf9 cells. Each data point is a mean of 3 replicates± 
S.E.M . 
5.4 General remarks 
There were no apparent differences between Sf9 cells expressing the WT or G4946E 
RyR in terms of cell viability or RyR protein expression levels. The latter was 
difficult to assess directly as there was no fluorescent tag attached to the G4946E 
RyR channel, and no P. xylostella RyR specific antibodies are currently available. 
However, in calcium release experiments a similar number of cells were seen 
responding to the agonists per field of view, and the Bmax values obtained in 
ryanodine binding assays for the WT and G4946E channel were similar. This 
suggests that a comparable receptor density is present for both sets of cells.  
The G4946E RyR channel responds to caffeine and binds ryanodine at comparable 
levels to the WT RyR, but does have a significantly lower sensitivity to diamide 
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insecticides. This is the first evidence at a molecular level that the presence of the 
G4946E mutation confers a high level of resistance to diamide insecticides in P. 
xylostella. More detailed experiments are however required to investigate if the 
G4946E mutation has any effects on the channels electrophysiological properties and 
whether the decreased sensitivity to diamide insecticides is the result of an allosteric 
effect or direct modification of the binding site.  
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Chapter VI: General Discussion 
This chapter summarises the work done in this PhD. Suggestions and 
recommendations for future research- on this topic are also presented.  
6.1 Identification, cloning and analysis of insect RyRs 
The discovery and introduction of the diamide insecticides has led to an increased 
interest in insect RyRs as a target for the development of novel compounds for 
controlling insect pests. Since the beginning of this project a number of insect and 
other invertebrate RyR DNA and protein sequences have become available (see 
chapter III, section 3.2.1). Sequences of RyRs from economically important pests 
which are controlled by diamides, published on-line and in peer review journals, 
include the small white butterfly (Pieris rapae) [221], the brown planthopper 
(Nilaparvata lugens) [201], the rice leafroller (Cnaphalocrocis medinalis) [170] and 
the diamondback moth (Plutella xylostella) [165]. The latter was investigated by 
several groups, including in this study, resulting in several independent sequences 
being deposited in online databases. Additional sequence information from other 
species has come from DuPont patents associated with the discovery and marketing 
of chlorantraniliprole and cyantraniliprole [22, 187], and by annotation of insect 
genomes by International consortia and initiatives such as i5K (5000 insect 
genomes). To date, sequencing of 58 insect genomes has been completed and an 
additional 120 initiated (http://www.arthropodgenomes.org/wiki/i5K). During this 
study draft genome sequences became available for both of the species under 
investigation, M. persicae (http://tools.genouest.org/tools/myzus/login) and P. 
xylostella (http://dbm.dna.affrc.go.jp/px/) [222].  
Before the commercial release of the diamide insecticides very few attempts were 
made to investigate insect RyRs, the most notable exceptions being the cloning and 
expression of the D. melanogaster RyR [163], B. mori [30] and an investigation of 
the C-terminus of the RyR of H. virescens [169]. These studies, together with 
information published subsequently and new sequence data available online, 
highlighted that insect RyRs are complex and diverse. Although all invertebrates 
studied to date have only one RyR gene (see Chapter I, section 1.5.1), there is 
considerable diversity in exon usage ranging between 26 (D. melanogaster) to over a 
hundred (106 - A. pisum) between different insect orders (Davies TGE, unpublished). 
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The RyRs in many insect species also appear to be polymorphic, with a number of 
alternative splice sites and SNPs (eg. in Drosophila melanogaster, Heliothis 
virescens). This was also found for the P. xylostella RyR investigated in this study, 
where a large number of SNPs were discovered together with 4 potential splice sites 
in the various cDNAs isolated (Chapter III, section 3.3.2). These findings were 
confirmed in an independent study which published the full coding sequence of the 
P. xylostella RyR [165]. Additionally, the P. xylostella RyR gene was found to be 
differentially expressed in different life stages and body parts of the moth [165, 188], 
and its expression modulated by exposure to sub-lethal doses of diamide insecticides 
[189]. Differential expression patterns of RyR mRNA were also found in 
Nilaparvata lugens and Cnaphalocrocis medinalis [170, 201]. In contrast, in the 
study reported here there were no significant changes in the expression of RyR 
mRNA in different life stages of M. persicae (Chapter III, section 3.3.1.1) and no 
splice sites or SNPs were found. It remains unclear why the fairly extensive RyR 
diversity found in other insects is not present in M. persicae, but it is possible that 
the lack of SNPs results from the asexual life cycle and clonal offspring. It is also 
unclear what the functional implications of differential splicing and modulated 
expression of insect RyRs are; it has been proposed that differential splicing 
introduces requisite functional diversity, as insects lack the specialised RyR isoforms 
found in mammals [168]. Interestingly, splicing of human RyR2 was shown 
experimentally to evoke different effects on cytosolic and nuclear Ca2+ signalling 
[195, 223]. Differential expression of RyR in some insects may be attributed to their 
biology, where the motionless egg and pupae do not require a high level of RyR 
protein [188]. Modification of RyR expression following exposure to diamides might 
be part of the insect defence mechanism, helping to protect the insect from the 
insecticide’s toxic effects [189]. 
In the present study, two insect RyRs were successfully cloned and propagated in 
different plasmid and expression vectors. The main challenge was the initial 
amplification and assembly of the very large mRNA (approx. 15Kb). The size of the 
final vector constructs also made them difficult to modify directly using methods 
such as SDM. Both of the insect RyRs show a high degree of sequence similarity at 
the protein level, but with very different cDNA profiles, with the P. xylostella having 
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significant cDNA sequence variability (SNPs, splicing) and M.  persicae in contrast 
being very conserved.  
6.2 In vitro expression of insect RyRs 
This study has reported the successful expression of the P. xylostella RyR in Sf9 cell 
lines (Chapter IV), but expression of the M. persicae RyR was not achieved. There is 
no obvious reason for this lack of expression of the aphid cDNA, since the aphid 
RyR sequence is very similar (almost 80% at the protein level) to that of P. xylostella 
and other successfully expressed insect RyRs (B. mori, D. melanogaster [30, 163]) 
and there are no obvious amino acid sequence differences in the highly conserved 
regions of the channel such as the transmembrane helixes and pore forming region 
that could impair functional expression. However, RyRs are complex proteins, with 
many accessory proteins involved in their modulation (see Chapter I, section 1.4.1); 
it is possible that the cell lines tested in this study lack essential components needed 
for successful expression of the aphid RyR. Alternatively there may be codon usage 
issues that could impair successful expression of the aphid cDNA in the cell lines. 
 During this study it became clear that although mammalian cell lines have been used 
to express insect RyRs, they are not best suited for the expression of the P. xylostella 
channel. Expression of this channel was much more robust in an insect derived Sf9 
cell line The expressed  P. xylostella RyR was shown to be sensitive to caffeine and 
flubendiamide in Ca2+ release assays, as was  seen for the B. mori RyR expressed in 
HEK293 cells [30]. However, a more detailed comparison between the two systems 
was not possible due to the exclusion of quantification of Ca2+ concentration in the 
experiments presented in this study. 
The results presented here (Chaper IV, section 4.3.5.2) also indicated that, as 
expected, the WT P. xylostella RyR is able to bind labelled ryanodine with a Kd 
value of ≈14nM, comparable to that obtained with native channels from H. virescens 
[29] but approximately 3 times higher than that obtained with native rabbit RyR1 
(≈3.4nM) [176]. This is in contrast to another study which showed that the  
ryanodine binding affinity of insect and mammalian RyRs is similar, with values 
ranging between 4.4-5.6nM for M. domestica, P, americana and mouse RyR1 [224]. 
This may be because in the present study the binding conditions for the P. xylostella 
RyR membrane preparation was not optimised and this resulted in low specific 
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binding. The differences might be also due to species-specific differences in [3H] 
ryanodine binding as reported for Homarus americanus (American lobster), M. 
domestica, A. mellifera, H. virescens and Agrotis ipsilon (black cutworm) [225]. The 
results of the ryanodine binding assays with P. xylostella RyR indicate that the 
receptor density in the Sf9 expression system is sufficient to carry out binding 
assays, and this was consistently repeatable across independent transfection 
experiments. Binding of [3H] flubendiamide to Sf9 mixed-membrane preparations 
was not determined due to the compound’s low water solubility.  
In summary, the data presented in Chapter IV shows that a good level of expression 
of one of the tested insect RyRs was achieved, giving a solid foundation for future 
optimisation of the system and a more detailed study of insect RyRs. 
6.3 Emergence of resistance to diamides, identification of the diamide binding 
site and implications for resistance management 
The results presented in Chapter V identified the first reported mutation (G4946E) in 
the RyR gene associated with a high level of resistance to both classes of diamide 
insecticides in P. xylostella. This work was published in 2012 [19]. A more detailed 
functional characterization of this mutation, by functional expression of modified 
RyRs in Sf9 cells (Chapter V, section 5.3.5), indicated a direct effect of the G4946E 
substitution on the channel’s sensitivity to diamides, thereby confirming the 
involvement of the mutation in the observed resistance phenotype. Data collected 
from Ca2+ release experiments with Sf9 cells expressing G4946E RyR demonstrated 
a lack of channel activation at high doses (10-30µM) of flubendiamide whereas a 
normal sensitivity to caffeine was retained. The Ca2+ activation effect of diamides 
was observable at a very high dose of chlorantraniliprole (100µM), indicating that 
the P. xylostella RyR mutation decreases diamide binding affinity rather than totally 
abolishing it. This has recently been confirmed by a study showing a  ≈2.5 fold shift 
in Kd for native membranes of P. xylostella with the G4946E RyR mutation, using 
labelled chlorantraniliprole in fluorescent polarization binding assays [226]. A 
complex picture of diamide binding comes from recent displacement studies using 
radiolabelled chlorantraniliprole and flubendiamide and native M. domestica RyRs, 
where it appeared that three distinct binding sites were present for flubendiamide, 
chlorantraniliprole and ryanodine respectively [28]. In a follow-up study it was 
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shown that the diamide binding sites in insect RyRs are likely to be species specific, 
with H. virescens and A. ipsilon having a single binding site for both classes of 
diamides and A. mellifera having low chlorantraniliprole binding and no 
flubendiamide binding. The mammalian (rabbit RyR1) and crustacean (H. 
americanus) RyRs showed no diamide binding, as expected [225]. 
Despite a range of studies, the location of the diamide binding site on the insect RyR 
remains elusive. Initial results from B. mori RyR, using a series of deletion mutants, 
narrowed it down to the TM region (amino acids 4111-5084) of the protein [30]. A 
recent study, using D. melanogaster / plant parasitic nematode (Meloidogyne 
incognita) chimeras, identified a small (45 amino acids) area within the TM region 
(between highly divergent residues 4610-4655) as essential for diamide binding. 
[227]. However, there is no clear evidence that these 45 amino acids, present 
between TM5 and TM6, form the actual binding site for the diamides or whether 
they have an allosteric effect. The G4946E mutation identified in the present study is 
located outside of the region identified in the chimeric D. melanogaster / M. 
incognita RyR, and much closer to the pore region. One of the possible explanations 
is that G4946E and the 45 residues form part of the binding pocket, when assembled 
into the functional channel but without the 3D structure of the RyR TM region or a 
homology model this hypothesis cannot be tested. However, mapping the location of 
the mutation and the chimeric region on to TM topology model (shown in Chapter 
V) places them on the opposite sides of the ER membrane, with the chimeric region 
facing the luminal side. Unlike in most insects and mammals, in nematodes such as 
M. incognita glycine 4946 is substituted with a serine; additionally adjacent amino 
acids are also different (see Figure 33, Chapter 5), which could be one of the 
contributing factors explaining the poor nematicidal properties of diamides [227].  
The emergence of high level resistance to diamides in P. xylostella soon after their 
introduction for the control of Lepidopteran pests emphasises the importance of 
establishing good agronomic practices and integrated pest management as part of the 
overall pest control strategy. It is well established that over reliance on a single 
compound leads to a high selection pressure and the emergence of resistance. For the 
diamides a global integrated effort from companies marketing these compounds is 
currently underway to minimize and manage the spread of resistance and to monitor 
product efficacy in the field [228]. 
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6.4 Future work 
Overall, the results presented in this study provide a good foundation for further 
characterization of insect ryanodine receptors.  
Potential areas for study are: 
• The experiments presented in Chapters III, IV and V show that expression of 
the WT and G4946E P. xylostella RyR constructs in insect cells is at 
sufficient levels to allow more detailed receptor characterization to be made. 
It was also noted that the Sf9 cells were able to divide while expressing the P. 
xylostella RyR and that they did not suffer the severe cytotoxic effect usually 
associated with unregulated expression of RyRs. Since the pIZ/V5-His 
expression vector is suitable for the isolation of stable cell lines, an attempt 
should be made to isolate cells stably expressing both WT and G4946E P. 
xylostella RyR. This would eliminate the variability in protein expression 
associated with individual transient transfection experiments.  
• In this study only a basic characterization of both WT and G4946E P. 
xylostella RyRs was possible. A more detailed study is now required 
involving (i) quantification of the released Ca2+ in the calcium release 
experiments and (ii) dose response measurements for caffeine and other 
known agonists, to identify more subtle differences between WT and 
G4946E channels.   
• The decent level of receptor density in isolated Sf9 membranes, which has 
allowed the radio ligand binding assays with [3H] ryanodine and the detection 
in artificial bilayers of ‘ryanodine-like’ channels (in mixed-membrane 
preparations), suggests that more in-depth electrophysiological experiments 
are possible. Purification of the expressed P. xylostella RyR from Sf9 cells 
should be attempted to determine the electrophysiological properties of the 
insect channels and compare them to their mammalian counterparts. The 
effects of diamide insecticides and other well-known agonists (such as 
caffeine, ryanodine) on single channel gating could also be investigated, 
bridging the knowledge gap between invertebrate and mammalian RyRs 
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• The identification and characterization of the target site mutation G4946E, 
conferring resistance to diamide insecticides in P. xylostella, will allow 
monitoring of resistance proliferation in field populations and could help in 
the identification and analysis of diamide resistant strains that may appear in 
other high risk insect species. e.g. Spodoptera exigua  and Tuta absoluta. 
There is already confirmed resistance to diamide insecticides in the leafminer 
(Liromyza trifolli) in the USA and control failures in other Lepidoptera 
including beet armyworm (Spodoptera exigua) in Indonesia, rice stem borer 
in Malaysia and shoot borers in India and the Phillipines (source: IRAC 
diamide resistance group) 
• Modification of the WT P. xylostella RyR by site-directed mutagenesis and 
analysis of different splice forms using the established expression system will 
allow the identification of structurally important parts of the channel. 
Analysis of single channels will identify dissimilarities between insect and 
mammalian RyRs and could help in understanding the specificity of diamide 
binding. 
• The Sf9 expression system could also be used to investigate insect RyR 
accessory proteins identified (by their homology to known mammalian 
accessory proteins) from available online genomic resources e.g. 
KONAGAbase. This will give information on which components are 
important in the RyR macromolecular complex in invertebrates. In turn this 
could lead to the identification of novel targets for insecticidal chemistry. 
• A well-established expression system for the P. xylostella RyR could be used 
in cellular screening assays for the discovery of novel compounds targeting 
RyRs (potential novel insecticides). 
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Appendix A: Media and buffers recipes 
1. Bacterial media recipes 
SOC medium (per 1 litre) 
Tryptone    10g 
Yeast Extract    5g 
NaCl     0.5g 
250mM KCl    10ml 
Distilled H2O    up to 1L 
Autoclave at 15 psi, 121-124°C for 15 minutes, then add 5ml of sterile 2M MgCl2 
and 20ml of sterile 1M glucose. 
LB (Luria - Bertani) medium and agar (per 1 litre) 
Tryptone    10g 
Yeast Extract    5g 
NaCl     10g 
pH adjusted to 7.0 with NaOH 
distilled H2O    up to 1 L 
Autoclave at 15 psi, 121-124°C for 15 minutes. 
To make LB agar add 15g of Bacto-agar before autoclaving. 
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2. Calcium phosphate transfection solutions 
2x HEPES (500ml) 
NaCl (280mM)     8.18g 
KCl (10 mM)     0.373g 
Na2HPO4 x7H2O(1.5 – 1.8 mM)  0.201 g -0.241g 
Glucose (12mM)    1.08 g 
HEPES (50mM)   5.96 g 
pH 6.95 – 7.05  
Make up to a final volume of 500 ml with DIW 
Solution filtered through a 0.2µm sterile filter and stored at RT in a sterile sealed 
50ml tube. 
3. Hypo-osmotic buffer (per 1 litre) 
Tris (20 mM)    2.42g 
EDTA  (1 mM)   0.29g 
H2O (double distilled)   900ml 
pH to 7.4 with HCl and top up to 1l with double distilled H2O. Before use add 1 
protease inhibitor (EDTA free) tablet per 50ml of buffer. 
4. Western blots gel/buffers 
Resolving gel 5% (20ml): 
DIW water    12.16ml 
40% (w/v) Acrylamide  2.5ml 
1.5M Tris pH 8.8   5ml 
10% (w/v) SDS   160µl 
10% (v/v)APS    160µl 
TEMED    20µl 
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Stacking gel (6.675ml): 
DIW water    4.73ml 
40% (w/v) Acrylamide  583µl 
0.5M Tris pH 6.8   1.25ml 
10% (w/v) SDS   50µl 
10%(v/v) APS    50µl 
TEMED    8.3µl 
TBS-T(Tris buffered saline (TBS) x1 (per 1 litre): 
Tris (20 mM)    2.42g 
NaCl (137 mM)   7.99g 
0.1% (v/v) Tween-20  
H2O (double distilled)   900ml  
pH to 7.6 with HCl and adjust volume to 1l with double distilled H2O 
5.  [3H] Ryanodine binding assay buffers 
5.1 Filter disc assay binding buffer (per 1litre) 
KCl (1M)    74.55g 
PIPES (25mM)   7.56g 
1M CaCl2 (100 µM)   100µl 
H2O (double distilled)   900ml 
pH to 7.4 with KOH and adjust volume to 1l with double distilled H2O 
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5.2 96 well filter plate assay buffers 
Buffer A (per 250ml) 
Tris (20mM)    0.606 g 
Sucrose (0.3M)   25.67g 
DTT (1mM)    0.0385g 
BSA (0.8%)    2g 
H2O (double distilled)   200ml 
pH to 7.4 with HCl and adjust volume to 250ml with double distilled H2O 
Buffer B (per 1 litre) 
HEPES (10mM)   2.383g 
CaCl2x2H2O (1.38mM)  0.203g 
ATP (10mM)    5.511g 
KCl (1.5M)    111,83g 
H2O (double distilled)   900ml 
pH to 7.4 with KOH and adjust volume to 1 litre with double distilled H2O 
Wash buffer (per 1 litre)  
HEPES (10mM)   2.383g 
KCl (150mM)    11.18g 
H2O (double distilled)   900ml 
pH to 7.4 with KOH and adjust volume to 1 litre with double distilled H2O 
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6. Solubilisation and gradient buffers 
Solubilisation buffer (per 250ml) 
NaCl (final conc. 1M)   14.61g 
1M CaCl2 (final conc. 0.15 mM) 0.0375ml 
EGTA (final conc. 0.1 mM)  0.0095g 
NaPIPES (final conc. 25 mM) 1.89g  
pH to 7.4 with NaOH  and adjust volume to 250ml with double distilled water. Add 
1 (EDTA free) protease inhibitor tablet per 20ml. 
Gradient buffer (per 100ml) 
2.5 M NaCl    11.96ml 
1 M/ 2M Tris/HEPES   2.49ml 
 0.1 M EGTA     300μl 
 1 M CaCl2     10μl 
 10 % (w/v) CHAPS/PC   3ml 
 H2O (double distilled)  82.24ml 
Add 1 EDTA free protease inhibitor tablet per 25ml 
7. Electrophoresis buffers 
TAE x 50 agarose gel electrophoresis buffer (per 500ml) 
Tris base    121g 
Acetic acid    28.5ml 
EDTA 0.5M    50ml 
Adjust pH  to 7.4 with acetic acid.  Make up to 500 ml with DIW water. 
 
To make 1x TAE buffer, take 20 ml of 50X stock and dilute to 1 litre with double 
distilled H2O. 
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8. Calcium imaging solutions 
Standard Ringer’s solution (per 1l) 
150mM NaCl     8.76g 
4mM KCl     0.29g 
2mM MgCl2    0.19g 
2mM CaCl2    0.22g 
10mM HEPES   2.38g 
H2O (double distilled)   900ml 
pH to 3 (with NaOH) and adjust volume to 1 litre with double distilled H2O. Pass 
through a 0.22µm filter to sterilize.  
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Appendix B: Vector maps 
1. pCR-XL-TOPO 
 
2. pJET1.2 
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3. pcDNA3.1(-) 
 
 
4. pIZ/V5-His 
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Appendix C: Primer sequences  
1. Vector and eGFP tag specific primers 
Vector/tag Primer name Sequence 5’-3’ Description 
pCR-XL-
TOPO 
M13(-20) F GTAAAACGACGGCCAGT 
Sequencing 
M13(-24) R AACAGCTATGACCATG 
pJET1.2 
blunt 
pJET 1.2 F CGACTCACTATAGGGAGAGCGGC 
pJET 1.2 R AAGAACATCGATTTTCCATGGCAG 
pcDNA3.1 
T7 universal 
primer 
TAATACGACTCACTATAGGG 
BGH R TAGAAGGCACAGTCGAGG 
pcDNA-CMV F GGCCAGATATACGCGTTGACATTG Promoter 
amplification pcDNA-CMV R CAGCTCTGCTTATATAGACCTCCCA 
pIZ/V5-
His 
pIZ/His-NruI 
SDM-F 
CCCTCTCCTCGGTCGCGATTCTACGCG
TACC  Mutagenesis 
primers (NruI) pIZ/His-NruI 
SDM-R  
GGTACGCGTAGAATCGCGACCGAGGA
GAGGG 
Piz-gfp-stop-R CTAGACTCGAGCGGCCTATCTTGTACA
GCTCG Mutagenesis for 
pIZ eGFP control Piz-gfp-stop-F CGAGCTGTACAAGATAGGCCGCTCGA
GTCTAG 
GFP tag 
eGFP -F GGTAGGCGTGTACGGTGGGAGG 
GFP cloning 
cassette eGFP -R GCGGCCGCTCTTGTACAGCTCGTCCAT
GCC 
GFPseq-F GGCATCAAGGTGAACTTCAAGATCCG
C GFP sequencing 
GFPseq-R CCGGTGGTGCAGATGAACTTCAGG 
eGFP-EcoRI -F GAATTCAAAATGGTGAGCAAGGGCGA
GG 
GFP pIZ cassette 
 
2. M. persicae RyR sequencing primers 
Cloning 
fragment Primer name Sequence 5’-3’ 
N6Kb 
N1-F1,2 GGAACAGGACGATGTCTCGTTTCTC 
N3-R2 GGTATTGTCAAACACTCGTCGCCG 
N6F SEQ1 GGCGACGAGTGTTTGACAATACCG 
N6F SEQ2 CATGTAAGTGGATCTGCTGTTTATAG 
N6F SEQ3 CGAGGTTATTCAGATGATCCTGTTG 
N6R SEQ4 GCCCACTGATGTGGTCTTAAACATTG 
N6R SEQ5 GGGAACATGTGAACCTGGCCC 
N6R SEQ6 GTGATAATGTTAACTTTATCAATGGC 
Mz.N3f TACCAGCTGGTTCAGATACACCACC 
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Mz.N1r ATGCGGGACGGTGGATTATCAATAG 
Mz.N2r GGTACAAATCCTTCTCCTTGGACTTC 
Mz.N4r GCACTAACACTGTGCTGTCACCATAC 
Mz.N5r GCCCACATTTCGTGAATATTCTCTGC 
N6F SEQ7 GCGTGCTCACGGGTCCATGG   
N4KbR 2 CATGCCTCGATAATGACCCCTTTCGTG 
N2KbR 21 GCCCATCCAATGCGAATGTGCGGAT 
N6F SEQ8 CCAAATAAGAGTTTCACAAATGG 
N6Kb/LNK1 Mz.NL1f TAGAGTCCCATGCCACAACAATGGAGG 
LNK1 
Mz.L1r GAAGCTCCGTATATTCCTTGACCTCC 
Mz.L1F-1 GAGTTCCGATGTCCACCTCGAGAAC 
LNK1 seq1R GCATTTGGCTAGTTAATGCCACC 
LNK1 seq3F GGAAGGAGAGCTCAAGCCCAATCAC 
Mz.L1F-2 TACGCAGGCCTGAATGTTTGG 
LNK2 
Mz.L2r CGTTTCAAGAGTGGGCATAGTGCCTTCC 
Mz.L2F-3 GGGTACATTTAGCAGGCGTTCTAG 
Mz.L2F-2 CCATTCTTACCACTTGCGGAACGAG 
LNK2 seq3F GGTCGCTAGTTTATTTTGTAAGTTAGC 
L2 seq1R CGTAACCAGTGATTGCGTTGAAG 
L2 seq2F CTGCGCCCAAGACACTTGAAGC 
LNK2/C4Kb Mz.LC1f CAAGCATCATTGATGGTTGCTTGTC 
C4Kb 
Mz.C4f GCCAACCGTGGTGTCGCAGAAATGG 
Mz.C4r GTCAATTAGCTCTTTGCTCGAATAATGCC 
C1-F2 GCTGGGGTCACAATCACAGACAACG 
C1-R1,2 CGGAAACAGTCTCCCACTGGGAAGA 
C4F SEQ1 CGGAGGGTTTAGGAGTAGGATCGG 
C4F SEQ2 GTTGACTAACCTATCAGAACACATGC 
C4R SEQ3 GTTGCATGAGAATACGAGATATATACC 
C4F SEQ4 CGCATACACGCACCGTGCATTGAG 
C4R SEQ5 CAAGAGCAAGACGGTCAATACCAGC 
C4F SEQ6 CCCAACAATGATGGTTGGGTACATCC 
C3KbF 2 GACACAAGCAGGAAATACCACGACTGT 
C2KbF 21 CCCATTCGAAGAGGTATACAGGCCA 
1Used in colony PCRs, 2Primers found in DuPont patent 
3. M. persicae RyR mutagenesis and cloning cassette primers 
Primer name Sequence 5’-3’ Description 
Mz.Afe-SDM-F GTGTTTTTGTCATTGAACAAGCGCTATCTGTGAGGG
CTTTACAAG 
Introduction 
of AfeI site 
Mz.Afe-SDM-R CCCTCACAGATAGCGCTTGTTCAATGACAAAAACAC
ACTG 
Mz.N12-F TCAGCAAGATACGATGGCCGACAGCGAGG Removal of 
additional 
START codon 
Mz.N12-R GCTGTCGGCCATCGTATCTTGCTGAAAAACTC 
Mz.Eco-F GCCAGAAGATTAGAGTTCGACGGCCTCTACATTG Removal of 
EcoRI site Mz.Eco-R GAGGCCGTCGAACTCTAATCTTCTGGCAATTTC 
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Mz.mutdel-F GATGTAATTTTGCCGGTTTTGTCATCACTTTTTGATG
ATTTAGC 
Removal of 
PCR error 
Mz.mutdel-R GCTAAATCATCAAAAAGTGATGACAAAACCGGCAA
AATTACATC 
Mz.Kozak1-F TCAGCAAGATACCATGGCCGACAGCGAGGGC Introduction 
of  Kozak seq. Mz.Kozak1-R GCCCTCGCTGTCGGCCATGGTATCTTGCTGAAAAAC
TC 
Mz.NotI-F CAGCGGCCGCATGGCCGACAGCGAGGGCAGTTCG Amplification 
of Afe cassette Mz.AfeI-R CACAGATAGCGCTTGTTCAATGACA 
 
4. P. xylostella RyR sequencing primers 
Cloning 
fragment Primer name Sequence 5’-3’ Description 
N7Kb Px.N1f GCGACGTGTTGCGTTTCTTCCACG
G Amplification 
primers Px.M1R CAGCAGCCGGATCACCAGGTTCG
C   
 Px.Nseq3R CCATCACGTTCTCGTGGACGCGGA
GG 
Sequencing 
primers 
Px.Nseq1f GGACCTCATCAACTACTTCGCGCA
GC 
Px.N3f TGGCTACGTCCCATACCCAGGG 
Px.N3rB GGTCCGACTGTTTGATCTCTACGT
AAC 
Px.N4R CCATGGTGGTGGCGTGCGACTCTA
GATGC 
Px.N-4Fa GGCTGGATGTACGGCGAGCATCG 
Px.N-4Fb GGCAACGGAGTGGGCGACGATC 
Px.N-5R1 CCGTGGAACTTCGACCGGCACT 
Px.N-5Fa GAACAGCTCCGAGTCGTTCGGC 
Px.N-5Fb CTCCGGCAAGTGGTACTTCGAG 
Px.N2f1 GGTGTGCCTGTCCTGCACGGCCAC
G 
N7Kb/M2 Px.M2-seq1f GCTGTCGCGGCCATCTTTAAGAGG Additional  
seq. primers  
Px.M2-seq2r TCGTTGTTTAGAGCCACTGAAGAC
G 
C7Kb Px.M1f GAACCTGGTGATCCGGCTGCTGAT
CC Amplification 
primers P.C2 R GCTCCGCAATGTACAGACCGTCA
AACTC 
 Px.Cterm-seq1F GGCTTCTGCGACCGCTTCCACGAG 
Sequencing 
primers 
Px.Cterm-seq2F GACGGAGGCAGCGGTGAAGAAGA
CG 
Px.Cterm-seq3F CCGTCGGGCTGAACCTGTTCGC 
Px.Cterm-seq4F CCGACGTCCGCATCACAGTCCG 
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Px.Mseq1F CGAATGTTAACCAAGGGTCAACG
TG 
Px.Cseq2R CGAAGCCGACACCGCCATCTGC 
Px.Cseq-5F TGGACGAGATCCAAGTGGCGTCG 
Px.Cseq-3f CGAGTGCTTGGACAGCTTGTCCTG
C 
Px.Mseq2F GTCGAGCACTCTGAAGTGGACAT
CC 
Px.Mseq3f CTCGACTCATCGAACTACTTCATA
GC 
Px.Cseq5r GGTCGCAGAAGCCGATGTAGTCC 
Px.C5r CTTGTCTTTGAGATGATTCAGCAT
ACCC 
Px.C5f CCGTTGGCTGAGAGGGTCAGG 
G4946E 
region 
Plut.Mut1-F CCTGTACTCTCTGTGGTACTTCTC
G 
Amplification/  
Sequencing 
 
5. P. xylostella mutagenesis and modification primers 
Cloning 
fragment Primer name Sequence 5’-3’ Description 
Nterm Px.mut (T-S) F CCTGAAGGATACTCGCCGCTAGTCGAG 
Correction of 
potential 
PCR errors 
Px.mut(T-S) R CTCGACTAGCGGCGAGTATCCTTCAGG 
M2 
Px.mut(H-Y) F CCAGACAACCCTCAGTACAACCCACAACCCATC 
Px.Mut(H-Y) R GATGGGTTGTGGGTTGTACTGAGGGTTGTCTGG 
Cterm 
Px.mut(I-M) F CTTGTCCGAGCACATGCCCAACGAACCCAG 
Px.mut(I-M) R CTGGGTTCGTTGGGCATGTGCTCGGACAAG 
M2 
Px.M2pvu-
SDM-f 
CAAGCCTGGTGCGATCGGCAAGCTGTA
CAAC Introduction 
of PvuI site Px.M2pvu-
SDM-R 
GTTGTACAGCTTGCCGATCGCACCAGG
CTTG 
N term 
Px.NO-tag-F GCCACCATGGCGGAAGCGGAAGGGG 
for the 
untagged 
construct 
Px.NotI -F CAGCGGCCGCATGGCGGAAGCGGAAGGG 
For the 
eGFP 
fusion 
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